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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
TO OUR NEW SUBSCRIBERS—  
WELCOME
With this issue, the Canadian Journal of 
Surgery assumes a new role. Henceforward, 
the Journal will be distributed to all Fellows 
of the Royal College in the Division of 
Surgery (and any other Fellows of the Col­
lege who may wish to receive it). The deci­
sion to do so is the outcome of several years’ 
activity by the Editorial Board of the Jour­
nal, the Canadian Medical Association 
Publications Committee, and the Royal Col­
lege of Physicians and Surgeons of Canada.
The Journal was founded in 1957 by Dr. 
Robert Janes as an organ for the publication 
of the results of Canadian surgical research, 
clinical and basic scientific observations 
and case reports. It has served this function 
with success during the past 17 years. With 
this issue, however, it accepts a new and 
somewhat different responsibility, the obliga­
tion to become an agent of continuing educa­
tion for all surgeons in Canada.
In May 1971, an executive committee of 
the Journal suggested to the Royal College 
that the Canadian Journal of Surgery become 
the official scientific organ of the surgeons 
of the College. The advantages of this ar­
rangement seemed to be manifold. Chiefly, 
it would further postgraduate surgical educa­
tion, provide a medium for the presentation 
of original surgical work to a larger audience, 
and act as a stimulus for the production 
of material of sufficiently high quality to sa­
tisfy the standards of the Editorial Board. At 
the annual meeting of the Editorial Board in 
1972 it was agreed that negotiations with 
the Royal College be carried further. Ac­
cordingly, the subject was explored at a
special meeting in June 1972 between rep­
resentatives of the Canadian Medical Asso­
ciation and the Royal College of Physicians 
and Surgeons, and at this time the following 
positions were agreed upon:
(1 ) The provision of professional or spe­
cialty journals is a function of the College.
(2 ) The survival of the Canadian Journal 
of Surgery with a change in editorial policy 
is important and should be ensured.
(3 ) A Canadian journal of clinical inves­
tigation is highly desirable.
(4 ) There is a need for a central publish­
ing agency in Canada to serve these needs.
Subsequently, a task force established by 
the Editorial Board at its January 1973 
meeting concluded that “affiliation of the 
Journal with a surgical society . . .  is essen­
tial, and the Royal College . . .  is the obvious 
choice.” The recommendation, supported 
by the Publications Committee of the Cana­
dian Medical Association, was then pre­
sented to the Publications Committee of the 
Royal College and its Executive and Coun­
cil. Early in January 1974, a meeting be­
tween the two organizations resulted in con­
currence that a joint advisory board be 
established with representation from both 
the College and the C.M.A. and with the Co­
editors as ex officio members. Responsibility 
for the editorial content is to be vested in 
an Editorial Board appointed by the Royal 
College of Physicians and Surgeons. This 
board is to be charged with maintaining a 
balance that assures the continuation of the 
bilingual nature of the publication and rep­
resentation of all aspects of Canadian sur­
gery. The new objectives of the Journal 
may be summarized as follows: (1 ) to serve 
in the effective continuing education of the
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Canadian surgical fellowship; (2) to provide 
the Canadian surgical fraternity with an ef­
fective vehicle for the dissemination of their 
clinical and scientific observations; and (3) 
to contribute to the extension and upgrading 
of the international image of Canadian sur­
gery. The Canadian Medical Association will 
continue to publish the Journal and be re­
sponsible for the business aspects of the 
operation.
Your Co-editors are pleased to accept the 
charge to move the Journal into new func­
tions in the Canadian surgical scene. We
hope that our new subscribers will find this 
journal attractive and informative and will, 
whenever they have the inclination, use it 
as a medium for the expression of ideas, 
convictions and concern. The editors invite 
contributions to the section Quill on Scalpel 
as well as correspondence relating to pub­
lished material on matters of general inter­
est to surgeons. We welcome you to our 
list of readers.
L. D. MacLean 
C. B. Mueller
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SURGICAL TECHNIQUE FOR TOTAL ARTIFICIAL HEART 
REPLACEMENT IN CALVES*
T. NISHIZAWA, D . T. MORRIS, M.Sc.[Eng.], Ph.D .t and
C. M. COUVES, M.D., F.R.C.S.fEdin. & C], F.A.C.S.,1 
Edmonton, Alta.
Summary: We have developed a standardized 
method of replacing the heart with an artificial 
device and have applied it to 43 orthotopic heart 
replacements in experimental animals.
The procedure was developed for the implan­
tation of air-powered hearts of our own design 
into 80-kg calves. Usually cardiopulmonary by­
pass was employed but occasionally we used a 
method utilizing deep hypothermia. Under halo- 
thane anesthesia the resected natural heart was 
replaced with the prosthesis by anastomoses to 
remnants of the atria and great vessels. After 
priming, the artificial heart was started and ad­
justed to provide normal blood flow and heart 
rate. Postoperatively vital signs and functions 
were monitored.
Our procedure, once standardized, has allowed 
us to support the circulation completely for 
periods up to 33 hours.
Resume: IMous avons mis au point une techni­
que standardisee pour remplacer le coeur par un 
dispositif artificiel et I'avons appliquee dans 43 
cas de remplacement orthotopique du coeur 
chez des animaux d'experience.
Cette methode a ete mise au point pour I'im- 
plantation de coeurs artificiels b I'air compri- 
me (dispositif de notre invention) chez des 
veaux de 80 kg. Nous avons eu surtout recours 
a la derivation cardiopulmonaire, mais nous 
avons parfois utilise la methode d'hypothermie 
profonde. Sous anesthesie a I'halothane, nous 
avons remplace le coeur naturel reseque par la 
prothese, en anastomosant I'appareil avec les 
moignons des oreillettes et des gros vaisseaux. 
Une fois la circulation amorcee, et le coeur 
artificiel mis en marche, on proceda au reglage 
de la circulation et du rythme cardiaque. Apres
♦From the Department of Surgery and the Sur­
gical Medical Research Institute, The University 
of Alberta, Edmonton, Alta.
Supported by a grant from the Alberta Heart 
Foundation.
tPresident, Bio-Medical Engineering Services Ltd., 
Edmonton.
tProfessor and Chairman, Department of Surgery, 
Memorial University of Newfoundland, St. lohn’s, 
Nfld.
Reprint requests to: Dr. D. T. Morris, Bio-Med­
ical Engineering Services Ltd., 14710-112th Ave­
nue, Edmonton, Alta. T5M 2T9.
la transplantation, on surveilla les signes vitaux 
et les fonctions organiques.
Notre procede, une fois standardise, nous a 
permis de soutenir integralement la circulation 
pendant des periodes allant jusqu'a 33 heures.
The development of a total artificial heart 
capable of supporting the circulation in man 
for long periods remains a challenge.1’4 
Although the surgical technique required for 
the insertion of such a device is not the 
main limiting factor at the moment, it is 
essential to have a standardized, uncom­
plicated method of replacing the heart with 
an artificial device. This paper describes our 
method of inserting the total artificial heart 
in calves.
M a t e r ia l s  a n d  M e t h o d s
Artificial Heart
The prosthetic heart we have devised has 
been described previously.3’ 5- 6 Both sac- 
type and diaphragm-type air-driven artificial 
hearts were used as replacements for the 
natural heart in animals (Figs. 1 and 2).
Animal and Preoperative Preparation
Calves weighing between 65 and 90 kg 
were fasted except for water and milk for 
48 hours before operation. Penicillin G 
(KaPen, Pfizer), two million units, was given 
intramuscularly on alternate days for one 
week before the experiment. Blood for 
transfusion was obtained from a local 
slaughterhouse and stored in ACD contain­
ers (anticoagulant citrate phosphate dex­
trose solution) to which one million units of 
penicillin per litre of blood was added. Tri- 
flupromazine, 0.2 mg/kg, and atropine, 
0.02 mg/kg, were given intramuscularly to 
the animal for premedication.
Anesthesia
Thirty minutes after premedication anes­
thesia was induced with halothane. A  
conical face mask and partial rebreathing 
system with 2% to 3% halothane and 7 to
262 THE C A N A D IA N  JO U R NA L OF SU RG ER Y Vol. 17
10 1/min of oxygen were used. The animal 
was then placed on its back on the operat­
ing table and an endotracheal tube inserted. 
Before the chest was opened, anesthesia 
was maintained with 0.1% to 1.5% halo- 
thane with spontaneous respiration. Once 
the chest was opened, the lungs were me­
chanically ventilated by an Engstrom res­
pirator model 200. The tidal volume was 
set at 750 ml with a respiratory rate of 18 
to 20/min.
Fig. 1.—The latest diaphragm-type artificial 
heart is powered by an extracorporeal supply 
of compressed air. Each ventricle can pump 8 1 
at 95 beats per minute. Ventricle valve holders 
and arterial connectors are all lined with Silastic.
Fig. 2.—Each side of the artificial heart is 
separate and weighs 135 g. Dacron graft arteries 
and atria simplify anastomosis to the natural 
vessels.
Establishment of Cardiopulmonary
Bypass
The surgical field was shaved, washed 
with 3% hexachlorophene and painted with 
10% providone-iodine NF. The left ex­
ternal jugular vein and carotid artery were 
exposed for later insertion of cardiopul­
monary bypass cannulas. The left subsca­
pular artery and vein were exposed and 
used for arterial pressure monitoring and 
for an infusion line. The chest was entered 
through a midline sternotomy. Tapes were 
passed around the superior vena cava, in­
ferior vena cava, azygous vein, hemiazygous 
vein, pulmonary artery and the aorta. He­
parin, 4 mg/kg, was given intravenously 
before insertion of the venous cannulas. A 
no. 28 Bardic catheter was inserted into the 
left external jugular vein and positioned in 
the superior vena cava. A no. 40 Bardic 
catheter was inserted into the inferior vena 
cava through the right atrial appendage. A 
no. 20 Bardic catheter placed in the left 
common carotid artery was used for arterial 
inflow.
A Bentley or a Travenol adult disposable 
oxygenator with a Sarns roller pump was 
used for cardiopulmonary bypass (Fig. 3). 
The oxygenator and circuit were primed 
with 1,500 to 2,000 ml of either 5% dex­
trose in water or Ringer’s solution providing 
a hemodilution factor of 16% to 21%. 
Flow rates of approximately 60 ml/kg/min 
were achieved. The total bypass time was 
between 60 and 90 minutes. During cardio­
pulmonary bypass the lungs were manually 
inflated with a pressure of 30 cm H 26  
every 10 minutes. Ventilation was reinsti­
tuted with 100% oxygen about five min-
Fig. 3 •—The cardiopulmonary bypass technique 
was used for 40 out of 43 implantations.
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utes before the start of artificial heart 
pumping.
Hypothermia as an Alternative to
Cardiopulmonary Bypass
Thirty minutes after premedication with 
triflupromazine, 0.3 mg/kg and atropine, 
0.015 mg/kg, halothane was used for in­
duction and intubation. The anesthetic level 
was maintained at the third stage of anes­
thesia during cooling. Catheters for arterial 
and venous pressure monitoring, blood sam­
pling and fluid administration were inserted 
through the femoral vessels. Electrodes for 
electrocardiogram and electroencephalo­
gram and thermister probes for mid-eso­
phageal and mid-rectal temperatures were 
positioned. The animal was then immersed 
in a tub with ice and water in the kneeling 
position. Rheomacrodex 10% (low-molecu- 
lar-weight dextran), 10 ml/kg, was given 
intravenously during the cooling period 
when the rectal temperatures were between 
35° and 28° C. At 28° C rectal tempera­
ture, triflupromazine, 0.3 mg/kg, and he­
parin, 1 mg/kg, were given intravenously. 
After the body temperature had fallen be- 
Iqw 28° C the animal was ventilated manu­
ally and halothane was decreased to 0.3% 
to 0.5%. Cooling was terminated at 
a rectal temperature between 24° and
Fig. 4.—The ventricles are resected at the atrio­
ventricular groove and the arteries are divided 
close to the ventricles.
21° C. The animal was hyperventilated to 
produce respiratory alkalosis prior to cir­
culatory arrest. After termination of cool­
ing the body temperature usually drifted 
down to between 18° and 20° C. Circu­
latory arrest time was approximately 50 
minutes. About one minute before begin­
ning artificial heart pumping, the animal 
was mechanically ventilated at about 4/min. 
After completion of the surgical procedure 
the animal was placed in a tub of water at 
42° C in the kneeling position. Hyperventi­
lation was employed during rewarming but 
correction of acid-base imbalance was gen­
erally not necessary. Rewarming was ter­
minated at a rectal temperature between 35° 
and 37° C.
Resection of the Natural Heart
After blood flow to and from the heart 
was interrupted by occluding the vessels 
with pieces of umbilical tape passed through 
Tygon tourniquets, the apex of the heart 
was grasped by a large Kocher’s forceps. 
The left and right ventricles were incised at 
the apex, and the blood in both ventricles 
was aspirated. Most of the ventricular muscle 
was quickly excised. The pulmonary artery 
was divided near the pulmonary valve. The 
remaining ventricular muscle and fatty 
tissue was carefully excised along the atrio­
ventricular groove. The aorta was then tran­
sected near the aortic valve, care being tak­
en to separate gently the aorta from the 
right atrium (Fig. 4).
Insertion of the Artificial Heart
The atrial cuffs, which were separate 
from the ventricles, were inverted into the 
atria. The rims of the natural atria and the 
cuffs were then held together with four or 
five Allis forceps, and sutured in a continu­
ous manner with 000 Mersilene (Fig. 5). 
After completion of the right and then the 
left anastomosis, four flaps attached to the 
free edge of each atrial cuff were grasped 
by forceps and pulled upwards, everting the 
cuffs into a normal position. The ventricles 
and the atria were connected by wiring the 
atrial cuffs over the ventricular valve sup­
porters (Fig. 6). The artificial and natural 
aortas were connected by tying the vessels 
over a rigid aluminum connector (Fig. 7). 
The pulmonary artery connection was ac-
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complished in a similar fashion. The driving 
lines were passed through stab incisions in 
the chest wall and attached to the driving 
system of the artificial heart.
Priming and Pumping with the
Artificial Heart
After the anastomosis was complete, the 
lines to the atrial pressure transducers were 
used for priming the heart with ACD blood 
(Fig. 8). The air vents placed at the upper 
parts of each artificial ventricle were closed 
after the artificial heart was completely 
primed and all air evacuated. As soon as 
both ventricles were fully primed, the tour­
niquets around the veins were released and 
the aortic clamp was removed. Pumping of 
the artificial left ventricle was begun first
Fig. 6.—Each atrial cuff is wired over a ven­
tricular valve holder.
with a rate of 30/min and a stroke volume 
of about 50 ml. The right atrial pressure 
was maintained above 0 mm Hg to avoid the 
aspiration of air through the anastomosis. 
The superior vena caval catheter was 
clamped and the pulmonary artery clamp 
was completely released. The pump pressure 
and frequency were gradually increased as 
cardiopulmonary bypass flow was reduced. 
Finally, the inferior vena caval catheter was 
clamped to increase the right atrial pressure. 
Residual fluid in the cardiopulmonary by­
pass circuit was gradually infused into the 
animal until an arterial mean pressure of 
70 to 100 mm Hg could be maintained or 
the right and left atrial pressures remained 
above 0 mm Hg (Fig. 9). After the animal’s 
condition was stabilized and further blood
Fig. 7 .—The natural arteries are pulled over the 
connectors and secured with umbilical tape.
Fig. 8.—After the ventricles have been primed 
with blood via atrial pressure lines, pumping at 
a slow rate with a low driving pressure is initiated.
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transfusion was not required, the venous 
and arterial lines of the cardiopulmonary 
bypass were removed.
Postoperative Treatment
Protamine sulfate was given intravenously 
in a dose of 6 mg/kg or until the whole- 
blood clotting time returned to between 
eight and 12 minutes. Chest tubes were in­
serted into both pleural spaces and con­
nected to chest suction. The halves of the 
sternum were approximated with stainless- 
steel wire sutures and the chest wall was 
closed in two layers. The animal was trans­
ferred to a specially constructed mobile cage 
in the kneeling position (Fig. 10). Res­
piratory assistance was continued to main-
Fig. 9 . - When a mean arterial pressure of 70 
to 100 mm Hg is reached at about 90 beats per 
minute, all pressure lines are removed from the 
heart and the chest is closed.
Fig. 10.—In this special cage the calf is re­
strained only by head bars and can stand up at 
will. This calf is breathing spontaneously during 
the second postoperative day.
tain acceptable levels of arterial oxygen 
saturation. Intravenous fluids and blood 
were given to the animal as occasion de­
manded.
Vital signs were carefully observed. 
Urine output, systemic arterial, pulmonary 
arterial, right atrial, left atrial and central 
venous pressures were continuously moni­
tored. Arterial and venous blood gas, rou­
tine hematology and blood chemistry 
examinations were also monitored in the 
postoperative phase.
C o m m en t
A few critical points of technique are: 
(1) careful resection of ventricular muscle 
along the atrioventricular groove; (2) re­
section of the pulmonary artery before 
division of the aorta; (3) careful transection 
of the aorta to avoid damaging the right 
atrium; (4) careful closure of the sternum 
to avoid dehiscence; (5) careful planning 
of the initiation of pumping. The left ven­
tricle is started first with a small stroke 
volume and slow rate; once stabilization has 
occurred, the right ventricle is started and 
weaning from cardiopulmonary bypass is 
easily accomplished.
Sum m ary
We have developed an uncomplicated 
surgical procedure for orthotopic total arti­
ficial heart transplantation in calves. Our 
procedure can utilize either cardiopulmonary 
bypass or deep hypothermia. Forty-three 
implantations by these methods have led to 
routine survival for up to 33 hours.
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GIANT CELL TUMOUR OF DISTAL RADIUS REPLACED
BY MASSIVE
FIBULAR AUTOGRAFT: A CASE REPORT
S. M. PARKER, M.D., D. E. HASTINGS, M.D., F.R.C.SJC] and 
V. L. FORNASIER, M.D., Toronto, Ont.
Summary: The authors present a case of giant 
cell tumour of the distal radius replaced by 
massive fibular autograft. Recurrence rates for 
giant cell tumours treated by curettage and bone 
grafting are extremely high. Complete excision 
of the tumour is the procedure of choice.
Resume: Les auteurs presenter^ un cas de 
tumeur a cellules geantes du radius distal qui a 
ete remplacee par une homeogreffe peroniere 
massive. On sait que les tumeurs a cellules 
geantes qui sont traitees par simple curetage ou 
par greffe osseuse sont sujettes a des recidives 
tres frequentes. Le traitement par excellence 
consiste a exciser completement la tumeur.
Reprint requests to: Dr. D. E. Hastings, Ortho­
paedic Office, The Wellesley Hospital, 160 Wel­
lesley Street East, Toronto, Ont. M4Y 1J3.
R e c u r r e n c e  rates of up to 70% for giant 
cell tumours of bone treated by curettage 
and bone grafting have been reported.1 In 
1965 Wilson and Lance,2 in a series of 32 
primary tumours of bone, reported 13 giant 
cell tumours of which four were situated in 
the distal radius. Three of these were treated 
with curettage and bone grafting and all 
recurred; in one the procedure was repeated 
before resorting to resection of the tumour 
and reconstruction with iliac bone graft and 
wrist fusion; two eventually required ampu­
tation for recurrence of the tumour. Com­
plete excision of the tumour offers the best 
chance for cure but presents significant 
reconstructive problems.
F'g- 1 -—Ca) Anteroposterior and (b) lateral radiographs of the left distal radius showing an expansile 
lesion with a trabecular pattern extending up to the articular surface of the radius.
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Case R eport
A 19-year-old housewife was admitted to 
the Wellesley Hospital, Toronto, in August 
1971 with an 18-month history of left wrist 
pain aggravated by motion and a rapidly en­
larging mass of four months’ duration.
She appeared a healthy young woman, who 
was four months pregnant. At the left wrist 
there was a firm, tender, fusiform swelling of
Fig. 2.—Lateral radiograph of the left forearm 
18 months after operation showing replacement of 
the distal radius by fibular autograft.
the distal radius. Movement of the wrist was 
as follows: dorsiflexion 15°, volar flexion 35°, 
pronation 30° and supination 80°.
Laboratory investigation and chest radio­
graphs were normal. Radiographs of her left 
wrist (Fig. 1) showed an expanding lesion with 
a thin trabecular pattern in the distal radius, 
which crossed the epiphysis and extended to 
the articular surface of the radius. This ap­
pearance was characteristic of a giant cell tu­
mour.
The distal radius was excised en bloc with­
out previous biopsy. This was done through 
a midline dorsal incision, reflecting the ex­
tensor retinaculum and its tendons in an ulnar 
direction. A separate incision was made in the 
sheath of extensor pollicis brevis and abductor 
pollicis longus. The inferior radioulnar joint 
was divided and the distal 8 cm of the radius 
excised with a lVi-cm length of healthy bone 
proximally.
Ten centimetres of the proximal left fibula 
was removed. The fibular autograft was cut to 
the same length as the excised radius. How­
ever, it was necessary to add another 6 mm in 
length to obtain appropriate tension on the 
carpus. The graft was secured to the distal 
radius with a seven-hole AO plate. The distal 
end of the ulna was stabilized by suturing the 
extensor retinaculum to the periosteum on the 
dorsal aspect of the fibula and dorsal aspect 
of the carpus. This also covered the plate. The 
overall stability following the soft tissue repair 
appeared satisfactory.
After the operation a long-arm plaster was 
applied for six weeks and a forearm plaster 
for a further six. At three months the patient 
was fitted with a moulded forearm support to 
protect her graft. Radiographs of her forearm 
at 18 months (Fig. 2) suggested that union be­
tween the fibula and proximal radius had be­
gun. Eighteen months after reconstruction she 
had 10° of dorsiflexion, 20° of palmar flexion, 
nearly full pronation and 20° of supination. 
She was free of pain.
D iscussion
Starr,3 in 1945, was the first to describe 
the fibular autograft. This was for the treat­
ment of congenital absence of the radius 
and he refers to earlier cases where it had 
been used as replacement for distal radius 
resected because of tumour. In 1952 Law- 
son4 described a case of fibular transplant 
for osteoclastoma of the radius. Parrish,3 
in 1966, reported two cases of fibular 
transplant to replace resected distal radius
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and advised that the head of the fibula be 
fashioned in a semilunar shape to avoid 
carpal dislocation. No such modification 
was made to the fibula in our case and no 
carpal dislocation has occurred.
Segments of long bones in large measure 
die after transplantation, with only the most 
superficial parts surviving to be a source 
of osteogenesis. Long-bone grafts are re­
vascularized from the periosteal surface and 
by vessels growing into the medullary canal 
from the ends.6
Tuli,7 in 1972, noted that successive ra­
diographs taken during follow-up of massive 
autologous bone grafts revealed the pro­
cesses of resorption and reconstruction 
occurring simultaneously. Reconstruction 
seemed to spread from the host-graft junc­
tion towards the centre of the graft. Radio­
logical evidence of complete reconstruction 
occurred seven to 18 months after opera­
tion. He noted that fracture of the graft 
may take place when reconstruction lags 
behind resorption and therefore advised 
prolonged splinting of the limb. Our patient 
continued in her protective forearm splint 
for 18 months.
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ILEAL CONDUIT DIVERSION FOR BENIGN DISEASE: 
A CRITICAL REVIEW AND LONG-TERM FOLLOW-UP*
J. K. WYATT, M.D., F.R.C.S.[C], F.A.C.S,f London, Ont.
Summary: The ileal conduit has been criticized 
for having a high complication rate and doubt 
expressed as to its long-term effectiveness as a 
means of urinary diversion. The author has cri­
tically reviewed 73 cases of ileal conduit per­
formed for benign disease and has demonstrated 
that there is a rate of 21 % for early and of 39%  
for late complications. Twenty-one cases of the 
series had a follow-up of 10 to 15 years. Their 
analysis demonstrated that the major complica­
tions and loss of renal function occur in the first 
few years after operation and, furthermore, that 
the ileal conduit is a satisfactory means of 
preserving renal function for a long period of 
time.
Resume: On a accuse le processus consistant a 
utiliser le conduit ileal comme moyen de detour- 
nement urinaire d'entrainer de nombreuses com­
plications et on a formule des doutes serieux 
quant a son efficacite a long terme. L'auteur a 
passe au crible de la critique 73 cas de conduit 
ileal pratique pour des pathologies benignes et 
a fait remarquer que cette operation entraine 
des complications precoces dans 21 % des cas 
et des complications tardives chez 39% des 
malades. Dans 21 cas de cette serie, les malades 
ont ete suivis pendant des periodes variant de 
10 a 15 ans. Cette analyse a permis de mettre 
en evidence que les principales complications et 
la perte de la fonction renale surviennent dans 
les quelques annees qui suivent I'operation et, 
par ailleurs, que le conduit ileal est un moyen 
de conserver la fonction renale pendant une 
longue periode.
Although the ileal conduit appears to 
provide one of the most satisfactory means 
of urinary diversion, not only is its forma­
tion an operation of considerable magnitude 
but two major criticisms are, first, that the 
complication rate is too high;1 r’ and, 
second, that the long-term results are un­
tested.6- 7 These criticisms led the author
*Presented at the Canadian Urological Associa­
tion Meeting, Vancouver, B.C., June 1973.
tDepartment of Surgery, Division of Urology, 
University of Western Ontario, London, Ont.
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to carry out a critical review of the proce­
dure with particular emphasis on the long­
term aspects of the ileal conduit as a means 
of diversion for benign disease.
Case Material and R esults
A review was made of 241 ileal conduits 
performed on the Urological Service of the 
Victoria Hospital, London, Ontario from 
1957 to 1970. Of these, 66% (159 cases) 
were performed for carcinoma of the blad­
der or other forms of pelvic carcinoma 
(Table I). It is obvious that in this group of 
patients many additional variables, such as 
the carcinoma itself and radiotherapy, made 
a true assessment of the diversionary proce­
dure difficult. It was believed that a more 
critical assessment of the ileal conduit would 
be best obtained by studying the cases of 
patients who had had their ileal conduit 
performed for non-malignant disease (Table 
II). Seventy-three such cases were critically 
reviewed with 100% follow-up. There were 
43 females and 30 males. The age range 
was from 2 to 77 years; 23 were children 
and 10 patients were over the age of 65 
years.
As mentioned, one of the major reasons 
for the study was what appeared to be a 
high complication rate. There were early 
complications during the initial hospital stay 
in 21% of cases (Table III). The common­
est of these was wound dehiscence. In all 
five cases in which this occurred the closure 
used was a running, chromic, catgut suture 
with reinforcing anterior fascial sutures of 
catgut. In only one of the five cases did there
TABLE I.—Ileal Conduits Performed for 
C arcinoma
Neoplasm
No. of 
cases Percentage
Bladder............................. 113 47
Cervix............................... 19 8
Prostate............................ 9 4
Bladder and prostate... 5 2
Other pelvic neoplasms.. 13 5
Total................................. 159 66
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appear to be any undue tension at the suture 
line and this was in a 4-year-old girl with ex­
trophy of the bladder. There has been no 
case of dehiscence in the last four years cov­
ered by the study, during which an inter­
rupted, through-and-through closure of non­
absorbable suture, preferably Dacron, has 
been used.
In an analysis of the problems related to 
ureteroileal anastomosis no common factor 
could be found except that all four of the 
complications occurred on the left side. 
Great care must be taken to minimize the 
dissection of the left ureter. In addition, one 
should bring the ureter through a window 
in the mesosigmoid rather than beneath 
the mesosigmoid in an attempt to prevent 
its involvement in an area of retroperitoneal 
fibrosis.
Both patients with septicemia in the early 
postoperative period had a significant degree 
of urinary tract obstruction and pyelone­
phritis before the ileal conduit operation. In
TABLE II.—Ileal Conduits Performed for 
Non-malignant D isease
Indication No. of cases
Neurogenic bladder: 35
Myelomeningocele................. 20
Spinal cord traum a...............  7
Multiple sclerosis................... 5
Poliomyelitis..........................  1
Arachnoiditis.......................... 1
Encephalitis...........................  1
Congenital anomalies: 22
Megacystitis-megaloureters. 16
Extrophy................................  4
Fistulas...................................  2
Cystitis: 11
Intractable.............................  6
Interstitial..............................  3
Irradiation.............................. 1
Tuberculous...........................  1
Perineal fistulas: 5
Urethral stricture..................  3
Rectovaginal..........................  1
Rectovaginovesical................ 1
TABLE III.- -E arly Complications (73 Cases)
Complication No. of cases
Wound dehiscence......................... 5
Ureteroileal disruption.................  4
Septicemia......................................  2
Fistulas...........................................  2
Small bowel obstruction..............  2
Operative death............................. 3
retrospect, perhaps a more vigorous attempt 
at preoperative control of the infection might 
have averted the septicemia. The author 
employs both mechanical and antibacterial 
bowel preparation. In the two instances of 
small bowel fistula, one developed at the 
original suture line and required a small 
bowel resection and reanastomosis. In the 
second case drainage occurred into the ileal 
conduit and in some unusual manner ceased 
spontaneously. The two cases of mechanical 
small bowel obstruction were at five and 13 
days after operation. One patient required 
the release of a loop of bowel and in the 
other the obstruction was associated with a 
local leak at the anastomosis and the patient 
required a small bowel resection. There were 
three deaths, two from septicemia and one 
from staphylococcal pneumonia, which gave 
an operative mortality rate of 4%.
Late complications of ileal conduit diver­
sion, that is, those occurring any time after 
the initial hospital discharge, were more fre­
quent than the early. Twenty-seven of 70 
patients developed these complications, an 
incidence of 39% (Table IV).
The most common complication in the 
late period was ureteroileal obstruction; 
there were eight such cases, seven of which 
required a revision of the anastomosis and 
in one patient a nephroureterectomy was 
done. These problems were equally divided 
between the right and left ureteroileal anasto­
moses. The time lapse from operation was 
from three months to seven years. In the 
seven cases of anastomotic revision, the 
etiological factor appeared to be devital­
ization and scarring of the ureterointestinal 
anastomosis. All of these anastomoses had 
been done by a similar technique with a 
two-suture, running type anastomosis using 
fine chromic catgut, usually 4-0.
The second commonest late complication 
was obstruction at some level of the conduit. 
Six cases fell into this category and three of 
them were stomal stenoses, which required
TABLE IV.—Late Complications (70 Cases)
Complication No. of cases
Ureteroileal obstruction...............  8
Conduit obstruction...................... 6
Renal calculi................................... 6
Small bowel obstruction..............  5
Hyperchloremic acidosis..............  2
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minor revision. One patient, a young girl, 
had her stoma revised on three separate oc­
casions, two, three and seven years after the 
original conduit operation. The obstruction 
in one patient was at the level of the fascia, 
in one it was in the loop itself, and one ob­
struction was produced by prolapsing of 
other small loops around the ileal stoma. 
The author has made no attempt to for­
mulate a program of stoma dilatation. Per­
haps this should be given some thought, 
particularly in the conduits done in children, 
as the three cases in this series all occurred 
in children. Once the stenosis has begun, it 
is very difficult to get either the child or the 
parent forcibly to dilate the stoma.
Renal calculi were found as late complica­
tions in six patients of the 70 reviewed, an 
incidence of almost 9 %, which compares 
favourably with the results in most long­
term follow-up studies.8' 9 Two patients had 
bilateral renal calculi; in two the calculi were 
left-sided and in two they were in the right 
kidney. Two patients were not submitted 
to operation but are being followed up while 
on a conservative regimen. In one of the 
four patients operated upon, one kidney was 
almost totally non-functioning and was re­
moved; in the other three patients a straight­
forward pyelolithotomy was performed.
Small bowel obstruction occurred in five 
cases. In two of these the obstruction in­
volved the ileal conduit as well, and con­
struction of a second conduit was necessary. 
In one instance small bowel resection was 
required and the other two patients were 
relieved without a resection.
Only two patients developed problems 
connected with hyperchloremic acidosis. In 
both rather long loops had been inserted 
initially and these required revision.
In most cases sufficient data have not 
been recorded to permit accurate compa­
rison of preoperative and postoperative 
renal function. If we use the excretory pye- 
logram as a crude measure, 24 of the 73 
patients had normal intravenous pyelograms 
preoperatively, and these remained so post- 
operatively (Table V). Twenty of the pa­
tients had marked bilateral hydronephrosis 
before operation; half of these remained 
unchanged, eight improved, and only two 
really showed any increase in the amount of 
hydronephrosis after operation. Fifteen pa­
tients had unilateral hydronephrosis and of 
these, four remained unchanged and four 
improved. Seven of the 15 deteriorated but 
this figure is weighted because in many of 
them the deterioration was due to obstruc­
tion of the anastomosis, already considered 
as a complication under that heading and 
subsequently operated upon and revised. 
Eleven of this group of 73 had bilateral 
chronic pyelonephritic changes on the in­
travenous pyelograms; seven of these re­
mained unchanged, two improved and two 
deteriorated. Three kidneys were lost in the 
entire group of 73 patients.
Discussion
The chief aim of ileal conduit diversion 
is to preserve renal function. This study em­
phasizes that if the upper urinary tracts 
are normal, this aim can be achieved. Twen­
ty-four e our 73 cases were in this category 
and in all of these renal function remains 
normal. Even of the 31 cases that had either 
massive bilateral hydronephrosis or chronic 
pyelonephritis before operation 10 showed 
marked improvement whereas only four de­
teriorated after the diversion. In the other
TABLE V.—Preoperative and P ostoperative Comparison of E xcretory Pyelography
Preoperative
Normal....................................................  24
Bilateral hydronephrosis........................  20
Unilateral hydronephrosis......................  15
Chronic pyelonephritis...........................  11
Postoperative
Normal.................................................  24
Unchanged.................................................. 10
Improved.....................................................  8
Deteriorated................................................  2
Unchanged...................................................  4
Improved.....................................................  4
Deteriorated................................................  7
Unchanged...................................................  7
Improved.....................................................  2
Deteriorated................................................  2
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17 cases the excretory pyelogram remained 
unchanged after the diversion.
In addition to the general follow-up of 
these patients, the author had the oppor­
tunity in 21 patients to carry out a long­
term follow-up of 10 to 15 years’ duration. 
It was possible to determine the blood urea 
nitrogen levels in 11 of these 21 patients and 
in 10 of the 11 the levels have remained 
normal. One 8-year-old boy had a preoper­
ative value of 35 m g/100 ml. Now, at the 
age of 20 years, this has risen to 76 m g/100 
ml and he is currently on the chronic renal 
dialysis program at our hospital. Only two 
patients, both with gross upper tract de­
struction when first seen, have had prob­
lems with hyperchloremic acidosis following 
the establishment of conduit drainage. Both 
received total ureteral replacement which 
required relatively long loops. One patient, 
14 years later and after a loop revision, has 
shown marked clinical improvement and is 
easily controlled with 30 g of sodium bi­
carbonate daily. The other patient is the 20- 
year-old man referred to above.
Sixteen of these 21 patients had follow-up 
excretory pyelograms to allow comparison 
with their preoperative status (Table VI). 
Of these, nine have improved or remained 
normal. In one instance the degree of hy­
dronephrosis has remained unchanged. Six 
of the patients showed an increase in the
TABLE VI.—Long-Term Follow-Up (21 Cases)
No. of cases
Blood urea nitrogen: 11
Normal.................................  10
Increased..............................  1
Hyperchloremic acidosis 2
Excretory pyelogram: 16
Normal or improved............ 9
Unchanged...........................  1
Increased hydronephrosis.. .  6
degree of hydronephrosis postoperatively, 
over the 10- to 15-year period; in three of 
them the hydronephrosis was unilateral and 
mild, and has remained unchanged in 
the long-term period. In the other three 
cases the kidneys have been lost as the result 
of ureteroileal obstruction and severe pye- 
lonephritic changes within 10 years of the 
conduit operation.
This long-term study emphasizes that the 
major complications and loss of renal func­
tion occur in the early years after conduit 
diversion. When 10 years and up to 15 years 
have elapsed there does not appear to be 
any increase in the complication rate or fur­
ther loss of renal function.
The author wishes to acknowledge the assistance 
of Mr. George Dundas, a final-year medical stu­
dent, who carried out the chart review. The 
author is also indebted to Drs. L. N. McAninch 
and J. L. Sales for allowing him to review their 
patients.
References
1. Kerr WK, Robson CJ, Russell JL, et al:
Collective review of urinary tract diver­
sions: Canadian Academy of Urological 
Surgeons. J Urol 88: 644, 1962
2. Parkhurst EC: Experience with more than
500 ileal conduit diversions in 12-year 
period. J Urol 99: 434, 1968
3. Engel RM: Complications of bilateral ure-
tero-ileo cutaneous urinary diversion: re­
view of 208 cases. J Urol 101: 508, 1969
4. H arbach LB, H all RL, Cockett AT, et al:
Ileal loop cutaneous urinary diversion: 
critical review. /  Urol 105: 511, 1971
5. Malek RS, Burke EC, D eweerd JH: Ileal
conduit urinary diversion in children. Ibid, 
p 892
6. Pyrah LN: Rectosigmoid bladder as method
of urinary diversion. J Urol 90: 189, 1963
7. Williams DF, Burkholder GV, G oodwin
WE: Ureterosigmoidostomy: 15-year ex­
perience. J Urol 101: 168, 1969
8. Logan CW, Scott R, Laskowski TZ: Ileal
loop diversion: evaluation of late results 
in pediatric urology. J Urol 94: 544, 1955
9. Cordonnier JJ : Ileal conduit in children.
Urol Int 23: 82, 1968
274 THE CANADIAN JOURNAL OF SURGERY Vol. 17
MUCOSAL DIAPHRAGM OF THE GASTRIC ANTRUM: 
CASE REPORT AND REVIEW OF THE LITERATURE*
C. N. GHENT, M.D.t and D. DENTON, M.D., London, Ont.
Summary: A 52-year-old woman had a mucosal 
diaphragm obstructing the gastric antrum. This 
rare but important and treatable cause of gas­
tric obstruction usually presents as pyloric 
stenosis without a history of ulcer dyspepsia. 
Diagnosis is possible by distinctive radiological 
features, but is often made only by endoscopy 
and/or surgical exploration. Surgical treatment 
has been highly satisfactory in most cases de­
scribed in the literature. Our case is unique in 
that the anomaly was associated with a gastric 
phytobezoar and with prolonged postoperative 
gastric aperistalsis.
Resume: Une femme de 52 ans souffrait d'un 
diaphragme muqueux, qui obstruait I'antre gas- 
trique. Cette pathologie curable, cause de ('ob­
struction gastrique s'observe rarement, mais est 
importante. Elle se presente frequemment sou3 
forme d'une stenose pylorique, sans antecedent 
de dyspepsie ulcereuse. On peut poser le diag­
nostic par des methodes radiologiques distinc- 
tives, mais on fait souvent ce diagnostic par 
simple endoscopie et par une exploration chirur- 
gicale (ou I'une des deux methodes). Dans la 
plupart des cas rapportes dans la litterature, le 
traitement chirurgical s'est revele tres satisfait- 
sant. Notre cas est unique, en ce sens que cette 
anomalie etait associee a un phytobezoard gas­
trique et a une absence prolongee de peristal- 
tisme gastrique, d'origine postoperatoire.
A mucosal diaphragm obstructing the an­
trum of the stomach is a rare abnormality, 
generally considered to be congenital. There 
is some disparity in the numbers of reported 
cases,1' - due, in part, to confusion over the 
nomenclature and classification of antral or 
pyloric lesions not obviously related to in­
flammatory, neoplastic or peptic ulcer di­
sease. The case we report below represents 
the type of lesion best described as an antral 
mucosal web, diaphragm, or membrane, and 
is unique in that it was associated with a 
large intragastric phytobezoar, and with
*From the University Department of Medicine. 
Gastrointestinal Unit and the University Depart­
ment of Surgery, Victoria Hospital, London, Ont.
i Liver Study Unit, Yale University School of 
Medicine, New Haven, Conn.
Reprint requests to: Dr. C. N. Ghent, 10 Sheahan 
Drive, Hamden, Conn. 06514.
prolonged postoperative gastric aperistalsis.
Case R eport
A 52-year-old housewife had a 10-year his­
tory of intermittent, increasing, abdominal dis­
tension, belching and vomiting after meals. 
These symptoms were better during the winter 
and worse during the summer. She related the 
seasonal exacerbations to the ingestion of fresh 
raw fruits and vegetables, especially salads and 
peas.
On physical examination the patient ap­
peared as a healthy-looking woman with no 
notable abnormalities apart from epigastric 
distension and a succussion splash. Results of 
routine laboratory tests were normal. Upper 
gastrointestinal radiographs (Fig. 1) showed 
a constant concentric narrowing of the distal 
antrum and a large bezoar in the fundus. The 
bezoar was cleared by voluminous, forceful 
tapwater lavage with returns of thick, greenish 
debris, containing vegetable fibre and peas.
At gastroscopy the mucosa appeared normal. 
A circular aperture, constant in size, was 
present in the distal antrum and beyond it was 
a small vestibule, lined by normal gastric mu­
cosa terminating at a normal pyloric sphincter. 
The aperture appeared to be centrally placed 
in a mucosal web across the antrum. By 
grasping its edge with biopsy forceps, the mem­
brane was shown to be mobile while the size 
of the opening remained unchanged. A biopsy 
from this edge showed normal gastric mucosa.
Fig- 1.—Note the constant concentric narrowing 
in the distal antrum and the phytobezoar in the 
fundus of the stomach.
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At laparotomy the serosal surface of the 
stomach and duodenum was normal, and there 
was a suggestion of an hour-glass deformity 
2 to 3 cm proximal to the pylorus. A “dough­
nut deformity” was palpable in the antrum 
separate from the pylorus. Through a proximal 
gastrotomy incision it was seen to be covered 
by normal gastric mucosa and there was no 
evidence of ulceration or neoplasm. The mem­
brane was incised longitudinally, closed trans­
versely and a small Heineke-Mikulicz pyloro­
plasty was performed. Postoperative progress 
was uninterrupted and the patient was dis­
charged seven days later.
Ten days after discharge she returned with 
complaints of postprandial nausea, vomiting 
and epigastric fullness. On examination there 
was obvious gastric dilation with a succussion 
splash. Barium examination revealed a widely 
patent pylorus, but no antral peristalsis and 
slow gastric emptying. Endoscopy two weeks 
later showed no evidence of the diaphragm and 
a normal pyloric sphincter, but again antral 
peristalsis was absent, even after administra­
tion of metoclopramide. Six weeks later she 
was tolerating a regular diet, had no symp­
toms and was gaining weight.
Discussion
Congenital anomalies of the stomach are 
rare, accounting for less than 1 % of all 
congenital gastrointestinal disease.1 Gerber2 
classified congenital obstructive anomalies, 
other than infantile hypertrophic pyloric 
stenosis, into four categories, namely pyloric 
membranes, antral membranes, pyloric 
atresia and antral atresia. The age range is 
from the neonatal period to 74 years3’ 4 
and there is no good reason for considering 
infant and adult cases separately. Sloop and 
Montague5 reviewed the reports to 1967 
and found 16 cases of a membrane occur­
ring at the pyloric sphincter, 21 in the antrum 
and three in which the exact location was not 
specified. In 1970 McBee and North6 re­
ported 47 patients, but did not differentiate 
them on the basis of site. Since then there 
have been four additional case reports of 
antral membranes7'9 including our patient.
From all available reviews and case re­
ports, and using Gerber’s classification, one 
arrives at the total number reported in each 
class as follows: antral mucosal membrane, 
36; antral atresia, 11; pyloric mucosal mem­
brane, 27; and pyloric atresia, six. There are 
another seven cases in which the data do not
permit classification. At least one case 
seemed to be a combination of partial antral 
atresia and antral mucosal membrane.7 
These anomalies may not be as rare as the 
above figures suggest. For example, Rhind10 
reported seven from personal experience, 
and Kenny11 and Strange12 reported four 
each.
Most authors consider the antral dia­
phragm to be due to a failure of canalization 
of the solid cord of gut epithelium at five to 
six weeks of fetal development. The rarity of 
these lesions in the stomach (compared with 
the duodenum) and the fact that all mem­
branes have at least a small aperture, may 
be related to the observation that during 
embryogenesis luminal occlusion in the 
stomach is never complete.13 There are 
other indicators of a congenital etiology. For 
example, one antral membrane consisted of 
ectopic pancreatic tissue.9 The age range 
of the reported cases, including infancy, the 
absence of significant evidence of inflamma­
tion in most cases and the embryological 
considerations all support the concept of a 
congenital etiology.
The clinical features in our patient are 
typical. Painless bloating and vomiting have 
b. A t the main symptoms and their duration 
before diagnosis has ranged from two months 
to 23 years. The first case, reported by Lan- 
derer14 in 1897, was an incidental autopsy 
finding, and there has been one recent 
report of an asymptomatic antral dia­
phragm.15 Muscular hypertrophy over­
coming the partial obstruction may have 
been responsible for this patient’s prolonged 
asymptomatic period; it is conceivable that 
removal of the bezoar alone would have 
eliminated her symptoms indefinitely.
The diagnosis has been made and missed 
by a variety of means.8 Although the con­
stant ring-like constriction has been present 
and observed on radiographs it has usually 
been misinterpreted. Gastroscopic examin­
ation has provided the correct diagnosis in 
at least five cases, including ours. In the 
majority the diagnosis has been made at 
laparotomy or when the organ was examined 
after gastrectomy.
In most cases treatment has been surgical 
and the results generally have been good. 
Initially gastroenterostomy was usually done 
but recently incision of the membrane com-
an em erging problem
“Bacteroides species are often over­
looked as a cause of serious infec­
tion both by clinicians and micro­
biologists. They are most commonly 
associated with intra-abdominal 
and pelvic sepsis following gastro­
intestinal surgery.”
“Our experience with this series of seriously 
ill patients provides clinical confirmation to 
complement recent in vitro evidence that 
clindamycin is the antibiotic of choice for 
use in bacteroides infections. Not only was 
the response in 17 of the 18 patients favour-., 
able, but in several it was dramatic.”
■ N
Tracy, 0 .,et al. (29 Jan.’72), 
Brit. med. J.,p.280.
Haldane, E. V. and van Rooyen, C. E. (1972). 
C.M.A.J.,p. 1177.
hie Absc - surgical removal and drainageU iK a u ,-
eillustraW ftfie surgeon is preparing to remove a right 
subphrenic abscess. The'patient is in the nephrectomy position, 
and the ^prge&stjK<|lpp|Jt to make the initial. incislon. H e w i^  
manually the right ektra-p^Wtonbai,S'pacfe'.‘■Whert lhe • ■
abscess i^e^countered, the finderyill'be pushed firmly through 
thejBaJI and the pus evacuated with a sucker. Before closing, /1
^irl is placed and brought out through a separate stab wound; 
iw the main incision. U
.bacteroides infection
•  I.M. injection or I.V. infusion 
achieves prompt and high peak 
serum levels of active clindamycin
•  well tolerated locally and sys- 
temically following I.M. injection
K or I.V. infusion
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bined with pyloroplasty has been advo­
cated.2 Katz15 has considered the possibility 
of dilating the aperture by a peroral tech­
nique. The postoperative problem of pro­
longed gastric stasis with aperistalsis, as en­
countered in our case, has not previously 
been reported nor has the association with 
a phytobezoar.
Although rare, pyloric or antral mem­
branes or areas of atresia should be consi­
dered in the differential diagnosis of upper 
gastrointestinal obstructive symptoms in pa­
tients of any age, especially episodic gastric 
outlet obstruction without any history of 
ulcer dyspepsia.
We wish to express our gratitude to Drs. W. C. 
Watson and J. Duff for allowing us to publish 
the details of this case, and for assistance in pre­
paring the manuscript.
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LYMPHOGRAPHY IN CASES OF EDEMA OF THE 
LOWER EXTREMITY
JEAN H. GAGNON, M.D.* and DAVID ARCHER, B.Sc.,t Montreal, Que.
Summary: Bilateral lymphography was per­
formed on 75 patients presenting with edema of 
the lower extremity. In 16 patients the lym­
phedema was classified as primary in type and 
in most of the 43 with secondary edema it was 
due to a malignant process. The remaining pa­
tients had a normal lymphogram and a normal 
venogram. The technique of the examination is 
briefly described and the results are evaluated. 
Radiographs of various types of lymphedema 
are presented.
Resume: Nous avons pratique une lymphogra- 
phie bilaterale chez 75 malades qui presentaient 
un oedeme des membres inferieurs. Chez 16 de 
ces malades, le lymphcedeme etait considers 
comme primaire et, chez la majorite des 43 ma­
lades avec oedeme secondaire, il etait cause par 
un processus malin. Les autres avaient un lym- 
phogramme et un phlebogramme normaux. Nous 
decrivons brievement la technique de I'examen 
et evaluons les resultats. Nous presentons ega- 
lement des radiographies de divers types de 
lymphcedeme.
L y m ph e d e m a  is the collection of lymph in 
the interstitial tissue resulting from a func­
tional overload on the lymphatic system.1 
The physiopathology is not yet fully under­
stood but the advent of lymphography has 
allowed better comprehension of this patho­
logical process and has made possible dif­
ferentiation between primary and secondary 
lymphedema. These two types of edema are 
discussed briefly below.
M aterials and M ethod
From a series of some 1,000 lympho- 
grams performed at the Royal Victoria 
Hospital in Montreal, we reviewed the 
records of 75 which were carried out as part 
of the investigation of edema of the lower 
extremity.
The method used was basically that of 
Kinmonth- with a few modifications. Usual-
*Department of Diagnostic Radiology, Royal Vic­
toria Hospital and McGill University, Montreal, 
Que.
fMedical Research Council of Canada — student 
1973.
ly the first web space was injected with Al- 
phazurine 2G but whenever marked edema 
of the foot was present the blue dye was 
introduced also into the third web space to 
utilize a wider supply of draining lympha­
tics. In all cases the procedure was per­
formed bilaterally through a longitudinal in­
cision on the dorsum of the foot. No signif­
icant delay in wound healing or local infec­
tion was observed. A strip of strong silk 
adhesive tape was applied to bring the edges 
of the incision together; no sutures were used 
except in two cases where the edema was 
so marked as to prevent adequate approxi­
mation of the edges.
Lipiodol, 3 to 5 ml, was injected over a 
period of 30 to 50 minutes by means of a 
Hobbs injector. It appears important to keep 
the amount of the radiopaque medium as 
small as possible in order to minimize the 
risk of lymphangitis from stagnation in an 
impaired lymphatic system and also to 
decrease the risk of pulmonary embolism; a 
disturbed lymphatic circulation may result 
in the opening of lymphovenous communica­
tions which would permit delivery of a large 
bolus of oil to the lungs. Some authors even 
recommend the use of a water soluble con­
trast medium to prevent this complication.
R esults
Of the 75 patients included in this study, 
16 were classified as having primary lym­
phedema since they showed no evidence of 
anatomic obstruction but had some mal- 
development of the lymphatic system (Figs. 
1 to 3). Eleven patients demonstrated chan­
nels either fewer in number or smaller in 
size than normal, or whose fragility was in­
creased. Two patients presented hyperplastic 
channels and three others were considered 
to have aplasia of lymphatics as no channels 
whatever could be found for cannulation. 
These last three all showed dermal staining 
after injection of the blue dye, indicating 
lack of patency of the usual major lymphatic 
routes. Fifteen of this group of 16 patients 
were women and over two-thirds were un­
der 35 years of age.
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Fig. I.—Primary lymphedema. A single hypo­plastic channel parallels the greater saphenous vein. The lymphatic shows weakness of its wall and extravasation.
Fig. 2.—Primary lymphedema. Hyperplastic, mul­tiple. tortuous channels are opacified in the leg of this 20-year-oid woman in whom edema had been present for three months.
In a second group of 43 patients (23 
women, 20 men), obstruction of the lym­
phatic system was demonstrated (Figs. 4 to 
7). A malignant process was the cause of the 
obstruction in 31 patients, 19 of whom had 
edema caused by carcinomatous nodes in the 
pelvis which interrupted the flow of lymph 
and/or compressed the iliac veins. Twelve 
patients had nodes involved by Hodgkin’s 
disease or other types of lymphomas.
A surgical operation in the groin was 
found to be the cause of the edema in six 
instances and lymphangitis in another six. 
It is quite possible that inflammation played 
a part in the edema resulting from an oper­
ation.
In a third group of 16 patients with edema
Fig. 3.—Primary lymphedema. Reflux of medium into distal collateral lymphatics after injection of a channel on the dorsum of the foot.
Fig. 4.—Secondary lymphedema. Opacification of collateral lymphatics and dermal backflow in a 53-year-old man who developed edema after resection of left inguinal nodes.
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of the lower extremity suspected on clinical 
grounds to have a lymphatic basis, not a 
single abnormality could be found in either 
the lymphogram or the venogram. The ede­
ma is probably due to a defect at the cellular 
level. In these cases, lymphography was 
most valuable in ruling out obstruction.
Only two of our patients underwent oper­
ation for their lymphedema. Both had 
omental transposition and were objectively 
improved but lymphography failed to de­
monstrate any lymphatic connections with 
the greater omentum.
D iscussion
Primary lymphedema is a congenital de­
ficiency of the lymphatic system which mani­
fests itself as hypoplasia, hyperplasia or 
aplasia of the lymphatic trunks. It pre­
dominantly affects women and is usually 
first noticed a short time after puberty.
Hypoplasia, i.e. vessels fewer in number 
and/or smaller in size than normal, is the 
most common lymphographic finding in 
primary lymphedema (approximately 60% 
of cases).s- 4 In 25% of the patients the 
abnormality is bilateral. The diagnosis of 
hypoplasia is a relatively delicate one to 
put forward on the basis of a static record 
which does not reflect circumstances that 
are entirely physiological. The interpretation 
of such a record must obviously be made 
with caution.
Fig. 5.—Secondary lymphedema. Extensive der­
mal collateral lymphatics in a patient who has had 
repeated episodes of lymphangitis.
Fig. 6. —Marked extravasation and filling of peri­
vascular spaces; another collateral pathway.
Fig. 7.—Lymphedema secondary to malignant 
metastases in the lymph nodes of the right external 
iliac region.
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Hyperplasia, indicating primary lymphe­
dema, is present in 10% to 20% of the 
cases.3’ 4 The channels are numerous, large 
and tortuous, usually more so than in sec­
ondary lymphedema. The edema is presum­
ably due to an incompetence of the valvular 
system in those abnormal channels.3 It is 
in these cases that the volume of oil required 
to fill such systems increases the possibility 
of clinically significant pulmonary oil em­
bolism.
True aplasia would seem to be a very rare 
congenital anomaly and the apparent ab­
sence of superficial lymphatic trunks does 
not necessarily mean that deeper trunks are 
not available. Three of our cases were clas­
sified as due to aplasia but incisions were 
made only on the dorsum of the foot. We 
realize it is quite possible that channels 
could have been found by injecting the blue 
dye in the retromaleolar regions.
Increased fragility or porosity of the walls 
of the channels has been invoked as a pos­
sible cause of lymphedema.6 However, the 
extravasation may be the result of increased 
pressure and higher speed in the course of 
making the injection rather than due to a 
defect in the lymphatic wall, so that careful 
interpretation is necessary.
Filariasis affects two hundred million 
people in the world today and is the most 
frequent cause of secondary lymphedema.7 
On the North American continent, where 
filariasis is rather rare, malignant disease is 
a much more common cause. In fact it is 
not unusual that edema is the first mani­
festation of a malignant process. Lympho­
graphy often will determine the site and 
nature of the lymphatic obstruction, it will 
help in planning the treatment and allow 
evaluation of the response to this treatment. 
A clinical diagnosis of primary lymphedema 
may even be altered to the secondary type 
if lymphography demonstrates obstruction.
On the radiograph, edema secondary to 
previous episodes of lymphangitis may be 
indistinguishable from primary lymphe­
dema8 and in such cases a clinical history 
often decides the issue. Abnormal diffusion 
of the blue colouring agent into lymphatic
spaces of the dermis merely indicates lack of 
patency of some or all the major trunks. This 
phenomenon of dermal staining can be seen 
in primary lymphedema but also in the sec­
ondary form, especially in those cases which 
are due to repeated bouts of lymphangitis.
The route of injection we have selected 
is the lymphatic trunks that parallel the 
greater saphenous vein and therefore allows 
direct assessment of this system only; the 
lesser saphenous and the deeper femoral 
systems are usually not opacified by our 
method. In most instances, however, indirect 
evaluation of these latter two systems is pos­
sible from the lymphographic findings in the 
greater saphenous system.
Conclusion
Physiological conditions are difficult to 
ensure during lymphography of the lower 
extremity since technical factors are apt to 
modify the appearance of the lymphatic 
system. As a result, in primary lymphedema 
careful evaluation of the roentgenographic 
findings is highly necessary. The practical 
contribution of lymphography in edema of 
the lower extremity lies mainly in the de­
tection of lymphatic obstruction and the de­
monstration of its cause.
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BIPOLAR DIATHERMY*
IULIAN L. ROBINSON, M.D., M.S., F.R.C.S.[Eng. & C]t and 
NORMAN J. DAVIES, B.Sc., C.Eng., M.I.E.E.,1 Quebec City, Que.
Summary: The authors present an explanation 
of the manner in which diathermy produces its 
effects. The advantages and special uses of 
bipolar diathermy are explained. Desirable char­
acteristics of an improved machine are listed 
and translated into three electronic terms. 
These are choice of wave form, stability of 
voltage output and floatability. A machine with 
these electronic features has been built and 
tested both in the laboratory and in the oper­
ating room. The authors hope that these anal­
yses will encourage surgeons in the different 
specialties to use bipolar diathermy, and also 
that they will help surgeons in evaluating any 
machine whose purchase they are considering.
Resume: Un neuro-chirurgien et un ingenieur en 
electronique ont fait des etudes sur la diather- 
mie bipolaire, ses avantages et le mecanisme 
de coagulation ainsi produite.
Les caracteristiques d'une bonne machine a 
diathermie bipolaire sont presentees en trois 
caracteristiques electroniques importantes et 
sont considerees comme etant: le choix de 
I'onde electronique, la stabilite de la source de 
ccurant de radiofrequence et une machine a 
diathermie bien flottante, c.a.d. que le courant 
n'a pas tendance a s'enfuir a la terre (ground).
Les resultats obtenus experimentalement et 
cliniquement justifient ('utilisation de cette tech­
nique dans diverses specialites.
D ia t h e r m y  causes its effect through radio­
frequency (RF) current. Every time an RF 
wave passes through the tissue (and it does 
this at least 70,000 times per second) the 
molecules tend to turn so as to lie along 
its path much as a compass needle will point 
towards magnetic north. In the next frac­
tion of a second, however, the polarity of 
the wave reverses. The molecules then tend 
to turn 180° so as to align themselves in 
their original position. This tendency to
*Supported by a grant from the Wellcome Trust.
tDepartment of Surgery, L’Hotei-Dieu de Quebec, 
Quebec City, Que.
^Liverpool Regional Polytechnical Institute, Liver­
pool, England.
Reprint requests to: Dr. J. L. Robinson, Depart­
ment of Surgery. L’Hotel-Dieu de Quebec, 11 
Cote du Palais, Quebec 4, Que. G1R 2J6.
turn back and forth with each oscillation of 
the RF current acts as a source of internal 
friction, which produces heat and this co­
agulates the tissue.
This phenomenon is known as dielectric 
loss, but there is another factor which is of 
importance. The RF current is driven by 
a voltage which is often large. Owing to its 
electrical resistance the tissue then resembles 
the element of an electric fire— both heat 
up when the current is switched on. Hence 
the effect of conventional diathermy is to 
coagulate tissue by heat, on the one hand 
internally from molecular movements of 
dielectric loss and on the other hand by the 
direct effect of the voltage of the RF cur­
rent and the resistance of the tissue.
Conventional unipolar diathermy causes 
a sphere of intense coagulation around the 
end of the operator’s instrument. As the 
distance from that point increases and the 
current disperses, the amount of coagula­
tion diminishes. There is no fundamental 
difference between coagulating and cutting 
diathermy except that in the latter the power 
is much greater. During cutting with dia­
thermy the tissue is actually vaporized in­
stead of being merely charred.
If diathermy is used extensively so much 
damaged tissue may be left in the wound 
that healing may be retarded and infection 
promoted. Complications of diathermy, such 
as explosions and burns, are potentially 
serious.1 Diathermy is often unsatisfactory 
for sealing large vessels and, most important, 
the spread of coagulation effect that occurs 
may prohibit its use in certain areas where 
damage to nearby structures cannot be 
risked. Thus it is often dangerous to use 
diathermy near an important nerve or vessel 
(e.g. during parathyroid surgery) or in a tis­
sue such as the testis connected to the body 
by a small structure constituting a high re­
sistance path, with the concomitant risks 
of thrombosis.
Greenwood2- first used forceps where 
the blades were insulated from each other 
and since then other bipolar coagulators 
have been described.4 Theoretically, in 
these machines the current will pass between
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the forceps points, and therefore only the 
tissue directly gripped in the jaws of the 
instrument will be coagulated.
Specificity of action in diathermy is very 
desirable. If really well-controlled coagula­
tion can be produced, then the number of 
areas where diathermy can be used is in­
creased. Ophthalmic, otolaryngological and 
neurological surgeons are most likely to find 
uses for a bipolar coagulator and, indeed, 
many of these are already aware of its ad­
vantages. Apart from these specialists, 
many of whom tend to use magnification 
during operation, there will be other sur­
geons who would at some time find valuable 
the use of safe and precise diathermy ap­
paratus.
For these reasons we attempted to de­
scribe the features that a surgeon would 
find desirable in a bipolar coagulator. 
These have been translated into electronic 
terms, and we have built a number of 
machines to test whether these features can 
be provided.
Objective
Desirable characteristics of an improved 
machine are:
(a) There should be no stimulation of 
neuromuscular tissue during use. A muscu­
lar twitch occurring during the course of 
fine work in an operative field, perhaps 
viewed through a loupe or a microscope, 
would be undesirable. (There is also a theo­
retical objection to using a wave form to 
which nervous tissue is sensitive.)
(b) Only the structure that is grasped 
between the points of the forceps should be 
coagulated. This accuracy of action without 
significant spread of RF damage to neigh­
bouring structures is a unique feature of a 
successful bipolar coagulator and distin­
guishes bipolar from unipolar machines.
(c) Shorting of one or both forceps blades 
higher up the shaft, when it does occur, 
should not affect the performance of the 
machine or damage the tissue causing the 
short circuit.
(d) Tissue touching the outside of the 
forceps point should not be affected. If two 
structures lie in contact with each other 
and it is desired to coagulate only one, then 
the other must be safe even if it does touch 
the outside of the forceps.
(e) The machine should produce the same 
voltage at each dial setting irrespective of 
the load, i.e. the type of tissue. Sometimes 
conventional diathermy works poorly on 
fat. If the dial is turned up to help at this 
stage, then as soon as muscle is reached 
coagulation may become violent.
(f) The machine should coagulate equally 
well in dry and wet conditions. This is a 
point of particular importance to neurosur­
geons whose operative field is likely to be 
flooded regularly with cerebrospinal fluid 
corresponding with the patient’s respirations. 
Apart from this, it is customary to irrigate 
the forceps with saline during use so as to 
prevent them sticking to the tissue, and to 
reduce charring to a minimum.
(g) There should be no interference with 
other electronic equipment in the operating 
room.
(h) The machine should be safe and 
reliable.
(i) It should be cheap to produce and 
easy to service.
(j) It should be silent.
R esults
We built machines using tubes rather 
than transistors because the former were 
readily available, cheap, and known to be 
practical as RF generators. We did not use 
spark-gap generators because they cause 
much interference, are inefficient and noisy, 
and produce a spiky non-repetitive wave 
form that makes design and measurements 
extremely difficult.
We found it relatively easy to achieve 
characteristics (g) to (j) listed above pro­
vided the machine was adequately grounded 
and screened. A remote switching device 
was used. Interference with other electronic 
devices did not occur, and tubes were both 
reliable and easy to replace if this became 
necessary.
Coagulators should be safe for both pa­
tient and operator. There are remarkably 
few regulations which apply to diathermy 
equipment with a rating of less than 50 
watts, which includes most bipolar coagu­
lators. Therefore certain precautions are 
necessary in the design and manufacture of 
some of these machines. For example some 
commercially available machines allow the 
full mains voltage of 110 volts (220 volts
September 197U BIPOLAR D IATH ER M Y 289
in some countries) to pass through the foot 
switch. Other points to be avoided are listed 
in Table I.
We found that the characteristics (a) to 
(f) listed above were functions of three 
electronic factors. Although in practice they 
all mutually interact, they will be described 
singly to clarify the basic principles involved.
Wave form and frequency of the RF  
current.-—Coagulation is achieved both by 
dielectric loss and by the actual voltage used 
to drive the current. The higher the fre­
quency the more the molecules shimmer, 
and the greater the heat generated internally 
from this source. Spark-gap machines pro­
duce a rather low-frequency wave (about 
1.14 mHz) with a large peak-to-peak volt­
age of about 550. The wave is damped and 
just as shock absorbers stop a car from 
swaying up and down after hitting a bump 
in the road so the oscillations quickly die 
away, being negligible at about 7 pcsec. 
There is then a gap of complete silence for 
about 10 /rsec before the spark gap fires 
again (Fig. 1). We chose a continuous RF 
wave form oscillating much faster (8 mHz) 
which eliminates the gap of electrical silence. 
Hence one can make the RF waves pass 
through the tissue seven times as frequently 
and, since the wave form is active continu­
ously instead of less than half the time, 
maximum voltage can be lowered to one-
seventh of that used in spark-gap machines.
There are several advantages to this ar­
rangement. The effect of dielectric loss 
is made as great as possible and the effect 
of conduction is reduced, thus equivalent 
degrees of coagulation are achieved with a 
much lower voltage. Dielectric coagulation 
is much more localized in its action than 
conduction heating. The pure wave form 
makes suppression and screening easy so 
that electrical interference does not occur. 
Laboratory tests showed that neuromuscular 
tissue is insensitive to RF current at 8 mHz 
and a maximum of 80 volts peak-to-peak. 
It is unnecessary, therefore, to add any 
other complicated electronic circuitry to 
avoid neuromuscular stimulation. Fig. 2
60 ysec
Fig. 1.—Diagram of a spark-gap-generated RF 
current. Note the initial high voltage, quick damp­
ing of the wave down to zero and long periods 
of electrical silence.
TABLE I.—Undesirable Characteristics in a Bipolar Coagulator*
C h a ra c teris tic D efect in  design  responsib le
Poor floatability Machines whose output coil is large compared with the driving coil 
Machines where the stray capacitances of the output coil are not 
symmetrically balanced about the earth
(Floatability in a transistorized machine may be poor for these 
reasons)
Unstable voltage output Machines whose output is controlled by crude resistance potentio­
meters
Neuromuscular stimulation occurs Spark-gap machines as well as some others whose oscillator prod­
uces a modulated envelope of RF that follows the 50 to 60 Hz sine 
wave of mains supply 
Machines whose R F is in the KHz range
(Note: some transistorized machines prevent stimulation by using 
a gate instead of raising the RF)
Noisy operation: interference Spark-gap machines
with electronic monitoring 60 Hz modulated envelope machines
equipment in the operating 
room
Poorly screened machines
Low safety level Overheating
Electronic circuitry partially exposed 
Sparking
Patient not separated from the machine by capacitors 
Not watertight
Mains voltage through a foot switch
*Technical details of laboratory methods and of calculations involved are being published separately.6
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shows a comparison of the two wave forms 
discussed.
Stability of voltage output.—With some 
bipolar coagulators the voltage changes ac­
cording to the load (thickness and type of 
tissue) across the forceps point. This fluctu­
ation of voltage caused by different loads 
accounts for the different speeds at which 
these machines coagulate different tissues 
even if the dial setting remains unchanged. 
These machines usually use crude resistance 
potentiometers to control power output and 
these, paradoxically, produce less power at 
high dial settings under heavy load. In other 
words if the tissue is not coagulating as the 
surgeon would wish, and he requests that 
the dial be turned up to a higher setting, 
then the machine produces less power.
To overcome this disadvantage and also 
to ensure that the machine will work as 
well in wet as in dry conditions we used a 
closed-loop feedback system. The output 
voltage is sensed, and then a comparison is 
made between what the output voltage 
actually is and the level chosen according 
to the dial setting. If these two are very 
different then the machine automatically 
produces more or less power as appropriate.
Floatability.—The mains electricity sup­
ply is grounded to earth at the generating 
station. This explains why one gets a shock 
if one touches a live electrical wire. Current 
flows through the observer to earth and back 
to the grounded wire at the generating sta­
tion to complete the circuit. This grounding 
to earth is not seen with a battery. If one 
terminal of a battery is connected to the 
ground the battery will not discharge to 
earth— the output is floating and will only 
return to itself. A battery-driven machine 
would be ideal but is impractical. It is there­
fore necessary to devise a mains-operated 
RF generator which produces a floating 
output that does not ground to earth al­
though the mains supply is grounded.
If a really high quality floating output can 
be achieved then there is no possibility of 
coagulation damage anywhere except be­
tween the forceps points where it is required. 
In spite of the fact that the patient is 
grounded to earth in the operating room, 
and is likely also to be connected to moni­
toring equipment which provides additional 
grounding connections, a truly floating RF
supply will only return to itself and will 
not avail itself of the electrical path through 
the patient to ground. The power will be 
concentrated on the inner surface of the 
forceps point as this constitutes the short­
est path for the current to complete the 
circuit. Spreading coagulation damage will 
be reduced to a minimum and this arrange­
ment will not be significantly affected by 
shorting the forceps or touching structures 
with the outside of the points.
In the laboratory we measured the float- 
ability of an average spark-gap machine 
and found that 50% of the power of the 
550-volt surge grounded to earth. Eventu­
ally we managed to reduce our loss to less 
than 5%. House and Hitselberger3 have 
shown that diathermy current tends to 
spread along blood vessels as these are the 
paths of least resistance. Presumably this 
effect is undesirable and to avoid it a high 
degree of floatability is essential.
Summary and Conclusions
An explanation is given of how diathermy 
causes its effects, and the advantages of 
bipolar coagulation are presented. Working 
together, a neurosurgeon and an electronics 
engineer have explored this field and tried 
to translate surgical needs into electronic 
terms. Against this background we drew up 
the characteristics that we believed a good 
surgical bipolar diathermy unit should pos­
sess. These were converted into the ap­
propriate electronic features and some
Fig. 2.—Comparison between the continuous 
RF current and the spark-gap-generated current. 
Because there is no gap of electrical silence (com­
pare Fig. 1), and because the frequency is much 
higher, the power from the purer, more manage­
able, continuous tracing is the greater.
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prototype machines were built and tested.
Our last prototype has been in use for 18 
months in the operating room (Fig. 3). It has 
been found that bipolar coagulation increases 
the range of operative procedures that may 
be undertaken with confidence. For exam­
ple, intrinsic spinal tumours and tumours 
of the conus medullaris and cauda equina 
may be operated on more easily and safely. 
Vascular neurosurgery, whether of the 
spinal cord or of the circle of Willis, has 
also been facilitated.
ANODE SUPPLY
Fig. 3. —Block diagram of our latest bipolar coagulator. First, the output coil consists of one 
turn only, which greatly reduces the stray capacitances, and what few there are have been symmet­
rically balanced about the earth. Second, the oscillator circuit consists of two 12-watt pentodes in a 
cross-coupled circuit. This “push-pull” arrangement means that any current flowing to ground through 
the stray capacitances from one-half of the driving tank coil will meet an equal but opposite current 
from the other half, and these two will tend to cancel out. The transmission line, of course, re­
quires capacitors to compensate for its inductance. These help to maintain the voltage at the forceps 
tips at a constant level. HT =  high tension voltage; oV =  ground (earth); G2 =  tube grid voltage; 
TX =  transmission line.
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FACTORS ASSOCIATED WITH FAILURE OF LUMBAR 
SPINE FUSION*
P. J. KOKAN, M.D., F.R.C.S.[C], P. C. WING, M.B., Ch.B., M.Sc. and 
W. J. THOMPSON, M.D., F.R.C.S.[C],
Vancouver, B.C'.
Summary: Twenty-eight World War II veterans 
were examined two or more years after a lumbar 
fusion. The success of operation was determined 
on the basis of a specially devised disability 
rating scale. One-third of the patients remained 
unemployed despite a solidly healed fusion. 
Degeneration of intervertebral discs above the 
fusion level and psychological disturbances 
are the main reasons for unsatisfactory results. 
It is recommended that the preoperative screen­
ing of patients include, along with other tests, 
a psychological assessment.
Resume: Nous avons examine 28 anciens com- 
battants de la deuxieme guerre mondiale deux 
ans au moins apres une fusion lombaire. 
Nous avons evalue le succes de I'operation 
d'apres une echelle de cotation de I'invalidite 
specialement con?ue a cet effet. Un tiers des 
malades sont restes chomeurs, malgre une 
arthrodese solidement fixee. Les principales rai­
sons susceptibles d'expliquer les resultats de- 
favorables sont la degenerescence des disques 
intervertebraux, au-dessus du siege de I'arthro- 
dese, et des troubles psychologiques. II serait 
done sage de faire figurer un test psychologique 
parmi la batterie d'epreuves auxquelles on sou- 
met les malades en vue d'un depistage preope- 
ratoire des candidats a ['intervention.
Posterior lumbar spine fusion has been 
employed frequently in the treatment of low 
back pain after conservative management 
has failed to relieve disabling pain. Although 
the operation has made it possible for many 
patients to return to productive life, some 
remain disabled in spite of a solid fusion. 
The treatment of the so-called “failed back- 
surgery” patient is one of the most difficult 
clinical tasks facing the orthopedic surgeon.1
The results of posterior lumbar spine 
fusion vary, depending on the level fused 
and the criteria used in the final assessment 
of patients. Based on the solidity of fusion 
the success rate is 80% to 95% ,2-0 being
*From the Orthopedic and Trauma Research Unit, 
Shaughnessy Hospital, Division of Orthopedic 
Surgery, University of British Columbia, Vancou­
ver, B.C.
Reprint requests to: Dr. P. J. Kokan, Ward G6, 
Shaughnessy Hospital, Vancouver 9, B.C.
somewhat lower when a two-level fusion 
has been performed. On the other hand, 
when the main factor in assessing the re­
sults is the state of employment two years 
after fusion, the success rate is only 40% .7-9
The causes for failure of posterior lumbar 
spine fusion to restore the patient to a use­
ful life can be grouped into four categories: 
pathologic changes in the lumbar spine, 
psychological abnormalities, socioeconomic 
drawbacks and the influence of compensa­
tion.
Pseudarthrosis, degeneration of interver­
tebral lumbar discs at levels above the fu­
sion, and narrowing of the lumbar canal due 
to bony overgrowth are commonly men­
tioned causes of failure of back fusion.8 
The finding of psychological abnormality in 
most patients with poor results following 
lumbar spine fusion has induced some to 
suggest that neurosis is a reason for failure 
of fusion.8 It is obvious that a poor educa­
tional background and dependence on 
manual work constitute a major handicap 
to the patient with backache, significantly 
enhancing his disability. Similarly, com­
pensation in the case of industrial accidents 
can contribute to disability following fu­
sion.7 The relative importance of various 
causes of failure is not clear and further 
studies are necessary to find out why spinal 
fusion relieves pain in some patients and 
not in others.
Our aim was to establish the success rate 
for posterior lumbar spine fusion in a vet­
eran population by assessing the function 
of the lumbar spine and overall disability 
arising from backache. A rating scale for 
appraising the success of fusion in returning 
the patient to employment was developed. 
Furthermore, an attempt was made to iden­
tify the factors responsible for success or 
failure of fusion, with the object of using 
this information in the selection of can­
didates for lumbar spine fusion.
Method
Seventy-seven veterans underwent a
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Boucher-type lumbar spine fusion2 at one 
or more levels for low back pain at Shaugh- 
nessy Hospital, Vancouver in the seven- 
year period 1962 to 1968. Of these, 28 pa­
tients appeared for re-examination from two 
to nine years after their last fusion. A com­
plete physical, radiological and psychological 
assessment was made. In order to determine 
the total amount of disability arising from 
the back condition, a rating scale was de­
vised (Table I). The sum of the scores as­
signed to various criteria was used to 
classify the patients in three groups: group 
I, the seven with the lowest scores (good 
result); group II, an intermediate group of
14 patients (fair result); and group III, the 
seven with the highest scores (poor result). 
We considered the results in the latter two 
groups as unacceptable.
R e s u l t s  (Table II)
Chronology of the Disease
Although the patients were of similar 
ages at the time of examination, those in the 
group with the most favourable results had 
developed their symptoms later in life than 
the others and had a shorter time interval 
from the onset of back pain to their first 
fusion (Table III).
TABLE I.—Scoring Criteria for P atient Classification
Category Factor M a x im u m  score
Work, pain Reduced level of employment 1 or
Discontinued work owing to low back pain 3
Time lost in last two years 2
Presence of pain 2
Examination Impairment of: 
Gait O
Lumbar flexion 2
Lumbar extension 2
Lateral flexion, left/right 2
Straight-leg-raising pain
Low back tenderness 2
Rating Patient’s opinion of results 2
Patient’s opinion of value of surgery 2
Opinion of orthopedic examiner 4
Maximum (i.e. worst possible result)
TABLE II.—Variables D iscriminating Between the Groups (Percentage)
Variable Overall G roup I Group I I G roup I I I
Onset related to traum a.................................. 86 57 100 86
Single admission for problem.......................... 25 57 21 0
More than one fusion....................................... 25 30 40 43
Return to work in less than
four months after fusion.................................. 28 43 36 0
DVA pension for back..................................... 68 28 78 85
Abnormal cervical or thoracic spine.............. 32 0 35 57
Calf or thigh asymmetry.................................. 34 0 43 34
Sensory impairment.......................................... 34 0 36 57
Contrast medium present................................ 57 29 57 86
Single-level fusion (L5-S1).............................. 39 86 36 0
Two-level fusion (L4-S1)................................. 46 14 50 71
TABLE III.—Chronology of the D isease (Average, Years)
Group I Group I I Group I I I T o ta l
Age at examination............................................. 50 54 55 53.3
Age at onset......................................................... 33 27 26 27
Time interval between onset and fusion......... 9 18 15 15
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Symptoms
Of the total, 11% (3/28) were symptom- 
free, all belonging to group I. Pain alone 
was the dominant symptom in 64% (18/28). 
Only 21% (6/28) had not had an attack 
of acute back pain in the last two years 
(71% in group I, none in group II). The 
pain was felt only in the back in 32%, 
predominantly in the back in 32% , equally 
in the back and legs in 11 % and predomi­
nantly in the legs in 7% .
Trauma
There is a significant, direct relationship 
of trauma at onset to the severity of the 
back condition at follow-up.
Operative History
Multiple operations were associated with 
the groups with a poor score.
General Health
Twenty-one percent (6/28) admitted to 
no other health problems. There were more 
health problems among patients in the un­
satisfactory groups.
Occupation
Of the total, 50% (14/28) were in full 
employment. None of group III patients 
but 86% of group I (6/7) were in steady 
employment. No conclusion could be drawn 
about any difference in occupation between 
the groups. A better result was associated 
with an earlier return to work after opera­
tion. On the other hand, the receipt of a 
Department of Veterans’ Affairs pension 
was more commonly seen in the groups with 
poorer scores.
General Examination
Forty-three percent (12/28) demonstrated 
some abnormality on abdominal examination 
and 21% (6/28) on rectal examination, 
often in the form of coccygeal tenderness. 
These abnormalities were present mainly 
among patients with only fair and poor re­
sults.
Musculoskeletal Examination
Abnormality of the cervical and thoracic 
spine was found in 32%, but none of these 
patients was in group 1. Similarly, abnormal­
ity of the lumbar curve, spasm and deficient 
tone of abdominal muscles, and localized 
back tenderness were found mainly in pa­
tients with poor results.
Neurological Examination
Positive neurological signs, such as lim­
ited straight-leg-raising, thigh or calf muscle 
wasting and sensory impairment, were 
found only in patients in the fair and poor 
groups.
Radiological Findings
The presence of radiopaque contrast me­
dium, indicating investigation for disc pro­
lapse, was found mainly among patients 
with fair and poor results, which is not sur­
prising if their neurological abnormalities 
are considered. No instance of pseudarthro- 
sis was seen in this series although four pa­
tients had previously been operated upon 
for this condition. Kissing vertebral spines 
were seen at one level in 31% (10/28) and 
at two levels in one patient. The presence 
of this did not correlate with the results nor 
with the presence of spinous tenderness in 
the same patients.
Degenerative changes (traction spurs, os­
teophytes, narrowing of the upper four lum­
bar intervertebral spaces) correlated well 
with the grouping of the patients, being 
more pronounced in those with the poorest 
results. Single-level appeared to be more 
successful than two-level fusion.
Psychological Findings
The mean I.Q. using the Wechsler Adult 
Intelligence Scale was 107.2, slightly higher 
than expected for a random sample. There 
was no difference in intelligence or educa­
tional background between the groups.
The differences in the Minnesota Multi- 
phasic Personality Inventory profiles, partic­
ularly in four of the scales, are striking 
(Fig. 1). Group II shows the “conversion V” 
configuration of the neurotic triad (scales 1, 
2 and 3), the elevation of 1 and 3 (hypo­
chondriasis and hysteria) being greater than 
2 (depression). In group III there is eleva­
tion of hysteria, hypochondriasis and de­
pression and a low ego strength compared 
with the normal values for group I. In 57% 
of the patients there was a history of psy­
chopathology, ranging from schizophrenia
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to alcoholism, but this was uniformly dis­
tributed among the three groups.
D iscussion
The validity of our conclusions in this 
study is affected by the selection, based on 
availability, of this predominantly male vet­
eran sample. All patients had a similar so­
cioeconomic background; many were eli­
gible for pension.
With solidity of fusion as the sole criterion 
for success no case could be judged as a 
failure since all these patients had a solid 
fusion when assessed (some had had a 
previous repair of pseudarthrosis); this is 
in agreement with many published reports.2 
However, if the degree of disability is con­
sidered, fusion failed to enable 50% of 
patients to return to a functional life, while 
one-third were not working. This corre­
sponds with the results in studies where the 
major criterion for success of fusion is a 
return to employment.7
The poor results in this series might in 
part be owing to self-selection, since it is 
possible that only patients with painful backs 
made themselves available for re-examina­
tion. However, in a review of the charts of 
all 77 patients who had had a fusion at
Group 3 ............Fig. 1.—The discrimination scales on the Minne- sota Multiphasic Personality Inventory. Hs =  hy­pochondriasis; D =  depression; Hy =  hysteria; Es =  ego strength.
least two years previously, we discovered 
that more than one-third of those patients 
were unemployed and had disabling low 
back pain.We believe that the presence of advanced 
generalized disc degeneration and the 
existence of psychological abnormalities are 
major factors responsible for unsatisfactory 
results from lumbar fusion. In addition, the 
availability of compensation, long duration 
of symptoms before fusion, history of sev­
eral back operations and the presence of 
other health problems all contribute to the 
overall disability following fusion.
The careful analysis of radiographs re­
vealed more advanced degenerative changes 
of the lumbar discs among the patients with 
poor results. It can be assumed, therefore, 
that in these cases either fusion had not 
included all the symptomatic discs or in­
creased stress on the discs above the fusion 
level had accelerated the degenerative pro­
cess. These patients were more likely to 
have had a two-level fusion.
The psychological assessment at follow­
up demonstrated increased neurosis, ob­
jectively measurable, in the patients with 
poor surgical results. We do not know 
whether the neurosis developed before or 
after the fusion. According to Beals and 
Hickman7 and White,5’ who studied psy­
chological factors in low back pain, a pre­
existing neurosis precludes successful surgi­
cal treatment. It is quite possible that the 
patients in our study with poor results had 
preoperative neurosis which interfered with 
the success of surgical treatment.
Most patients receiving compensation 
were in the groups with unacceptable re­
sults. Since the majority of these patients 
were eligible for compensation it may be 
assumed that the availability of a pension 
delayed rehabilitation following fusion. Beals 
and Hickman,7 White5' and others0’ 8 
have found that the results of lumbar spine 
surgery are much poorer when compensa­
tion is provided. Denker mentions a better 
rate of return to work in compensation pa­
tients when they receive a lump sum settle­
ment than when regular continuing instal­
ments are paid.10
The degree of success of lumbar fusion is 
inversely related to the duration of low 
back pain prior to fusion; patients with
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poor results had a longer history of pain. 
Persistent backache for many years before 
fusion had rendered these individuals less 
physically fit and more neurosis-prone, thus 
making successful rehabilitation following 
lumbar fusion less likely.
Patients with disabling backache follow­
ing fusion had, in addition, other health 
problems, affecting particularly the geni­
tourinary and gastrointestinal systems. It is 
possible that persistent back problems and 
other disabling illness reflect premature 
ageing of lumbar discs as well as of other 
body systems.
C o nclusions
The production of solid lumbar fusion is 
not the only prerequisite for alleviation of 
disabling low back pain. Lumbar disc de­
generation limited to only one or two levels 
(included in the fusion), freedom from 
neuroticism and a short history of back pain 
are additional equally important factors for 
a successful operation, in the sense of reliev­
ing disability. The availability of compensa­
tion and the presence of disease states af­
fecting other body systems contribute to 
disability following fusion. The history of 
repeated operations is a sign of a poor 
prognosis. One can assume that if a first
operation was not effective in relieving the 
patient’s symptoms, further surgical attempts 
to control back pain will be equally unsuc­
cessful.
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STERNAL RESECTION AND REPLACEMENT WITH REINFORCED
SILASTIC SHEETING
W. J. ENGELBRECHT, M.D., R. BISARYA, M.D., L. BURR, M.D. and 
G. D. SAXTON, M.D., F.R.C.S.[Edin. & C],* Vancouver, B.C.
Summary: A case is presented of sternal re­
section for solitary chondrosarcoma and replace­
ment with Dacron-reinforced Silastic sheeting. 
The advantages of this material are its excellent 
acceptance by body tissues combined with its 
rigidity. The latter quality provides the chest 
wall with immediate and adequate stability. 
General technical precautions are to be taken 
as with all prosthetic materials.
Resume: Les auteurs presentent un cas de re­
section sternale pour chondrosarcome solitaire 
et ou le sternum a ete remplace par une matiere 
de Silastic renforce par du Dacron. Les avan- 
tages de cette matiere: son excellente accepta­
tion par les tissus et sa rigidite, Cette derniere 
propriete confere a la paroi thoracique une sta­
bility immediate et tres suffisante. Les precau­
tions techniques generates a prendre avec cette 
substance sont les memes que celles qui con- 
cement I'usage chirurgical de tous les materiaux 
de prothese.
T he purpose of this paper is to review 
the methods of sternal replacement de­
scribed in the literature and to add our 
own experience with the use of reinforced 
Silastic sheeting.f
Case R eport
A 73-year-old housewife was admitted to 
the Vancouver General Hospital on Decem­
ber 22, 1972 because of a progressively painful 
swelling of the sternum. She had noticed this 
mass for six months, and in the three weeks 
before admission it had become painful and 
she thought it had increased in size.
In 1969 she had experienced pain in the 
right hip and the radiographic appearance was 
compatible with Paget’s disease of the right 
innominate bone. Radiographs of the chest at 
that time were unremarkable. The only ab­
normality on laboratory investigation was 
an elevated level of serum alkaline phosphatase 
of 35 King-Armstrong units (normal 3 to 13).
Physical examination revealed an ovoid.
‘'Division of Cardio-Thoracic Surgery, Department 
of Surgery, University of British Columbia and 
the Vancouver General Hospital, Vancouver, B.C.
Reprint requests to: Dr. G. D. Saxton, 1607-West 
28th Avenue, Vancouver, B.C. V6J 2Y6.
IDow Coming Company, Chicago, 111. 60645.
hard, immobile tender mass in the mid-sternum, 
measuring 5 x 5  cm. Radiologically, the lesion 
was noted to extend anteriorly and posteriorly 
from the sternum and to contain mottled cal­
cifications.
An incisional biopsy was performed and the 
diagnosis of a well-differentiated chondrosar­
coma was established. Subsequently the xiphoid 
and entire body of the sternum together with 
the adjoining costal cartilages and intercostal 
structures were resected en bloc (Fig. 1).
A piece of reinforced Silastic sheeting (0.08 
inches thick) was tailored to fit the defect. 
The sheeting was anchored to the remnants 
of the costal cartilages and to the intercostal 
muscles with fine silk mattress sutures. Poly­
ethylene tube drains were placed on the an­
terior and posterior surfaces of the sheeting 
and brought externally through separate stab 
wounds. The pectoralis major muscles, sub­
cutaneous tissue and skin were then approx­
imated (Fig. 2). The drains were removed 
48 hours after operation.
Convalescence was smooth, without occur­
rence of infection, seroma or respiratory prob-
Fig. 1.—The defect following sternal resection.
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lems. The patient was discharged three weeks 
after the operation and has continued to do 
well.
D iscussion
Although in some series the solitary plas­
macytoma was found to be the most fre­
quent tumour of the sternum,1 the chon­
drosarcoma is the most common primary 
malignant tumour of the chest wall and the 
most significant2 in relation to surgical re­
section of the sternum.
Adequate resection of this malignant 
tumour would necessarily result in a serious 
defect in the chest wall with its attendant 
complications:3
(1) Sucking chest wound. This may be 
overcome by an airtight closure of the skin 
and soft tissues (with or without flap mobi­
lization).
(2) Mediastinal flutter and paradoxical 
respirations. The harmful effect on ventila­
tion can be avoided by performing a type of 
repair that provides chest wall stability.
(3) Potential infection and fluid accumu­
lation. The likelihood of these complications 
can be minimized by meticulous hemostasis, 
obliteration of potential dead spaces by tis­
sue flaps, short-term drainage and use of 
broad spectrum antibiotics.
Fig. 2.—The Dacron-reinforced Silastic sheeting 
sutured in place.
The qualities of the ideal prosthetic ma­
terial for replacement of chest wall defects 
(as enumerated by Le Roux4) are: (1)
ability to provide chest wall rigidity, to 
prevent paradoxical respiration and protect 
the underlying viscera; (2) inertness, to en­
sure tolerance by the host and incorpora­
tion into the body without major tissue re­
action; (3) malleability, to allow manipula­
tion and tailoring to fit the defect, the size 
of which is not predictable; (4) radiolucency, 
to allow the underlying viscera to be clearly 
visualized by x-ray.
The acrylic resin used by Le Roux pos­
sessed most of the characteristics of the 
ideal prosthesis except that it was not in­
corporated into the host satisfactorily. Alon- 
so-Lej and De Linera5 successfully over­
came this problem by combining the acrylic 
resin with Marlex mesh. This was well toler­
ated and was incorporated into the host’s 
tissues; however, it lacks the rigidity of the 
acrylic resin.
To simplify this problem we have used 
Dacron-reinforced Silastic sheeting to min­
imize elongation or stretch and permit easy 
fixation of the material by sutures. This 
reinforced silicone polymer meets all the 
Le Roux prerequisites, is simple to use, 
readily available and can be sterilized by 
autoclave. It is superior to Marlex mesh in 
having adequate rigidity to stabilize the chest 
wall, while at the same time being well ac­
cepted by the body tissues.
As well as the importance of observing 
the general precautions used with a ll, pros­
thetic materials we would emphasize meti­
culous techniques, scrupulous asepsis, fine 
suture material and short-term postopera­
tive drainage.
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LA PREPARATION AU TRAITEMENT CHIRURGICAL 
DE L’HYPERTHYROIDIE A L’AIDE DU PROPRANOLOL: 
ETUDE DE 15 OBSERVATIONS*
A. Z. EL-KHODARY, M.D., C. THIFFAULT, M.D., F.R.C.PJC1,
L. DESCHENES, M.D. et JEAN COUTURE, M.D., F.R.C.S.jC], F.A.C.S.
Quebec, P.Q.
Resume: L'utilisation du propranolol comme seul 
agent preparatoire a la chirurgie fait I'objet du 
present travail. Afin d'evaluer I'efficacite de 
cette methode de traitement, 15 patientes, dont 
le diagnostic avait ete confirms par le pourcen- 
tage de captation de I'iode radioactif et les ni- 
veaux de la thyroxine serique, ont ete etudiees 
suivant un protocoie etabli a I'avance. Propra­
nolol a ete donne par voie buccale a la dose de 
40 mg/6 h chez la plupart des patientes, la dose 
quotidienne variant considerablement suivant les 
reactions individuelles et les modifications des 
signes d'hyperthyroidie.
Chez la plupart des patientes, les signes 
d'hyperthyroidie ont diminue tres rapidement: 
des les premieres doses de medicament on a 
observe un ralentissement du pouls qui s'est 
normalise en general moins de trois jours apres 
le debut du traitement. De meme, les autres 
signes d'activite adrenergique tels que la trans­
piration, I'hyperkinesie, la chaleur de la peau, et 
les tremblements peripheriques ont complete- 
ment disparu dans la meme periode. En conse­
quence, la periode post-operatoire n'a dure que 
5.6 jours en moyenne chez toutes nos patientes.
L'intervention chirurgicale a consiste en une 
thyroidectomie subtotale conventionnelle et 
s'est deroulee de fa?on normale. Le chirurgien 
a note que les glandes etaient fermes et 
n'etaient pas plus vascuralisees que les glandes 
preparees de fapon conventionnelle. Les resul- 
tats immediats ainsi que tes resultats eloignes 
du traitement chirurgical ont ete tout a fait 
satisfaisants. Apres une periode d'observation 
de 10.6 mois en moyenne, I'etat Clinique des 
malades et les epreuves de fonction thyroYdienne 
demontrent bien I'efficacite de cette methode de 
preparation.
En definitive, les resultats chez ces 15 pa­
tientes semblent indiquer que propranolol est 
un medicament sur, a une action rapide, et per- 
met de raccourcir considerablement la periode 
de preparation chez les malades souffrant 
d'hyperthyroidie.
*Travail de la section d’endocrinologie et du de- 
partement de chirurgie de l’Hopital du Saint- 
Sacrement, Quebec, P.Q.
Presente au Congres frangais de chirurgie, Paris, 
19 au 22  septembre, 1973.
Summary: The administration of propranolol has 
been used as the sole means of preparation for 
thyroidectomy in hyperthyroidism. To evaluate 
further the safety and efficacy of this method 
we studied 15 hyperthyroid patients. The 
diagnosis of hyperthyroidism was confirmed bio­
logically by I3II levels of T4  and T3. Propra­
nolol was given orally at four- to six-hour inter­
vals to a total dose ranging from 206 to 659 
mg/24 hr. The preoperative preparatory period 
varied from three to five days.
Pentothal was used for induction of anesthesia 
except in tw o patients in whom Valium was 
used; halothane and oxygen were used for * 
maintenance. During induction only one patient 
developed bradycardia which responded to intra­
venous atropine. In all patients the surgeon 
found the gland firm, easily resectable and not 
unduly vascular.
Postoperatively all patients received propra­
nolol perfusion at the rate of 1 mg/hr for 12 
hours. The drug was then given orally at the 
preoperative dose, gradually reducing the 
amount until it was discontinued by the fifth 
day after operation; this corresponds with the 
duration of our calculated T4  disappearance 
interval of 5.3 days. T-w ave changes were 
noticed in most patients on the third day after 
operation. Vectocardiography showed no evid­
ence of ischemia. In all patients any changes 
noticed had returned to normal before discharge. 
Follow-up one year later showed that two of 
the 15 patients had developed hypothyroidism. 
The electrocardiogram was normal in all.
It is concluded that propranolol when used 
alone is safe and efficient for the preoperative 
preparation of hyperthyroid patients.
L e traitement chirurgical de l’hyperthy- 
roi'die n’a pas subi de modifications appre- 
ciables depuis plusieurs annees. De meme, 
la preparation des malades a Foperation est 
demeuree sensiblement la meme, soit l’ad- 
ministration d’antithyroidiens de synthese 
pendant plusieurs semaines et de l’iode pen­
dant les quelques jours precedant l’interven- 
tion. Bien que cette methode jouisse d’une 
grande faveur aupres des chirurgiens et des 
endocrinologues, il n’en reste pas moins 
qu’elle presente certains desavantages, dont
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l’un des plus importants est la periode assez 
longue de preparation requise avant l’ope- 
ration.
Depuis plusieurs annees, l’emploi de me­
dicaments anti-adrenergiques a ete suggere 
assez frequemment dans le traitement de 
la crise thyro'idienne. A la suite des travaux 
de Brewster et al,1 il a ete demontre assez 
clairement que la thryrotoxicose reprodui- 
sait, jusqu’a un certain point, les effets 
secondaries a une augmentation de l’activite 
du systeme nerveux sympathique. Le role 
des recepteurs beta dans la production des 
symptomes de rhyperthyroidie a ete demon­
tre abondamment par Marsden et ses asso- 
cies, et plusieurs autres-'4 qui, par ailleurs, 
ont traite avec succes les diverses manifes­
tations de la crise thyro'idienne par le blo- 
cage pharmacologique de ces recepteurs. De 
meme la reproduction de certains sympto­
mes associes a rhyperthyroidie tels que la 
transpiration, la temperature, la vaso-dila- 
tation et l’augmentation du pouls, a ete ob- 
servee apres la stimulation des recepteurs 
beta.
L’utilisation du propranolol comme an- 
tagoniste des recepteurs beta a ete preconi- 
see par Black et al en 1964.5 Peu apres, 
l’efficacite de ce medicament dans le con- 
trole des manifestations cliniques de la 
crise thyro'idienne et de rhyperthyroidie a 
ete soulignee par quelques investigateurs.6' 8
Ce n’est qu’en 1968 que le propranolol 
a ete utilise comme agent preparatoire a la 
chirurgie, en association avec l’iode par un 
groupe d’Afrique du sud.° Enfin, tout re- 
cemment, soit en juin 1973, un rapport 
d’un groupe de Washington faisait etat des 
resultats tres satisfaisants du traitement chi- 
rurgical fait chez 20 patients prepares uni- 
quement avec le propranolol.10
E tude Clinique
Notre travail porte sur 15 patients, pre­
pares a la chirurgie avec le propranolol et 
traites dans la section d’endocrinologie du 
departement de medecine et le departe- 
ment de chirurgie de l’Hopital du Saint- 
Sacrement a Quebec. II s’agit de 15 fem­
mes, dont l’age moyen est de 27 ans, la 
plus jeune ayant 15 ans, et la plus vieille 
43. Bien que deux patientes aient regu au 
moins un an auparavant des antithyroidiens 
de synthese, aucune d’entre elles n’avait ete
soumise anterieurement a un traitement 
chirurgical.
Afin d’obtenir une evaluation juste de 
cette methode, un protocole, prepare a l’a- 
vance et realise dans l’unite metabolique de 
l’Hopital du Saint-Sacrement, Quebec, nous 
a permis d’avoir un bilan complet de chaque 
patiente, incluant toutes les donnees biolo- 
giques soit le protein-bound iodine, le T4, la 
captation de l’iode radioactif a quatre et 24 
heures et le scintigramme thyroidien. Le 
diagnostic de rhyperthyroidie a ete confirme 
dans tous les cas par les resultats de ces 
examens. Durant cette periode d’observa- 
tion, les signes importants a noter chez de 
tels patients, soit le pouls, la respiration, la 
tension arterielle, la transpiration, et les si­
gnes oculaires ont ete notes frequemment. 
Chez ces patients, l’asthme bronchique a ete 
une contre-indication a ce traitement.
Propranolol par voie buccale a ete donne 
a la dose de 20 mg/6 h chez les premieres 
patientes et par la suite a la dose de 40 
mg/6 h chez la plupart des autres patientes. 
La dose quotidienne a varie considerable- 
ment suivant les reactions individuelles et 
les modifications des signes d’hyperthyroi- 
die: en general, la dose moyenne a ete de 
237 mg avec des variables de 206 a 659. 
La periode pre-operatoire a dure en moyen­
ne 5.6 jours, mais n’a dure que deux jours 
chez deux malades.
La diminution rapide des signes d’hyper- 
thyroi'die a ete notee chez la plupart des 
patientes. Le plus souvent, un ralentissement 
du pouls a ete note des les premieres doses 
de propranolol; cet effet s’est poursuivi jus­
qu’a normalisation du pouls, assurant ainsi 
un pouls stable jusqu’au jour de l’operation. 
La tension arterielle a subi quelques modifi­
cations tres mineures, mais la temperature 
est demeuree normale. L’intervention chi- 
rurgicale n’a ete faite qu’apres stabilisation 
non seulement des signes vitaux mais aussi 
des signes accessoires d’activite adrenergi- 
que, tels que la transpiration, l’hyperkinesie, 
la chaleur de la peau, et les tremblements 
peripheriques. Chez trois patientes, une 
perfusion d’Isuprel a ete faite 24 heures 
avant l’operation afin de determiner plus 
objectivement l’efficacite du blocage des re­
cepteurs beta par le propranolol. La der- 
niere dose de propranolol a ete donnee deux 
heures avant le debut de l’intervention.
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Traitement Chirurgical
Concernant l’anesthesie, l’induction des 
patientes a ete faite avec le pentothal sauf 
chez deux patientes ou le Valium a ete utilise 
a cause d’une histoire anterieure d’allergie 
aux barbituriques. Ces deux patientes ont 
presente dans la periode post-operatoire im­
mediate des symptomes pseudomyastheni- 
ques assez importants, soit dans un cas, un 
broncho-spasme transitoire, et dans l’autre, 
une obstruction bronchique importante ne- 
cessitant l’intubation d’urgence a deux re­
prises: ceci nous a amene a eviter l ’emploi 
du Valium chez ce groupe de patientes. 
L ’anesthesie a ete maintenue avec de l ’halo- 
thane et de l ’oxygene sans aucun incident 
facheux.
L ’operation elle-meme a consiste en une 
thyro'idectomie subtotale conventionnelle 
et s’est deroulee de faqon normale. En 
general le chirurgien a note que les glan- 
des etaient fermes, et n’etaient pas plus 
vascularisees que les glandes preparees de 
fagon conventionnelle.
L ’examen histopathologique a montre les 
aspects connus de l’hyperplasie des vesicules 
thyroi'diennes, mais il n’y avait pas d’infil- 
tration appreciable du parenchyme par des 
lymphocytes et des plasmocytes comme on a 
l ’habitude de les rencontrer dans les goitres 
traites de fagon classique.
Propranolol a ete administre par la voie 
intraveineuse immediatement apres 1’opera- 
tion a un dosage de 1 mg/h pour les pre­
mieres 12 heures ou du moins jusqu’a ce que 
la patiente soit capable d’utiliser la voie 
orale, la posologie etant la meme que la 
periode pre-operatoire. Durant cette periode 
du traitement, une surveillance attentive des 
signes vitaux a ete faite par monitorat con- 
tinu. A  partir du troisieme ou quatrieme 
jour, une diminution progressive de la quan­
tity de propranolol a pu etre faite, suivie 
d’un arret complet apres cinq ou sept jours.
etant donne que cette fonction n’avait pas 
ete affectee dans la periode pre-operatoire, 
le propranolol n’agissant pas a ce niveau, 
du moins dans l’etat actuel des connaissan- 
ces.
A  cause de l ’effet anti-adrenergique du 
propranolol, nous nous sommes interesses 
particulierement aux modifications electro- 
cardiographiques que pourrait provoquer 
l ’utilisation de ce medicament. Durant la 
periode pre-operatoire alors qu’un fort do­
sage de propranolol etait necessaire, aucune 
modification n’a ete notee a l ’electrocardio- 
gramme. Cependant, des inversions des on- 
des T  et des changements non specifiques 
sont apparus au troisieme jour post-opera­
toire chez la majorite des patientes, sans 
qu’on puisse mettre en evidence des symp­
tomes ou signes evidents d’ischemie myocar- 
dique. Cependant, deux jours apres avoir 
cesse le propranolol, les ondes T  sont dis- 
parues de meme que les changements non 
specifiques. II nous est impossible actuelle- 
ment d’expliquer de telles modifications de 
l’electrocardiogramme. De plus, la vecto- 
cardiographie faite, avant, durant et apres 
l’administration de propranolol a donne des 
resultats tout a fait normaux.
La  captation de l’iode radioactif a atteint 
les limites de la normale apres sept jours 
chez sept patientes soumises a cet examen. 
De meme, la thyroxine serique indique clai- 
rement que la fonction thyro'idienne etait 
devenue presque normale au quatrieme jour, 
et que toutes les patientes etaient euthy- 
roi'diennes au septieme jour.
Le resultat est demeure presque constant 
jusqu’a ce jour puisqu’apres une periode 
d’observation de 10.6 mois en moyenne 
l’etat clinique et les epreuves de fonction 
thyro'idienne sont demeurees inchangees. 
Deux patientes presentent des signer clini- 
ques et biologiques d’hypothyroi'die, neces- 
sitant l ’emploi d’extraits thyroidiens (tableau 
1 ).
~c
r
>-
Sf
1
Resultats
Durant la periode post-operatoire, l ’equi- 
libre metabolique s’est maintenu chez tou­
tes les patientes, comme l’indiquaient le 
pouls, la respiration, la tension arterielle 
et la temperature. II s’agissait done de de­
terminer si l ’intervention chirurgicale avait 
modifie vraiment la fonction thyro'idienne
Discussion
A  la suite de cette etude, quelques points |
importants doivent etre soulignes dans l’e- ■
valuation de cette methode de traitement.
En premier lieu, le propranolol est un 
medicament sur, a l ’action rapide et qui ne 
donne aucun effet secondaire. Au contraire ^ :
des antithyroi'diens, son action est transi- I
September 197 b PROPR ANOLO L E N  L ’H Y P E R T H Y R O I D IE 307
toire, d’ou la necessite de continuer l’admi- 
nistration du medicament durant la periode 
post-operatoire soit cinq a sept jours, alors 
que le patient devient euthyroidien. Cette 
periode de temps correspond assez exacte- 
ment a la demie-vie de la thyroxine endo- 
gene qui, selon Lee et ses collaborateurs10 
est de 7.2 jours, et d’apres Sterling et 
Chodos,11 6.2 jours. Dans notre milieu, 
la demi-vie de la thyroxine a ete etablie a 
5.3 jours, le calcul etant fait sur ce groupe 
particulier de malades.
La rapidite d’action de propranolol per- 
mettrait de traiter assez rapidement certains 
patients porteurs d’hyperthyroidie et pre- 
sentant des pathologies aigues, telles qu’un 
ulcere perfore ou d’autres problemes chi- 
rurgicaux ou medicaux. Cependant, il n’est 
pas indique d’utiliser propranolol en etat 
de grossesse a cause de l’absence de don- 
nees a ce sujet.
Parmi les avantages les plus importants, 
notons le raccourcissement marque de la 
periode pre-operatoire, qui n’a ete que de 
trois a quatre jours chez la plupart des ma­
lades, dont plusieurs venaient de regions 
eloignees du Quebec. Cet avantage est qua­
lifies d’assez exceptional par le chirurgien 
et l’endocrinologue habitues a la preparation 
assez longue que necessite l’emploi d’anti- 
thyroi'diens et d’iode.
II n’y a pas eu de crise thyroi'dienne, 
mais, connaissant l’efficacite constante du 
propranolol dans le traitement de cette com­
plication, selon nous, il aurait suffi d’une 
legere modification du dosage du medica­
ment pour en controler les effets.
L’intervention chirurgicale s’est deroulee
dans la periode pre-operatoire et post-operatoire 
chez les patientes preparees avec propranolol.
normalement dans tous les cas, sans que le 
chirurgien ait note de difficultes particulie- 
res: dans certains cas, F operation apparais- 
sait meme plus facile que dans le cas de 
patients prepares de fa$on conventionnelle.
Bien qu’on semble d’avis que propranolol 
n’exerce aucun effet sur la glande thyro'ide, 
certaines etudes enzymatiques et histochimi- 
ques devraient etre faites afin de verifier 
cette hypothese: cependant, au point de vue 
pharmacologique, il semble peu probable 
que ce medicament ait une action quel- 
conque sur la glande elle-meme. De plus, 
facteur assez rassurant, malgre les modifi­
cations electrocardiographiques transitoires 
notees vers le troisieme jour post-operatoire, 
propranolol ne semble pas avoir affecte l’ac- 
tivite normale du myocarde chez nos patien­
tes, comme Font demontre les examens elec­
trocardiographiques faits avant, pendant, et 
apres le traitement chirurgical. Concernant 
ce point precis, cette tolerance assez parti- 
culiere qu’ont les patients souffrant d’hyper­
thyroidie de pouvoir recevoir d’assez fortes 
doses de propranolol sans inconvenients no­
tables doit etre soulignee; notons cependant 
que les changements notes a l’electrocardio- 
gramme vers le troisieme jour post-operatoire 
sont survenus au moment ou les patients re- 
cevaient des doses moins importantes de pro­
pranolol. Des modifications analogues d’or- 
dre hemodynamique ont ete rapportees chez 
des patients normaux recevant de faibles 
doses de propranolol.12
Les resultats du traitement chirurgical 
ont ete tout a fait satisfaisants, tant sur le 
plan clinique que sur le plan biologique. Il 
semble bien que le pourcentage de patients 
souffrant d’hypothyroidie apres operation 
sera a peu pres le meme que chez les pa­
tients prepares de fa?on conventionnelle.
De cette etude se degagent plusieurs 
points demontrant que cette fa§on de proce- 
der presente certains avantages dont les 
principaux sont les suivants: le medicament 
est sur, a une action rapide, et ne semble 
pas donner d’effets secondaires; la periode 
pre-operatoire est considerablement raccour- 
cie, permettant a l’intervention chirurgicale 
de se faire avec securite apres quatre a cinq 
jours de preparation; enfin les resultats 
du traitement chirurgical, chez de tels pa­
tients, sont satisfaisants et, jusqu’a present, 
comparables aux resultats qu’on peut obte-
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nir chez des patients prepares avec les anti- 
thyroidiens et l’iode.
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OSMOLALITY OF HYPERALIMENTATION SOLUTION INFUSED 
INTO THE SUPERIOR VENA CAVA*
MERVYN DEITEL, M.D., F.R.C.S.[C], F.A.C.S., F.I.C.S.t and 
VICTOR KAMINSKY, M.B., F.R.C.S.IEdin.), Toronto, Ont.
Summary: The solutions for intravenous hyper­
alimentation must be infused into a large central 
vein where they are rapidly diluted so that 
thrombosis will not occur. The rate of this dilu­
tion was studied in 12 patients.
The technique commonly used in intravenous 
hyperalimentation was employed: a 20-cm
catheter was threaded via the right subclavian 
vein to the superior vena cava, leaving 2.5 cm 
of catheter between the skin and the 5-cm 
needle. Thirty days later a left subclavian punc­
ture was performed and a catheter inserted in 
the same way into the superior vena cava. 
Because the great veins are on the right side 
of the mediastinum, the right catheter tip was 
1.2 to 3.1 cm (mean 2.1) in advance of the left 
catheter measured radiographically. The solu­
tions were pumped into the left subclavian 
catheter at a rate of 400 to 500 mg of glucose 
per minute (glucose:protein hydrolysate ratio 
of 5:1), and after withdrawing samples, serum 
osmolalities were measured.
Hyperalimentation solution osmolality ranged 
from 1,055 to 1,860 mOsm/kg H20 . Mean osmo­
lality of serum from the right caval catheter was 
286 mOsm/kg, from the femoral artery 286 
mOsm/kg and from the femoral vein 287 
mOsm/kg H20 . In all serum samples osmolality 
was in the normal range, and was not signifi­
cantly higher in samples drawn from the supe­
rior vena cava.
Dilution in the superior vena cava of extremely 
hyperosmolar hyperalimentation solutions, at 
the rates commonly administered, appears to be 
immediate.
Resume: Pour eviter le developpement d'une 
thrombose, on doit perfuser les solutions desti- 
nees a I'hyperalimentation par voie intraveineuse 
dans une grosse veine centrale, oil elles se 
diluent rapidement. La vitesse de cette dilution 
a ete etudiee chez 12 malades.
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Nous avons employe la methode couramment 
utilisee dans I’hyperalimentation par voie intra­
veineuse: nous avons introduit un catheter de 
20 cm dans la veine cave superieure, via la veine 
sous-claviere droite, en prenant soin de laisser 
un bout de catheter entre la peau et I’aiguille de 
5 cm. Apres 30 jours de perfusion, au moment 
oil on change le catheter, nous avons ponctionne 
une veine sous-claviere gauche et, de la meme 
fagon, nous avons introduit un catheter dans la 
veine cave superieure. Etant donne que les 
grandes veines sont situees du cote droit du 
mediastin, I’extremite du catheter droit etait en 
avance de 1.2 a 3.1 cm (moyenne 2.1 cm) sur le 
catheter gauche (mesure radiographiquement). 
Nous avons pompe les solutions dans le cathe­
ter de la sous-claviere gauche a un debit de 400 
a 500 mg de glucose par minute (le rapport glu- 
cose/hydrolysat de proteine etant de 5 a 1) et, 
apres avoir preleve des echantillons, nous avons 
mesure I’osmolalite du serum.
L’osmolalite de la solution d’hyperalimentation 
a varie de 1,055 a 1,860 mosm/kg d’eau. L’os- 
molalite serique moyenne provenant du catheter 
droit de la veine cave etait de 286 mosm/kg, de 
I’artere femorale de 286 mosm/kg et de la veine 
femorale de 287 mosm/kg d’eau. Dans tous les 
echantillons de serum, I’osmolalite est demeuree 
dans les limites normales, et n’etait pas nette- 
ment plus elevee dans les echantillons preleves 
directement dans la veine cave superieure.
Par ailleurs, la dilution dans la veine cave 
superieure de solutions d’hyperalimentation tres 
fortement hyperosmolaires, est immediate aux 
debits couramment utilises.
O sm o l a l it y  is a measure of osmotic pres­
sure which depends on the number of par­
ticles (ions and undissociated molecules) 
in solution, and is expressed as mOsm/ 
kg HoO.1 Normal serum osmolality is 270 
to 300 mOsm/kg H20 . In intravenous hy­
peralimentation, markedly hypertonic solu­
tions of glucose and amino acids are infused. 
- •  :i It is known that even a twice osmolar 
solution when introduced into a peripheral 
vein will eventually cause phlebitis. To avoid 
phlebothrombosis the highly concentrated 
solutions used in hyperalimentation are 
dripped into a large-diameter central vein, 
such as the superior vena cava, thus favour­
ing their rapid dilution. Passage of viscid
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Fig. 1.—(a) Anteroposterior and (b) lateral ra­
diographs showing the relative catheter positions.
solution through the pulmonary circulation 
could have deleterious effects. Furthermore, 
accumulation of the hyperosmotic solution 
could lead to intracellular dehydration and 
hyperosmotic non-ketotic coma.4 The rap­
idity of dilution of the hyperosmotic hyper­
alimentation solution in the superior vena 
cava was studied in 12 patients.
M ethod
The technique commonly used in intra­
venous hyperalimentation was employed:- 
using aseptic precautions, a 20-cm polyvinyl 
catheter was inserted via the right subclavian 
vein into the superior vena cava. A 2.5- 
cm length of the catheter was left between 
the 5-cm needle and the skin. After 30 days 
of hyperalimentation via the first catheter 
(the length of time we generally leave cathe­
ters in situ), a second 20-cm catheter was 
threaded down the left subclavian vein 
into the superior vena cava, and again 2.5 
cm of catheter was left between the needle 
and the skin. The positions of the catheter 
tips were confirmed by radiography, and 
the studies were carried out before the right 
catheter was removed.
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As the superior vena cava lies on the 
right side of the mediastinum, the right 
catheter tip lies 2 to 3 cm in advance of the 
left catheter if positioned correctly. Hyper­
alimentation solution of known osmolality 
was pumped at a constant rate (400 to 500 
mg of dextrose per minute, with a dextrose: 
amino acid ratio of 5:1) through the left 
catheter, while a sample of blood distal 
to the left catheter tip was withdrawn 
through the right catheter. The osmolality 
was determined of this sample, and of peri­
pheral venous and arterial samples obtained 
from the femoral vein and artery respec­
tively. Measurements were based on the 
depression of freezing point of the water 
in the patient’s serum below that of distilled 
water using the model 66-31 LAS advanced 
osmometer.
The distance between the proximal and 
distal catheter tips was measured directly 
from the chest radiographs (anteroposterior 
and lateral views, Fig. 1), and the percentage 
magnification was calculated from the ac­
tual 20-cm length of the catheter compared 
with the x-ray length (Table I).
Results
The mean osmolality of the hyperalimen­
tation solution was 1,361 mOsm/kg H.O, 
more than four times the osmolality of nor­
mal serum. The mean distance between the 
two catheter tips was 2.1 cm and the mean 
osmolality in the superior vena cava at the 
distal catheter tip was 286 mOsm/kg H.O. 
The mean peripheral arterial and venous
osmolalities were 286 and 287 mOsm/ 
kg H .O  respectively. In all patients the se­
rum osmolality in the superior vena cava 
and the peripheral vessels was within the 
normal range.
Comment
In patients who are being adequately hy­
drated and who are non- or controlled 
diabetics, the nutrients infused are meta­
bolized peripherally, so that serum concen­
trations do not rise and hyperosmolality 
does not develop. Moreover, the dilution 
of the infusion in the patients whom we 
studied appeared to be extremely rapid.
Summary
A study was conducted in 12 patients to 
ascertain how rapidly the markedly hyperos­
motic solutions used in intravenous hyper­
alimentation, at the rates commonly admin­
istered, are diluted in the superior vena 
cava. In all cases dilution appeared to be 
immediate.
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TABLE I.—Osmolality Measurements in P atients on Hyperalimentation
Patient
no.
Osmolality 
of IVH  
solution
(mOsm/kg H20 )
Serum osmolality (mOsm/kg HtO)
Superior Peripheral Peripheral 
vena cava vein artery
Distance between 
catheter tips 
on radiographs
(cm)
Magnifi­
cation
(%)
Corrected distance 
between 
catheter tips 
(cm)
i 1,370 287 290 287 2.7 10.3 2 42 1.292 297 298 297 1.9 8.8 1 73 1,517 294 293 294 3.3 11.7 2 94 1,135 286 287 288 3.4 10.3 3 15 1,148 291 291 291 1.6 8.8 1 56 1,671 283 286 280 2.4 14.7 2 07 1,055 297 295 295 1.3 10.3 1 28 1,200 268 275 273 1.4 13.2 1 29 1,860 270 268 268 3.2 3.3 3 110 1,272 276 278 277 2.3 9.8 2 1n 1,487 290 290 290 3.0 12.0 2 612 1,324 292 293 291 1.9 9.1 1.7
Mean
values 1,361 286 287 286 2.4 10.2 2.1
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CANCER RISK IN ULCERATIVE COLITIS: ITS INDEPENDENCE 
OF LUMINAL FACTORS
GILLES BEAUREGARD, M.D. and GHISLAIN J. DEVROEDE, M.D.,*
Sherbrooke, Que.
Summary: Two patients developed cancer of the 
rectum several years after an ileostomy had 
been performed because of ulcerative colitis. 
Bypass of the large bowel therefore does not 
reduce the significant risk of malignant change 
incurred by patients suffering from ulcerative 
colitis.
Resume: Deux malades ont presente un cancer 
rectal plusieurs annees apres avoir subi une 
ileostomie pratiquee pour colite ulcereuse. II 
s'ensuit que le court-circuitage du gros intestin 
ne reduit pas necessairement le risque incon­
testable de transformation maligne qu'encourent 
les malades atteints de colite ulcereuse.
The risk of cancer of the large intestine is 
markedly increased in patients with ulcera­
tive colitis, whether they contract their dis­
ease during adulthood1 or during child­
hood. 2-4
Once ulcerative colitis has developed the 
colonic mucosa remains permanently ab­
normal in most patients, at least if continuity 
of the bowel is maintained.5 Colectomy 
with anastomosis of the ileum to the dis­
eased rectum does not protect against can­
cer risk5 but we did not know whether by­
pass of the diseased bowel would protect 
against it. This question is relevant because 
intraluminal factors, particularly those of 
a dietary nature, have been implicated in 
the genesis of cancer of the colon and rec­
tum .7
Cancer of the rectum developed in two 
patients a number of years after colectomy 
and ileostomy had been performed for ul­
cerative colitis.
Case Reports
Case 1.—A 45-year-old woman sought help 
at the emergency department for a perineal 
mass.
A diagnosis of ulcerative colitis had been 
made when she was 20 years old. The onset
was acute and she had had two other acute 
episodes at the ages of 28 and 39. Ileostomy 
without colectomy was carried out during 
that third attack and was followed four months 
later by subtotal colectomy. Abdomino­
perineal resection was perform ed when she 
was 43 years old for persistent rectal bleed­
ing. A fter the last operation she suffered 
from interm ittent perineal discharges for 
six months but was th ereafte r asymptom­
atic.
Two weeks before her admission to the 
emergency department she noted a sensation 
of a perineal mass with progressive, localized 
pain. At examination, a small mass, dark and 
tender, could be seen protruding at the site 
of the perineal incision. During vaginal exami­
nation, a 3 x 7-cm cystic mass was palpable 
at the former location of the rectum. Colour­
less mucoid fluid (300 ml) was drained from 
the cyst via the perineum. A biopsy was taken 
of the cyst wall which showed mucus-secreting 
cells. When the cyst was completely resected 
a well-differentiated adenocarcinoma was 
demonstrated, originating in a portion of resid­
ual rectal wall (Fig. 1). A review of the original
fP Jr '•
y t j
# 1
^  m *  . ' ^  >
*Gastrointestinal Research Unit, University of 
Sherbrooke, Sherbrooke, Que.
Reprint requests to: Dr. Ghislain J. Devroede, D e­
partment of Surgery, Centre Hospitalier Universi- 
taire, Sherbrooke, Que.
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Fig. I.— Mucus-producing adenocarcinoma.
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gical patients who have a functional 
gastrointestinal tract and who need a 
low residue diet. FLEXICAL may also 
serve as an alternative to clear fluids 
which, although low residue, are fre­
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by a food pump if additional calories 
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and may be adjusted by the dilution 
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specimens of colon and rectum  failed to dem­
onstrate any malignant changes.
Case 2 .— A patient we have kept under 
surveillance since the onset of ulcerative colitis 
during childhood2 developed cancer of the 
large intestine8 originating in the rectum. 
Forty-four years earlier, at the age of 11 years, 
she had had a diverting ileostomy and had 
refused  f u r th e r  operation. D rain ag e  of re ­
cent onset fro m  the bypassed in te stin e  led 
to a proctocolectomy, and a grade I mucoid 
adenocarcinoma was found in the rectum.
D iscussion
These case histories indicate that bypass 
of the colon in patients with ulcerative colitis 
will not prevent the genesis of cancer of 
the large bowel. Few physicians will leave 
permanently bypassed a rectal stump, and 
the development of a cancer in residual rec­
tal mucosa is, of course, the result of a 
technical error. Hence it is difficult to quan­
tify the risk of cancer in a bypassed segment 
of large intestine involved by colitis. This 
brief report serves only to indicate that if 
operation is performed to protect the patient 
with ulcerative colitis against cancer risk, 
proctocolectomy should be done. It appears 
also that cancer may develop as a complica­
tion of ulcerative colitis even if the fecal 
stream has been diverted and therefore that 
luminal factors are not predominant ele­
ments in the genesis of these cancers.
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PREDUODENAL PORTAL VEIN: A SIGNIFICANT ENTITY? 
REPORT OF TWO CASES AND REVIEW OF THE LITERATURE*
P. BRAUN, P. P. COLLIN, M .D.t and
I. C. DUCHARME, M.D., M.Sc.(Med.), F.R.C.S.[C],§
Montreal, Que.
Summary: A preduodenal position of the portal 
vein is rare. To the 39 cases already mentioned 
in the literature, we add this report of two cases 
in which the condition was diagnosed during 
surgical exploration for neonatal duodenal ob­
struction. A short explanation of the embryolo­
gy of the malformation is presented. The habitu­
al presence of associated anomalies is empha­
sized. W e believe these, and not the preduodenal 
portal vein, produce the clinical picture of 
duodenal obstruction and these lead to the 
discovery of the abnormal position of the ves­
sel.
Resume: La situation preduodenale de la veine 
porte est rare. La litterature comporte seulement 
39 cas. Les auteurs rapportent deux observa­
tions personnelles dont la malformation a ete 
decouverte lors de I'exploration chirurgicale 
pour occlusion duodenale neonatale. Le rappel 
embryologique permet d'analyser les differentes 
dispositions anormales de la veine porte. Les 
malformations associees frequemment presen- 
tes sont, selon les auteurs, la cause d e s tr u c ­
tion duodenale dans la majorite des cas.
V a r ia t io n s  in the tributaries of the portal 
vein are numerous,1' 2 but the course of 
the portal vein itself, behind the duodenum, 
and its relationship to the porta hepatis are 
quite constant. In a review of the world 
literature we have been able to find only 
39 reported cases of an anomalous position 
of the portal vein.
The first description of a preduodenal 
portal vein was published by Begg:! in
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1912, in a 10-mm pig embryo. Nine years 
later Knight4 found this anomaly in a hu­
man at autopsy and pointed out its surgical 
implication. In 1926 Schnitzler5 was the 
first to operate successfully on such a case, 
in an adult.
Within the past few years we have had 
the opportunity to treat two newborn in­
fants with this malformation. In both in­
stances the malformation was discovered 
during surgical exploration for duodenal 
obstruction. The experience gained from 
our cases and a critical review of the 39 
published cases make us question whether 
the easy explanation, that symptoms of duo­
denal obstruction are attributable to a pre­
duodenal portal vein, is the correct one. 
The symptoms may be caused by other as­
sociated anomalies.
C ase  R epo r ts
Case B. P., born on June 22, 1968, was
transferred to Ste Justine Hospital for Chil­
dren, Montreal, 15 hours after birth because 
of bilious vomiting. The family history was 
non-contributory and there had been no poly­
hydramnios during the pregnancy.
The baby was slightly hypotonic and dehy­
drated on admission. The abdomen was soft 
and scaphoid, with no hepatosplenomegaly or 
any adventitious mass. Bowel sounds were ab­
sent. No meconium had been passed but the 
anus was patent.
A plain radiograph of the abdomen with the 
child in the upright position showed air in the 
stomach and as far distal as the second portion 
of the duodenum but none beyond. A barium 
enema confirmed the normal position of the 
colon.
After rehydration a laparotomy was per­
formed on June 24 when a preduodenal portal 
vein was found associated with complete ob­
struction of the intestinal lumen at the junction 
of the second and third portions of the duo­
denum. As it was impossible to pass a Levin 
tube or even inject air beyond that level, it 
was concluded that atresia was complete, and 
enterotomy to demonstrate a diaphragm was 
not performed. Side-to-side duodenoduodenal
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anastomosis was carried out. The postoper­
ative course was uneventful.
Case 2.—R. C., born on June 26, 1972, was 
admitted on the sixth day of life to Ste Justine 
Hospital because of persistent emesis of green 
material since birth. There was no pertinent 
family history.
The general clinical picture was one of 
high intestinal obstruction. Plain radiograph
Fig. 1.—Case 2. Abdominal film on admission 
demonstrating the presence of an air-fluid level 
in the first portion of the duodenum and air in 
the small bowel on the left side of the abdomen.
Fig. 2. —Case 2. Dilated first and second por­
tions of the duodenum and a small amount of 
contrast material in the third and fourth duodenal 
portions following the administration of barium.
of the abdomen with the infant in the upright 
position showed air-fluid levels in the stomach 
and first portion of the duodenum. Air was 
also seen in the small bowel, especially on the 
left side of the abdomen (Fig. 1), suggesting 
an incomplete obstruction at the second por­
tion of the duodenum. An upper gastrointes­
tinal series done through a gastric tube opaci­
fied a normal stomach and dilated first and 
second portions of the duodenum. A small 
amount of barium could be seen trickling along 
the third and fourth portions of the duodenum 
(Fig. 2).
The baby was operated upon the next day. 
A malrotation was found and the Ladd proce­
dure performed. Then, through a Stamm gas­
trostomy, a size 10 French Foley catheter was 
introduced into the duodenum but could not 
be pushed beyond the junction of the first and 
second portions, where there were still some 
bands holding the duodenum to the gallblad­
der. While freeing those bands we came upon 
a large vessel lying in front of the duodenum 
at the level where the Foley catheter was ar­
rested. Through a duodenotomy, and with the 
help of the Foley catheter, we were able to 
demonstrate an intraluminal diaphragm (wind­
sock type) with a 1- to 2-mm aperture located 
eccentrically. The ampulla of Vater was 
located within the wall of the diaphragm 
posteriorly (Fig. 3). The diaphragm was ex­
cised except for its posterior portion. After 
closure of the duodenotomy the Foley catheter
Fig. 3.—Case 2. Drawing representing the find­
ings at operation.
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could be easily inserted to the fourth jejunal 
loop; even with its balloon inflated it could 
be withdrawn without hindrance. A gastro­
stomy tube was left in the stomach and the 
wound closed. The postoperative course was 
smooth.
E m bry ology
The embryological development of the 
portal vein in man provides a satisfactory 
explanation for its preduodenal position.6'8 
At the 4-mm stage of embryonic life the two 
parallel vitelline veins of the yolk sac, which 
drain the venous blood from the primitive 
gut, are connected by three anastomotic 
branches (Fig. 4): (1) the superior anasto­
mosis which lies within the liver; (2) the 
middle anastomosis which is subhepatic and 
retroduodenal; and (3) the inferior anasto­
mosis which is preduodenal and lies below 
the entrance of the common bile duct into 
the duodenum.
Parts of this vascular arrangement be­
come atrophic and at the 9-mm stage of 
embryonic life the superior and inferior 
anastomoses as well as the superior part of
Fig. 4.—Embryological development of the por­
tal vein (after Patten7): (A) 4-week-old embryo, 
(B) 5-week-old embryo, (C) 6-week-old embryo and 
(D) 7-week-old embryo. 1 =  sinus venosus, 2 =  
liver bud, 3 =  left vitelline vein, 4 =  left um­
bilical vein, 5 =  vitelline duct, 6 =: hepatic capil­
lary plexus, 7 =  intestine, 8 =  ductus venosus, 
9 =  superior, middle and inferior vitellovitelline 
anastomoses, 10 =  inferior vena cava, 11 =  por­
tal vein.
the left vitelline vein and the inferior part 
of the right vitelline vein normally disap­
pear. The middle anastomosis persists and 
becomes the origin of the portal vein which 
passes in the form of an “S” behind the 
duodenum.
If the middle retroduodenal anastomosis 
atrophies and the inferior preduodenal an­
astomosis remains patent, the result is a 
preduodenal location of the portal vein. 
Several other abnormal patterns may de­
velop but this one is the most common.
It is also important to realize that ana­
tomical abnormalities of the portal vein 
can also be caused by an embryological 
maldevelopment of the gut. Malrotations of 
the foregut, for example, can result in an 
inversion of varying degree. Thus, a situs 
inversus of the stomach and duodenum can 
lead to a preduodenal location of the portal 
vein, although the embryological develop­
ment of the vessel is normal.0
D iscussio n
Of the 39 cases of preduodenal portal 
vein that we found in the literature and the 
two cases reported above (Table I),4’ 3 8-33 
34 (83%) had other associated malforma­
tions, often multiple (Table II).
The most frequent of these were intestinal 
malrotation (30 cases) and situs inversus 
(12 cases). Next in order were anomalies 
of the duodenum; stenosis in one, atresia 
in three and intrinsic diaphragm in seven 
cases. It is well known that malrotation and 
intrinsic duodenal obstruction are frequent­
ly associated; this was so in nine cases 
(30%).
If one considers that anomalies of the 
pancreas (10 cases), biliary atresia (four 
cases), duodenal malformations (11 cases) 
and congenital duodenal bands (eight cases) 
also can be found with a preduodenal por­
tal vein, it becomes evident that the em­
bryological defect involves many neighbour­
ing structures located in an area of “great 
embryological activity”.
From a pathophysiological point of view, 
the preduodenal portal vein is probably the 
least significant feature of this composite 
picture. A detailed analysis of these 41 cases 
has not convinced us that in the anterior 
position the portal vein can obstruct the 
duodenum. From a theoretical standpoint
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it seems difficult to believe that a low venous 
pressure within a thin-walled vessel can 
cause such an obstruction. It is more likely 
that the reverse is true, that the duodenum 
obstructs the portal vein and creates portal 
hypertension. Yet this has never been re­
ported. Furthermore, in most cases (83%) 
the associated malformations, e.g. duodenal 
bands, annular pancreas and malrotation, 
can adequately explain the symptoms. Final­
ly, many of the above cases were treated 
by performing a short-circuiting anastomosis 
around the portal vein without making any 
real attempt to exclude intrinsic stenosis of 
the duodenum. The fact that many cases 
of preduodenal portal vein have been re­
ported in adults does not rule out an in­
trinsic diaphragm as the real cause of ob-
TABLE II.—M alformations Associated with 33 
Cases of Preduodenal Portal Vein
Intestinal malrotation, non-rotation and
incomplete fixation............................................ 30
Abdominal situs inversus, partial or complete 12
Duodenal malformations: ................................. 11
stenosis.......  1
diaphragm.. 7
atresia.........  3
Pancreatic malformations.................................  10
Cardiovascular malformations and
dextrocardia....................................
Congenital periduodenal bands. . .
Splenic anomalies 
Biliary atresia. . .
Sacral agenesis....................................................  1
Down’s syndrome............................................... 1
Total.................................  92
TABLE I.—Reported Cases of Preduodenal Portal Vein
Duodenal obstruction due to:
Author Age Sex Portal vein Other causes
Knight 19214...................................................... 60 yrs M No No
Pernkopf 1926* ° . .............................................. — M No No
Newborn M No No
Child M No No
Schnitzler 1926®................................................ 41 yrs M Yes No
Pernkopf 1928s .................................................. 19 yrs M No No
Lehmann 193111................................................ 5-- M Yes No
Pernkopf 193212................................................ Adult — No No
Stengel 193413.................................................... 9 mths F No No
50 yrs F No No
Ravitch and Woods 195014.............................. 8 days M No Yes
Grab 195.3'5....................................................... 7 days M No No
Snavely and Breakell 1954'6.......................... 24 yrs F No No
Roviralta 1958'7............................................... 3 days F No Yes
Bernard, Perry and Walker 195918................ 48 yrs F Yes No
Block and Zikria 196119.................................. 10 yrs F Yes Yes
Boles and Smith 196120................................... 3 mths M No No
3 days — Yes Yes
5 days — No Yes
7 days — No Yes
Debray et al 196221........................................... 65 yrs M No No
Majewski 196222............... 57 yrs F No Yes
Renner and Child 196323 .............................. 7 wks M No No
Moreaux, Pette and Chapuis 196524............ 27 yrs F No No
Kopecky and Halatova 196825....................... 7 days F Yes No
Kakkar and Tompkin 196826......................... 29 yrs M Yes No
Laube and Weise 196927........ 48 yrs F No No
Horovitz and Riesenfeld 197128..................... 3 days F Yes No
Mooney 197129................ 3 days F Yes Yes
Braun and Cuendet 19719............................... 8 days M No Yes
4 days M No Yes
Johnson 197130.............. 2 mths F No No
2 days F No Yes
Welte and Gharib 197231. . Newborn F Yes No
11 days M No Yes
Bower and Ternberg 197232............................ 3 yrs F Yes No
4 days F No Yes
5 days F Yes No
Lamesch, Eydt and Steinmetz 197233........... 3 yrs F Yes No
This report............................................. 1 day M No Yes
6 days M No Yes
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struction; Smiley, Perry and McClelland:i 4 
reviewed 20 cases of congenital diaphragm 
in adults and state that 29% of the patients 
first developed symptoms after the age of 
24 years.
In conclusion, we believe that a preduo- 
denal portal vein is probably never respons­
ible for duodenal obstruction and when it 
is found in association with some degree of 
this condition the duodenum should be ex­
plored to discover whether a diaphragm is 
present. This can be done easily by insert­
ing a Foley catheter into the duodenum, in­
flating the balloon and then withdrawing it, 
as suggested by Richardson and Martin.3 r’ 
If such a diaphragm exists, its excision 
through a duodenotomy should correct the 
abnormality.
The main surgical implication of a pre- 
duodenal portal vein is the recognition of 
this anomaly and the avoidance of injury 
during operations on the biliary tract and 
the duodenum.-7
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SURGICAL ASPECTS OF AMEBIASIS*
E M LENCZNER, W. J. E. SPENCE, M.D., F.R.C.S.[C]I and
M. M. LENCZNER, M.D., F.R.C.P.[C],§ Toronto, Ont.
Summary: Forms of amebiasis likely to be en­
countered by the surgeon are discussed by 
reference to illustrative case reports. The clinical 
picture may be one of intestinal, hepatic or 
pleuropulmonary disease. It is desirable that 
surgical procedures should be preceded by a 
course of medical treatment. In cases where the 
diagnosis of amebiasis has been unsuspected 
before operation, medical treatment should be 
instituted afterwards without delay.
Resume: Les diverses formes d'amibiase que le 
chirurgien est susceptible de rencontrer sont 
presentees par des rapports cliniques typiques. 
Le tableau Clinique peut comporter des lesions 
intestinales, hepatiques ou pleuropulmonaires. 
II est souhaitable que I'intervention chirurgicale 
soit precedee d'un traitement medical mais, 
dans les cas ou I'infection a ete meconnue avant 
I'operation, il importe d'entreprendre un traite­
ment medical sans delai tout de suite apres 
I'operation.
A m ebiasis is endemic in many parts of the 
world, particularly in certain parts of Africa, 
Asia and Central and South America, but it 
occurs also in temperate climates.
Amebiasis can be of particular interest 
to the surgeon. Its varied modes of pre­
sentation often make the diagnosis difficult. 
Moreover, complications that require sur­
gical treatment develop in an estimated 
0.5% of dysenteric patients,1 and although 
this is a small fraction of the total amebic 
morbidity, the life-threatening potential of 
these cases lends them special importance.-
By means of illustrative cases we will 
endeavour to answer several questions in 
this paper. When should the surgeon ex­
pect amebiasis? How may he make the diag­
nosis? What should he do if the diagnosis 
is only made at operation? What is the cur­
rent medical regimen?
*From the Departments of Surgery and Medicine, 
Toronto General Hospital and the University of 
Toronto, Toronto, Ont.
■('Resident in Surgery, Toronto General Hospital. 
JStaff Surgeon, Toronto General Hospital. 
§Staff Physician, Toronto General Hospital.
C ase M aterial
From 1966 to 1972 Entamoeba histo­
lytica infestation was diagnosed by the Uni­
versity Clinic for Tropical and Parasitic 
Diseases, Toronto, in over 900 patients. 
Many of these patients were carriers with­
out signs of active infection. Typical case 
reports are supplied below.
C ase R epo rts
Case 1.— L. O., a 55-year-old man from 
northern Ontario, presented with right-sided 
abdominal pain accompanied by nausea, vomit­
ing and constipation. He had never been out­
side Ontario and previously had been an insti­
tutional psychiatric patient. A subhepatic 
abscess developed which was drained through 
a subcostal incision of 1,200 ml of purulent 
material from which a Proteus species was 
cultured. Continuous drainage of pus from 
the incision followed despite antibiotic treat­
ment and fistulas developed between the 
abscess cavity, the liver and the transverse 
colon. When transferred to the Toronto Gen­
eral Hospital six months after the initial sub­
costal incision, the drainage was similar to 
anchovy sauce. Entamoeba histolytica was 
recovered from the fistula tract. The patient 
was treated with dehydroemetine and carbar- 
sone, and within three weeks drainage had 
completely subsided and the fistula had closed. 
No further surgical treatment was required.
Case 2.—D. H., a 36-year-old man from 
Toronto, developed repeated respiratory in­
fections accompanied by fever and diarrhea. 
He had travelled in Colorado, Nevada, On­
tario and Michigan and experienced some 
fatigue following this trip. He suffered from 
chills, malaise and fever. A liver scan revealed 
a large cold area over the superior aspect of 
the right lobe of the liver. At laparotomy a 
liver abscess was drained of whitish-yellow 
purulent material which was sterile on routine 
culture. The pus was also negative for Enta­
moeba histolytica. The abscess cavity was irri­
gated daily and the patient's condition im­
proved. Sudden onset of chest pain and fever 
resulted in two further hospital admissions 
during which pulmonary scans were thought 
to be consistent with the presence of pul-
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monary emboli. Hemoptysis occurred on sev­
eral occasions. Treatment with anticoagulants 
and antibiotics produced some clinical im­
provement.
Six months after the initial illness the pa­
tient again became ill with recurrent cough 
and his weight fell by 35 lbs. Diagnostic in­
vestigations included angiography, esophageal 
motility studies, bronchoscopy and mediastino­
scopy. Examination of the stool revealed Enta­
moeba histolytica and hemagglutination tests 
for the parasite were highly positive. Treatment 
with dehydroemetine and carbarsone resulted 
in rapid symptomatic improvement with reso­
lution of the cold area previously observed 
on the liver scan and improvement in the chest 
radiograph within two weeks.
Case 3.—J. D., a 68-year-old man, pre­
sented with diarrhea, abdominal pain and a 
70-lb weight loss a few months after a world 
tour which included Europe, India, Singapore 
and Thailand. On examination a rectal mass 
could be felt, biopsy from which showed 
chronic inflammation without evidence of 
carcinoma. A rectal smear showed cysts of 
Entamoeba histolytica and a diagnosis of rec­
tal ameboma was made. Treatment with de­
hydroemetine and carbarsone cleared the in­
festation, and the mass shrank to one-third its 
original size but did not disappear completely. 
A repeat biopsy was then carried out which 
revealed adenocarcinoma.
Case 4.—H. G., a 51-year-old war veteran, 
contracted amebiasis in 1948 in Korea. Despite 
some residual diarrhea at the time of dis­
charge from the service he was told that he 
was cured. He remained well until 1971 when, 
in association with some weight loss and ma­
laise, he developed an acute abdomen. A 
diagnosis of perforated appendix was made and 
at laparotomy an abscess was discovered in 
the mesentery of the terminal ileum. This 
abscess drained green, odourless fluid. Post- 
operatively the patient developed a fistula 
from the sigmoid colon to the small bowel and 
cecum. An amebic abscess was suspected and 
treatment with emetine and chloroquine was 
instituted. A further drainage procedure was 
carried out and at that time the diagnosis was 
established on histological examination of tis­
sue sections (Fig. 1). Further medical treat­
ment was followed by radical excision of the 
fistulas and defunctioning sigmoid colostomy. 
The colostomy was closed at a later date. The 
patient remains well and free from disease.
In contrast to Cases 1 and 2, two cases 
of liver abscess resolved on medical therapy
alone without surgical intervention as de­
monstrated by changes in liver scans (Figs. 
2 and 3). One of these is described below.
Case 5.—T. G., a 60-year-old man from 
southern Ontario, suffered from diarrhea while 
travelling through Europe. This was effectively 
treated with a kaolin-pectin mixture. He con­
tinued to Australia via Japan, Hong Kong, 
Bangkok and Singapore. In Australia he had a 
recurrence of the diarrhea followed a few 
weeks later by anorexia, fever and right upper 
quadrant pain. Amebic liver abscess was diag­
nosed and a course of metronidazole (Flagyl) 
provided symptomatic improvement. On re­
turning to Ontario he experienced further night 
sweats, fever and anorexia. On examination 
dullness and rales were present at the right lung 
base. The liver was markedly enlarged and the 
scan showed multiple filling defects. A diagno­
sis of amebiasis was confirmed by a strongly 
positive latex test and the presence of cysts of 
Entamoeba histolytica in the stool concentra­
tions. Repeated courses of treatment with de­
hydroemetine and carbarsone resulted in symp­
tomatic enduring relief with gradual diminu­
tion in the size of the filling defect on the scan.
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Fig. 1.—Case 4. Multiple cysts of Entamoeba 
histolytica in tissue excised at operation (x 25).
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D iscussion
The diagnosis of amebiasis depends on a 
high index of suspicion. A history of travel 
through endemic areas with subsequent on­
set of diarrhea is suggestive. Within North 
America the incidence of the carrier state 
is much higher in areas where hygiene and 
waste-disposal methods are not of high 
standard. Certain Indian reservations and 
mental institutions have a high prevalence 
of endemic carriers.
Modes of Presentation
The clinical pictures compatible with the 
diagnosis may be divided into intestinal and 
extraintestinal presentations. This classifica­
tion is useful in determining what diagnostic 
tests and mode of therapy are appropriate.
Diarrhea.—Patients with amebiasis may 
be asymptomatic or suffer from mild ful­
minant diarrhea. Such presenting symptoms 
are less likely to come to the attention of 
the surgeon.
Peritonitis.— Marked peritonitis may ac­
Fig. 2.—(a) Anteroposterior and (b) lateral liver 
scans before therapy.
company amebic dysentery even in the ab­
sence of perforation of the bowel. In these 
circumstances laparotomy is generally con­
traindicated. However, acute peritonitis may 
occur in the absence of diarrhea and be the 
result of bowel perforation. Laparotomy and 
fecal diversion are then indicated after com­
mencement of specific anti-amebic therapy.
A ppendicitis.— Amebic typhlitis and ame­
bic appendicitis are not uncommon. Ap­
pendectomy may be indicated but unless 
amebicidal therapy is given, the prognosis 
is much graver than in cases of baoterial 
appendicitis, owing to suture slough and 
resultant peritonitis and fistula formation.
Ameboma.— This development, as in 
Case 3, is a relatively uncommon occur­
rence. Radke:i collected 78 cases and re­
ported on 41 others. He found the most 
common site to be in the rectum or cecum. 
The most common complication of ameboma 
is intermittent or complete obstruction. The 
possibility that this lesion may be mistaken 
for adenocarcinoma and be attacked sur­
gically before the start of anti-amebic
1° ■ L<cU.rcU f)
Fig. 3.—(a) Anteroposterior and (b) lateral liver 
scans after repeated therapy.
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therapy may result in peritonitis, perfora­
tion, abscess and fistula formation. The 
coexistence of ameboma with carcinoma 
may lead to misdiagnosis, but still demands 
initial anti-amebic therapy before operation.
Cutaneous amebiasis.— This condition is 
rare and is almost always adjacent to the 
opening of a fistulous tract. It is character­
ized by necrosis of skin and subcutaneous 
tissues caused by a synergistic amebic-bac­
terial invasion.4
Hepatic amebiasis.—Amebic liver abscess 
is more common in men than in women and 
in the right lobe of the liver. This is postu­
lated to be a result of a selective portal 
venous flow by which the drainage from the 
right colon is primarily to the right hepatic 
lobe. These abscesses are commonly single 
and their contents may be creamy white 
even in the absence of secondary bacterial 
infection, although the anchovy-paste aspi­
rate is considered pathognomonic. It must 
be emphasized that, even in proved cases, 
amebic trophozoites may not be demon­
strable in the aspirate yet be observed in 
the pseudocyst wall. Similarly, cases of liver 
abscess may no longer show the presence 
of ameba in the stool. Liver abscesses may 
rupture into any adjacent cavity—pleural, 
pericardial or peritoneal. Direct extension 
to the right pleural cavity and lung occur 
in 20% of cases. Secondary infection by 
bacteria of an amebic abscess is not uncom­
mon and should not discourage the clinician 
from searching for the underlying cause.
Pieuropulmonary amebiasis.— This usual­
ly occurs as a direct extension to the right 
lower chest secondary to amebic liver 
abscess. It may take the form of pneumo­
nitis, lung abscess, bronchohepatic fistula or 
empyema. Lung abscesses can be blood- 
borne, associated even with abscesses in the 
inferior vena cava.r>
Diagnostic Methods
Diagnosis requires demonstration of En­
tamoeba histolytica by microscopic exami­
nation of stool, pus or scrapings. The para­
site may also be cultured on special media. 
It is not unusual for cysts or trophozoites 
to be absent from stool or pus, particularly 
after incomplete or unsuccessful courses of 
medication. In these cases indirect methods 
of diagnosis may be used. These include
the hemagglutination test, complement fixa­
tion, latex, precipitin and fluorescent anti­
body techniques. These methods are more 
reliable in the tissue forms of the disease. A 
cutaneous amebic antigen is presently being 
used experimentally and may prove valuable 
in cases where the diagnosis is difficult.
Current Therapy
General.—Amebiasis is an infectious, 
contagious and notifiable disease. Infection 
occurs by way of hands soiled with feces, 
pus, contaminated linen, infected water or 
food. Isolation of the patient, his linen, ex­
creta and utensils is advisable. Bed rest 
and a bland low-fat diet are necessary as 
well as the monitoring of adverse effects of 
drug therapy.
Intestinal and tissue infection.—In any 
case of intestinal infection there is no means 
of excluding definitely the presence of En­
tamoeba histolytica already in the tissues. 
Therefore we recommend the use of tissue 
amebicidals followed by surface amebicidals 
in the full spectrum of cases including those 
which are asymptomatic. Broad spectrum 
antibiotics are used in cases where second­
ary bacterial invasion is suspected or demon­
strated.
Preferred Schedule of Treatment in
Amebic Dysentery
Dehydroemetine hydrochloride (tissue 
amebicidal) is given for 10 days. The adult 
dosage is 60 mg daily (20 mg three times a 
day intramuscularly or orally).
In cases of increased peristalsis, intestinal 
hurry and gastrocolic and hepatocolic fis­
tulas, intramuscular administration is recom­
mended as tablets may not be absorbed.
Dehydroemetine has a myocardiotoxic ef­
fect which reverses 10 to 14 days after dis­
continuance of its use. Electrocardiographic 
changes may be seen (low voltage, T-wave 
inversion, sinus tachycardia) which demand 
continuous monitoring and complete bed 
rest during the treatment.
After completion of the course of dehy­
droemetine, a course of tissue and surface 
amebicidals is administered, viz carbarsone, 
250 mg orally three times a day for seven 
days or diphetarson, 500 mg orally three 
times a day for 10 days.
September 197 b AM EBIASIS 327
Other schedules of therapy may also be 
used. Chloroquine combined with carbarsone 
or diphetarson followed by diiodohydroxy- 
quin is effective.
Metronidazole is widely used for symp­
tomatic suppression. We strongly counsel 
against reliance upon it as the sole anti- 
amebicidal agent as several cases of liver 
abscess have been noted after its use.6
Tissue manifestations may require two or 
more complete courses of treatment. Dimi­
nution in size of liver abscesses as shown 
by serial scans may take months, lagging 
behind completion of treatment.
Recently Tsai7 reported a series of 2,322 
cases of amebic liver abscesses in Taiwan, 
treated by repeated courses of combination 
medical therapy. He achieved a very ac­
ceptable mortality rate of 21.3% and con­
cluded that aspiration is unnecessary as 
part of the routine treatment of amebic 
abscess.
Topical therapy in the form of irrigation 
of fistulas or abscesses with sterile solutions 
of Vioform 3 % or acriflavine 1 % are 
helpful.
Surgical Procedures
Empyema, perforation, fistulas or large 
liver abscesses may all necessitate some 
surgical intervention, but this should be
precede4 by suitable amebicidal medication.
If the diagnosis is not suspected until 
the time of operation (e.g. in amebic ap­
pendicitis or amebic liver abscess) place­
ment of drains in the wound is mandatory. 
Anti-amebic treatment is instituted on con­
firmation of the diagnosis.
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PROGNOSIS OF CUTANEOUS MALIGNANT MELANOMA: 
A CLINICOPATHOLOGICAL STUDY*
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Summary: A retrospective study was done of 
the clinical findings and histological features of 
cutaneous malignant melanoma in 112 patients 
treated at the Winnipeg General Hospital 
between 1947 and 1967. The findings indicate 
that tumours in women, tumours in the younger 
age group and tumours in the upper extremity 
have a better prognosis provided the neoplasm 
has not spread beyond the primary site. The 
prognosis of melanoma correlates well with the 
depth of tissue invasion. Histological grouping 
appears to be of value in selecting patients for 
prophylactic node dissection. In this study, node 
dissection was found most useful in improving 
the survival of patients with intradermal lesions.
Resume: Nous avons entrepris une etude retro­
spective des donnees cliniques et des constata- 
tions histologiques des 112 cas de melanome 
cutane malin traites a I'Hopital General de 
Winnipeg de 1947 a 1967. II ressort de cette 
analyse que les tumeurs chez la femme, celles 
qui frappent les jeunes et celles qui se trou- 
vent dans les membres superieurs ont un mei- 
leur pronostic, a condition que le neoplasme 
n'ait pas essaime au-dela du foyer primaire. Le 
pronostic du melanome etait en excellente cor­
relation avec la profondeur de I'invasion tissu- 
laire. Le groupement effectue suivant les don­
nees histologiques s'est revele precieux pour 
choisir les malades devant subir une dissection 
nodale, a titre prophylactique. Dans notre etude, 
nous avons note la grande valeur de la dissec­
tion nodale pour prolonger la survie des malades 
porteurs de lesions intradermiques.
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R ecen t  reports indicate that the prognosis 
of malignant melanoma depends on a num­
ber of factors related both to the patient1'3 
and to the malignant potential of the tu­
mour.4' 6 The clinician, however, is still 
faced with decisions in the management of 
these patients, particularly with regard to the 
extent of surgery required for the primary 
tumour and the advisability of prophylactic 
node dissection.
From a retrospective study of the clinical 
findings and histological features of cuta­
neous malignant melanoma in 112 patients 
treated at the Winnipeg General Hospital 
between 1947 and 1967 we have attempted 
to determine the factors that may influence 
management and prognosis of this disease.
Material and M ethods
Only those patients were included who 
underwent part or all of their initial treat­
ment at the Winnipeg General Hospital. The 
diagnosis of malignant melanoma was based 
on histological examination and lesions in 
all stages were included. Melanoma of the 
eyes, paranasal sinuses, viscera and mucous 
surfaces were excluded from this series. 
Clinical information was obtained from the 
medical records of the Winnipeg General 
Hospital, the tumour registry of the Mani­
toba Cancer Treatment and Research Foun­
dation and records of the Radiotherapy 
Department. Follow-up data were compiled 
from inpatient and outpatient records, death 
records and, in some cases, direct inquiries 
to other hospitals and individual physicians.
C linical D ata
The youngest patient was 19 and the 
oldest 96 years of age, the average age be­
ing 53 years (Fig. 1). The peak incidence of 
melanoma was in the sixth decade in men 
and the seventh decade in women. There 
were 64 women and 48 men, with a female: 
male ratio of 1.4:1. Fifty-seven percent of 
the women and 32% of the men were under 
50 years of age.
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The most frequent sites of melanoma 
were the head and neck and the lower ex­
tremity (Table I). The trunk and upper 
extremity had a lower frequency relative 
to surface area. When analyzed according 
to sex, we found that lesions involving the 
head and neck occurred with almost equal 
frequency in the two sexes. The next most 
common sites in men were the trunk and 
lower extremity, whereas in women these 
were the lower and upper extremities. Tu­
mours of the trunk were quite infrequent in 
women. In two patients the primary site 
was unknown; one presented with axillary 
node metastasis and the other with pul­
monary metastasis.
Eighty-nine patients (79.5%) with tumour 
confined to the primary site were classified
age in decades
Fig. 1.—Age and sex distribution.
as Stage I, 16 patients (14.3%) with clinical 
evidence of metastases to the regional lymph 
nodes as Stage II, and seven patients 
(6.2%) with disseminated melanoma as 
Stage III (Table II). Of the 89 patients with 
Stage I disease, 61.8% were women and 
38.2% men. When related to age and sex, 
it was found that the majority of Stages II 
and III patients were men over the age of 
50 years.
T r e a t m e n t
Of the Stage I patients, 53 underwent 
local excision of the primary tumour, only 
22 had local excision and subsequent dis­
section of clinically positive nodes occur­
ring within one to five years after initial 
treatment, and 14 had local excision with 
prophylactic node dissection. There was 
no fixed policy regarding prophylactic node 
dissection, the decision being solely that of 
the attending surgeon. Thirteen Stage II pa­
tients underwent local excision with thera­
peutic node dissection and three had local 
excision with excisional biopsy of a regional 
lymph node. In the group undergoing 
prophylactic node dissection, four of 14 
patients (28 %) had metastases in the lymph 
nodes on histological examination. Of the 
patients subjected to therapeutic node dis­
section, six of 35 (17%) had no histological 
evidence of metastases in the lymph nodes.
In one patient with no identifiable pri-
TABLE I.—Location of the Lesion
Women M en Total
No. o f No. o f No. of
Location patients % patients %  patients %
Head and neck..............  22 34.3 16 33.3 38 33.9
Upper extremity............ 13 20.3 5 10.4 18 16.0
Lower extremity............ 21 32.9 13 27.1 34 30.4
T runk..............................  7 10.9 13 27.1 20 17.9
Unknown prim ary........  1 1.6 1 2.1 2 1.8
TABLE II.—Clinical Stage
Women M en Total
No. o f No. of No. of
Stage patients % patients % patients %
\ 55 8179 34 70  8 89 79.5
II 5 7.8 11 22.9 16 14.3
III ........................  4 6.2 3 6.2 7 6.2
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mary lesion, biopsy of a metastatic axillary 
lymph node was done. Six patients with ad­
vanced disease received no definitive sur­
gical treatment except diagnostic biopsy, 
either of the cutaneous lesion or a meta­
stasis; one patient of the six had no iden­
tifiable primary lesion. Palliative radio­
therapy either alone or with chemotherapy 
was used in patients with recurrent or meta­
static disease. No major amputations were 
done in this series either for cure or pal­
liation.
H istological F indings
Slides of 60 patients were available for 
review by the pathologist (D.W.B.) without 
his knowledge of their clinical status. Fac­
tors such as mitotic index, pleomorphism, 
pseudoepitheliomatous hyperplasia, lym­
phoid infiltration, depth of invasion and 
vascular invasion were assessed. The most 
valuable indicator of prognosis appeared to 
be the depth of tissue invasion. Melanomas 
were classified into three groups according 
to the depth of invasion as described by 
Mehnert and Heard.6 Group I or super­
ficial lesions (Fig. 2) are those limited to 
the papillary dermis down to the depths of 
the rete pegs, Group II or intradermal 
lesions (Fig. 3) penetrate the reticular dermis 
down to appendage structures, and Group 
III or subcutaneous lesions (Fig. 4) involve
Fig. 2.—A cutaneous malignant melanoma showing a Group I or superficial lesion. The tu­mour is limited to the papillary dermis superficial to the deepest extension of the rete pegs, with con­siderable lymphocytic infiltration about the tumour (H & E  x 400).
Fig. 3.—A cutaneous malignant melanoma show­ing a Group II or intradermal lesion. The tumour infiltrates the reticular dermis just superficial to the appendage structures with minimal lympho­cytic infiltration (H & E x 400).
Fig. 4.—A cutaneous malignant melanoma showing a Group III or subcutaneous lesion. The tumour invades the subcutaneous fat (H & E x 400).
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the subcutaneous fat. In situ or Group 0 
lesions, e.g. Hutchinson’s melanotic freckle, 
were excluded from this series. These gen­
erally occur on exposed surfaces in elderly 
patients, remain confined to the epidermal 
layer without breaking through the base­
ment membrane for a long period of time 
and seem to have much better prognosis than 
invasive melanoma.7’ 8 Eighteen patients 
were found to have Group I, 27 Group II 
and 15 Group III lesions.
Clark et al5- 8 have defined five levels of 
tissue invasion (levels I to V). This classifi­
cation is similar to that of Mehnert and 
Heard,6 which is the one used in this study, 
except for the inclusion in the latter of one 
additional category where tumour extends 
right to the junction of the papillary and 
reticular layers of the dermis without in­
vading the latter. However, we found it 
impossible to distinguish this category in 
histological examination of several sections 
of the same tumour because of the variable 
depths of the rete pegs and the skin ap­
pendages.
R esults
One hundred and nine patients have been 
followed up for at least five years. Seventy- 
six patients are dead, 29 are alive without 
disease and four with disease. Sixteen are 
alive without any evidence of their disease 
10 years or more since their initial treat­
ment, and three patients have been lost to 
long-term follow-up. Ninety-five patients 
were alive at the end of one year, 63 at the 
end of three years and 51 at the end of five
years after initial treatment
Fig. 5.—Survival according to sex.
years, giving an average five-year survival 
rate of 42% .
Survival related to age and sex.— Survival 
rates seemed better in women than in men 
(Fig. 5), irrespective of the age. The five- 
year survival rate was 54.1% in women and 
21.4% in men. The patients were arbitrarily 
divided into two groups, above and below 
50 years of age. Five-year survival was 
better in individuals under 50 years of age 
than in those over 50 (Fig. 6).
Survival related to location of the lesion 
(Fig. 7).— Melanoma of the upper extremity 
seemed to have the best, and those occurring 
on the trunk the worst, prognosis. Survival 
at five years was 56.2% for upper-extremity 
lesions, 44% for head and neck lesions, 
41.9% for lower-extremity lesions, and 
22.2% for trunk lesions.
years after initial treatment
Fig. 6.—Survival according to age.
*------ U P P E R  E X T  (18)
years after initial treatment
Fig. 7.—Survival according to location of the 
lesion.
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Survival related to clinical stage (Fig. 8). 
— The prognosis of patients with Stage I dis­
ease was significantly better than of those 
with Stage II disease, five-year survival being 
46.6% in the former group compared with 
13.3% in the latter. Only one patient with 
Stage III disease survived two years and 
none lived longer than three years.
Survival related to treatment.— Of the 53 
Stage I patients who underwent local exci­
sion alone, 26 (49%) survived five years. 
In this group, 20 of 37 women, but only 
six of 16 men, survived five years. Of the 
22 Stage I patients who were initially treated 
with local excision only but later underwent 
therapeutic node dissection, six (27%) lived 
for five years from the time of initial treat­
ment. In this group also the women fared 
better than the men. Thus, of the 75 Stage 
I patients who did not undergo prophylactic 
node dissection initially but were observed 
for nodal metastases, 33 (44%) survived for 
five years. In contrast, of the 14 Stage I 
patients who underwent prophylactic node 
dissection, seven (50%) lived five years. In 
this group seven of 10 women but none of 
the four men survived for five years, again 
suggesting a better prognosis in women. It 
is evident from Fig. 9 that the prognosis of 
patients who underwent prophylactic node 
dissection was always better than for those 
who did not over a five-year period, al­
though the difference is not statistically sig­
nificant.
Survival related to histological features.— 
To correlate depth of invasion with the 
prognosis of the disease, slides of 43 pa­
tients with Stage I disease were reviewed.
years after initial treatment
Fig. 8.—Survival according to clinical stage.
According to depth of invasion, six were 
classified as Group I, 25 as Group II, and 
12 as Group III lesions. The survival in 
Stage I melanoma according to depth of 
invasion and treatment method is presented 
in Table III. Survival in these patients cor­
relates well with the depth of invasion. In 
Group I lesions local excision alone resulted 
in five-year survival of four out of six pa­
tients. In Group II lesions local excision with 
or without prophylactic node dissection re­
sulted in five-year survival of all of four 
patients and 10 of 21 patients respectively. 
In Group III lesions none of the seven pa­
tients undergoing local excision survived five 
years. With local excision and prophylactic 
node dissection only one of five patients 
survived five years.
D isc u ssio n
Our findings indicate that tumours in 
women, tumours in the younger age group 
and tumours in the upper extremity have 
a better prognosis provided the neoplasm 
has not spread beyond the primary site 
(Stage I). Others have also reported a bet­
ter survival for women1’ 2> 911 and younger 
patients,12 although these conclusions have 
been disputed.13- 14
In this study, lesions of the upper ex­
tremity had the best prognosis, as was re­
ported by McLeod et al15 and tumours of 
the trunk had the worst, as reported by
year* after initial treatment
Fig. 9.—Survival according to treatment in pa­
tients with Stage I disease. Of the 75 patients 
treated without prophylactic node dissection. 22 
subsequently underwent therapeutic node dissec­
tion.
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others.2’ 10' 1X- 13 Perhaps late diagnosis 
and variable lymphatic drainage may con­
tribute to the grave outlook of melanoma 
of the trunk as suggested by these authors.
Clinical stage is the single most important 
factor influencing prognosis. In this series 
as well as in those of others,2- 3- 10- 16- 17 
it is evident that when malignant melanoma 
has spread beyond the primary site none of 
the current methods of treatment is effective 
in controlling the disease. Therefore of para­
mount importance are early diagnosis and 
definitive treatment when the tumour is 
still confined to the site of origin.
Our findings suggest that patients with 
Stage I disease had a better prognosis with 
prophylactic node dissection than without 
(Fig. 9), as previously reported.2- 3- 9- 10- 
14, is, 1 7 - 2 1  a  regional basis for elective 
node dissection is also supported by the fact 
that five out of 14 patients who were clas­
sified as belonging to clinical Stage I were 
found to have histological evidence of me­
tastasis in their dissected lymph nodes. 
Fortner et al22- 23 showed that 21 .9 % of 
patients with melanoma of the trunk and 
38% with melanoma of the lower extremity 
with clinically negative nodes had micro­
scopic metastases found in electively excised 
lymph nodes. They22- 23 and others17- 19 
have also reported that the patients with 
clinically negative and histologically positive 
lymph nodes had a better prognosis after 
elective node dissection than those under­
going therapeutic node dissection for clinic­
ally positive nodes. On the basis of survival 
figures, the difficulty of assessing the status 
of regional lymph nodes, and the grave 
prognosis associated with Stage II disease, it
seems that elective dissection of clinically 
tumour-free nodes should be favoured. How­
ever, other authors24- 25 do not share this 
view except in special circumstances, e.g. 
where the primary lesion is near the regional 
lymph node and thus can be excised in con­
tinuity. These authors have also suggested 
that other factors, including the size of the 
lesion, its anatomic location and the depth 
of invasion, should be considered in selecting 
patients for prophylactic node dissection.
The findings of the histological study sug­
gest that prognosis for clinical Stage I di­
sease correlates well with the depth of in­
vasion as reported by others,4’8 Group I 
lesions having the best and Group III the 
worst prognosis. None of the patients with 
Group I lesions underwent prophylactic 
node dissection, precluding a valid compa­
rison of results of local excision with and 
without prophylactic node dissection. How­
ever, survival figures following local excision 
alone are encouraging, and a small improve­
ment in survival rate may not justify the 
increased morbidity associated with prophy­
lactic node dissection as indicated by Meh- 
nert and Heard.6 Patients with Group III 
lesions, with or without prophylactic node 
dissection, had poor survival. Prophylactic 
node dissection seemed most useful in im­
proving survival of patients with Group II 
lesions since the results with node dissec­
tion are clearly better than without. Thus, 
depth of invasion appears to be an important 
factor in the prognosis of melanoma pa­
tients and may be of value in selecting pa­
tients for prophylactic node dissection. Fur­
ther prospective study is required to verify 
this.
TABLE III .—Survival in Stage I M elanoma According to D epth of Invasion and
T reatment M ethod
Depth o f invasion T ype o f operation N o . of patients Five-year survival
Group I (superficial).......................... ........ Local excision only 6 4
Group II (intradermal)...................... ........ Local excision only
Local excision with 
prophylatic node
21 10
dissection 4 4
Total 25 14
Group III (subcutaneous)................. ........ Local excision only
Local excision with 
prophylactic node
7 0
dissection 5 1
Total 12 1
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DELAYED ARTERIAL EMBOLECTOMY*
M. A. NAQVI, M.D., F.R.C.S.[C], F.A.C.S., D. H. MacKENZIE, M.D., F.R.C.S.[C], F.A.C.S., 
L. S. ALLEN, M.D., F.R.C.S.[C] and D. GAUM, M.D.,
Sydney, N.S.
Summary: The belief that poor results are to be 
expected from embolectomy performed more 
than eight to 12 hours after acute occlusion of 
an artery should be modified. It has become 
increasingly apparent that there is a group of 
patients who suffer an embolus to an extremity 
but who retain a viable limb for several weeks 
after the insult. It is in these patients that de­
layed embolectomy is advised. A limb that is 
severely ischemic and pregangrenous cannot 
tolerate this long interval.
Resume: Nous estimons qu'il faut reviser I'opi- 
nion qu'une embolectomie pratiquee plus de huit 
a 12 heures apres I'occlusion aigue d'une artere 
risque de donner des resultats mediocres. II est 
devenu de plus en plus evident qu'un certain 
nombre de malades aui ont souffert d'un embole 
a une extremite conservent un membre viable 
pendant plusieurs semaines apres cette lesion. 
C'est chez ces malades qu'on conseille de re­
tarder I'embolectomie. Par contre, les malades 
dont le membre est gravement ischemique et 
dans un etat de pregangrene ne peuvent tolerer 
ce long retard.
Sudden embolic occlusion of a major artery 
is followed in most instances by vascular 
necrosis of the tissue supplied by it. In the 
lower limbs, the likelihood of gangrene is 
extremely high if treatment is delayed for 
more than eight to 12 hours. There is gen­
eral agreement that the earlier an embolus 
is removed, the better is the outlook for 
the patient. However, if the limb is still 
viable, irrespective of the time that has 
elapsed since the onset of occlusion, em­
bolectomy may be successful. Late embo- 
lectomies are well documented by various 
authors. In different series the success rate 
of embolectomy ranges from 40% to 
90% T'5
The following seven cases are presented 
to emphasize that late embolectomy can be 
rewarding. The impression that a poor re­
sult is to be expected when the operation is
♦From the Department of Surgery, Sydney City 
and St. Rita Hospitals, Sydney, N.S.
Reprint requests to: Dr. M. A. Naqvi, Medical 
Arts Building, 336 Kings Road, Sydney, N.S.
performed more than eight to 12 hours 
after acute occlusion of the artery should 
be modified.
Case Reports
Case 1.—W. C., a 54-year-old white man, 
was admitted to hospital in a state of shock 
due to myocardial infarction. One week later 
he complained of sudden pain, loss of sensa­
tion and weakness in the left leg. Both fe­
moral pulses were present but the distal pulses 
could not be felt on the left side. The left 
leg and foot were cold and pale. As the pa­
tient’s general condition was too poor to allow 
immediate embolectomy, heparin was used sys- 
temically. Seventy-two hours later, in spite of 
his poor condition, embolectomy was done 
using a Fogarty balloon catheter. The patient 
had a straightforward recovery.
Case 2.—R. Macl., a 77-year-old white 
woman with auricular fibrillation, underwent 
an appendectomy for acute appendicitis. On 
the sixth postoperative day she developed in­
creasing pain and paralysis in the left leg. The 
limb was cold, discoloured and paralyzed. The 
left femoral pulse was present but the distal 
pulses were absent. The electrocardiogram sup­
plied evidence of myocardial infarction and 
24 hours later the patient was referred to us 
for an embolectomy. The operation was car­
ried out using a Fogarty balloon catheter. The 
patient made an uncomplicated recovery and 
was discharged home three weeks later.
Case 3.—G. B., a 79-year-old white man 
with atrial fibrillation, was admitted to hos­
pital on March 11, 1969. One week earlier he 
first noticed pain, anesthesia, and bluish dis­
colouration of the left hand. Two days later 
he developed pain in, and paralysis of, the left 
leg. On examination the left arm and hand 
were pulseless but viable. The left leg was dis­
coloured and paralyzed. The left femoral pulse 
was absent as well as the distal pulses. An 
embolus was removed from the common 
femoral artery under local anesthesia. In the 
postoperative period the patient received he­
parin and the left leg remained viable although 
the pedal pulses did not return. The brachial 
artery embolus was not treated surgically as
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the hand was viable and sensation returned to 
normal.
Case 4.—W. C., an 80-year-old white man, 
was transferred from a sanatorium, where he 
had been treated for active pulmonary tuber­
culosis, because of pain, paresthesia and dis­
colouration of the left leg of 24 hours’ dura­
tion. The limb was cold, discoloured and 
paralyzed; the left femoral pulse was present 
but the distal pulses were absent. An intra­
venous heparin drip was started and an emer­
gency left femoral embolectomy was success­
fully performed. Anticoagulants were given 
during the postoperative period and the leg 
remained viable and the pedal pulses returned.
Case 5.—K. M., a 75-year-old white woman, 
had a three-week history of pain and pallor in 
her left foot and calf of sudden onset. She 
was known to have atrial fibrillation, and 
three months previously she had undergone a 
right femoral artery embolectomy with a good 
result. The femoral pulses were palpable but 
the distal pulses in the left lower extremity 
were absent. A femoral arteriogram showed 
blockage of the femoral artery proximal to the 
knee joint with no arterial visualization distal 
to this point. After operative removal of the 
embolus from the popliteal artery, using a 
Fogarty balloon catheter, her recovery was un­
eventful and she was discharged home on a 
regimen of long-term anticoagulants.
Case 6.—P. B., a 23-year-old man, was ad­
mitted to hospital because of severe pain in 
the right leg for two days. Two years earlier 
he had suffered pulmonary embolism and three 
months before he was treated for recurrent 
pulmonary embolism and thrombophlebitis. 
Two weeks before this admission a laparotomy 
had been performed for acute abdominal 
symptoms but no abnormality was discovered. 
He had an uncomplicated postoperative course 
and was discharged home on the tenth day. 
He was readmitted two days later because of 
severe pain in his right leg. The leg was pale 
and the calf was markedly tender. The right 
femoral pulse was present but the distal pulses 
were absent. In view of the previous history 
the diagnosis of recurrent deep thrombophle­
bitis with associated arterial spasm was made 
but no improvement was obtained by conserva­
tive treatment. A femoral arteriogram (Fig. 1) 
showed a blockage of the popliteal artery. 
After embolectomy using a Fogarty balloon 
catheter, his recovery was uneventful with the 
return of the pedal pulses. The interval be­
tween the onset of the embolism and opera­
tion was seven days. The postoperative femoral 
arteriogram was normal (Fig. 2). The source 
of his embolus could not be found.
Case 7.—J. D., a 67-year-old man, was ad­
mitted to hospital because of rest pain and 
intermittent claudication in his right leg of one 
month’s duration. Three months before he had 
had a myocardial infarction. One year pre­
viously he had had a femoropopliteal auto­
genous vein graft on his left leg with a suc­
cessful result and a similar operation had been 
performed on his right leg four months before 
his most recent admission. A month after the 
second operation he developed sudden pain in 
his right foot and symptoms of claudication; 
there was no pulsation in the femoral graft 
and his symptoms were attributed to graft 
closure.
A femoral arteriogram following admission 
showed a patent vein graft but there was seg­
mental occlusion of the popliteal artery for a 
distance of 4 cm. A lumbar sympathectomy 
was done and the popliteal artery was explored 
below the graft. An embolectomy was carried
Fig. 1.—Case 6. Preoperative femoral arterio­
gram showing complete obstruction above the 
knee with no distal arterial opacification.
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out utilizing a Fogarty balloon catheter, with 
return of the pedal pulses. The source of the 
embolus was intracardiac.
D isc u ssio n
Delayed embolectomy is receiving con­
siderable attention in the current medical 
literature.1, 2’ 0 8 Billig, Hallman and 
Cooley9 reported on 31 patients in whom 
embolectomy was performed more than 12 
hours after embolization. They noted that 
loss of neuromuscular function is an impor­
tant factor in prognosis irrespective of the 
length of delay. Successful embolectomy in 
these patients is explained by the hypothesis 
that clot extends into small inaccessible ar­
teries only after muscle necrosis has occur­
red. A clinical corollary is that a vigorous 
surgical attack on any embolized extremity, 
regardless of its duration, is warranted as 
long as muscle necrosis has not developed.4
In most instances emboli have an intra­
cardiac origin and the occurrence of acute
Fig. 2.—Case 6. Postoperative femoral arterio­
gram showing patent femoral vessel.
ischemia of a limb in a patient with atrial 
fibrillation constitutes the classical clinical 
presentation. In the presence of good col­
lateral vessels the severity of the ischemia 
is not so marked and clinical deterioration 
progresses gradually in a manner closely 
resembling that of progressive arterioscle­
rotic obliteration. Eventually rest pain and 
gangrene supervene in a substantial propor­
tion of cases.
The correct diagnosis depends largely 
upon clinical suspicion and the observation 
of localized occlusion on angiography in 
otherwise apparently normal vessels.
The introduction of the Fogarty balloon 
catheter technique of embolectomy has 
greatly simplified the surgical management 
of the condition. It is now possible to per­
form major embolectomies under local 
anesthesia in extremely ill patients whose 
likelihood of survival would otherwise be 
seriously compromised by the effects of 
toxic absorption and subsequent amputation.
Certain details of operative technique as­
sume critical importance when extensive 
clots have formed in the distal arterial tree. 
The femoral vessels are exposed through 
longitudinal incisions made directly over 
the occluded artery. The operative approach 
to the popliteal artery varies with the posi­
tion of the patient. In embolism of the popli­
teal bifurcation exposure is commonly ob­
tained through a below-knee incision placed 
near the medial edge of the tibia. Immedia­
tely following localization and isolation of 
the affected vessel heparin, 50 mg, is given 
intravenously and the embolus is removed 
by means of a Fogarty balloon catheter 
passed first to the distal and then to the 
proximal end of the vessel.
Following removal of the embolus some 
distal thrombi may be removed by digital 
compression of the muscle in the extremity. 
If there is no free back-bleeding a distal 
arteriotomy is made of the posterior tibial 
vessel and the intervening segment of the 
artery is flushed vigorously with saline solu­
tion. If the saline irrigation is ineffective, 
an endarterectomy stripper or catheter is 
introduced through the tibial vessel and 
passed upwards to the proximal arteriotomy 
site in order to dislodge and remove clot.
Embolectomy most often fails because of 
incomplete removal of distal thrombi. This
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occurs because clinical findings indicating 
residual thrombi are unreliable unless a 
pulse can be palpated at the ankle. Arte­
riography at the time of operation is the 
simplest and most reliable method of evalu­
ating patency of the distal arterial tree. It is 
performed by injecting sodium diatrizoate, 
10 to 15 ml of 50% solution, into the 
lower end of the distal arteriotomy. Com­
plete removal of the clot is confirmed by 
finding an arterial tree patent in the ankle.
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SECRETORY
PERFUSED
FUNCTION OF TOTALLY ISOLATED PORCINE STOMACH 
EX VIVO WITH HOMOLOGOUS BLOOD: EFFECT OF 
HISTAMINE*
K. KOWALEWSKI, Ph.D., M.D., F.A.C.P., F.R.C.P.jC], D. C. SECORD, D.V.M. and 
A. KOLODEJ, D.V.M., Edmonton, Alta,
Summary: The authors describe a method of 
isolation and ex vivo perfusion of the whole 
porcine stomach. The stomach was perfused 
extracorporeally with homologous blood of a 
supporting pig which served as a living oxygen­
ator and dialyzer. Histamine given by intra­
arterial infusion was used as a secretagogue. 
Samples of gastric juice and blood were col­
lected every 30 minutes during the perfusion 
period for analysis. All porcine stomachs se­
creted H + and pepsin. The results demonstrated 
that ex vivo porcine stomachs secreted about 
one-third of the volume and acid but about five 
times more pepsin than did canine stomachs in 
similar situations. This new experimental tool 
appears to be adequate for the study of gastric 
secretory function of the porcine stomach.
Resume: Les auteurs decrivent ici une methode 
permettant I'isolement et la perfusion ex vivo 
de I'estomac de pore entier. L'estomac a ete 
perfuse en dehors du corps par du sang homo- 
logue et un pore de soutien servant d'oxygena- 
teur et de dialyseur vivant. Comme secretago­
gue, on a utilise de I'histamine par voie intra- 
arterielle. Pendant ('experience, nous avons re- 
cueilli, toutes les 30 minutes, des echantillons 
de sue gastrique, aux fins d'analyse. Chez tous 
les pores ayant servi a I'experience, l'estomac a 
secrete H + et de la pepsine. II resulte de cette 
experience que l'estomac de pore ex vivo a 
secrete pres d'un tiers du volume de sue gas­
trique et d'acide, mais environ cinq fois plus 
de pepsine que I'estomac de chiens places 
dans des conditions similaires. Ce nouvel outil 
experimental semble convenir a I'etude de la 
fondation secretoire de l'estomac du pore.
Most available literature on the porcine 
stomach is concerned with spontaneous1'3 
and experimental 6'!' peptic ulcer. Despite 
the biomedical and economic importance of 
gastric ulcer in the pig and the apparent rela-
*From the Surgical-Medical Research Institute 
and Department of Surgery, The University of 
Alberta, Edmonton, Alta.
Reprint requests to: Dr. K. Kowalewski, Sur­
gical-Medical Research Institute, The University 
of Alberta, Edmonton, Alta. T6G 2H7.
tionship between gastric secretion and ulcer 
in a variety of animal species, little is known 
about gastric secretory function of the 
porcine stomach. In a series of pigs bearing 
a gastric fistula or Heidenhain pouch and 
used for the induction of experimental 
ulcers, only gastric HC1, chloride and pep­
sin were studied.6 Histamine-stimulated gas­
tric secretion of HC1 and pepsin were in­
vestigated in miniature swine bearing gastric 
fistulas.10 No information appears avail­
able regarding the effect of various humoral 
or cholinergic stimulants on gastric secretion 
of domestic swine.
We found previously that various aspects 
of gastric secretory function can be investi­
gated using a totally isolated canine stomach, 
perfused extracorporeally with homologous 
blood.1117 To our knowledge, no study 
of the totally isolated porcine stomach has 
ever been reported.
The present preliminary report describes 
a method of isolation and ex vivo perfusion 
of the whole stomach of domestic swine. 
We also present experimental evidence that 
the isolated porcine stomach may be used 
for the study of gastric secretory function.
Materials and Methods
Animals
For each perfusion experiment we used 
two pigs, one as the stomach donor, another 
as the “supporting animal”. “Supporting ani­
mal” means an anesthetized pig supplying 
oxygenated blood to the perfusion circuit. 
This pig served as a living oxygenator and 
a dialyzer. It supplied homologous blood by 
perfusion to the stomach of another pig. 
As in our studies on canine stomachs, the 
whole stomach of the donor animals was 
totally isolated for ex vivo homologous per­
fusion. Body weights of pigs used in this 
study varied from 28 to 32 kg. Before de­
scribing the surgical procedure and perfu­
sion system, we shall discuss briefly some 
aspects of the morphology of the pig 
stomach.
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Gastric Mucosa in the Pig
Topographic distribution of various re­
gions of mucosa in the porcine stomach is 
different from that observed in the canine 
stomach routinely used for experimental 
purposes. A small non-glandular esophageal 
region, absent in the dog, constitutes the 
first portion of the pig stomach. The non- 
glandular cardiac region, very small in the 
dog, is very large in the pig and occupies 
about half of the stomach. The region of 
fundic glands extends over half of the 
stomach of the dog, but occupies only about 
one-quarter of the pig stomach. Finally, the 
pyloric region, amounting to more than one- 
third of the canine stomach, represents only 
about one-quarter of the porcine stomach. 
In the pig, cardiac glands contain mucus- 
secreting cells, chief cells and gastrin-secret­
ing cells; the fundus glands contain both 
chief and parietal cells; the pyloric glands 
produce mucus and gastrin. Characteristic 
species differences of the pig stomach are:
Fig. 1.—Anatomy of the pig stomach, a =  
cardia; b =  fundus; c =  body; d to e — pyloric 
part, d =  pyloric antrum, e =  pyloric canal; 
f =  pyloric opening; g =  esophagus; h =  cranial 
part of duodenum; i =  greater curvature; k =  
lesser curvature. 1 =  gastric diverticulum; 1’ =  
spiral fold at base of gastric diverticulum; 2 =  
proventricular part of mucous membrane; 3 =  
cardiac gland region; 4 =  region of proper gas­
tric glands with high folds; 5 =  pyloric gland 
region; 6-6 — gastric groove; 7 =  pyloric
sphincter; 8 =  torus pyloricus; 9 =  major duo­
denal papilla with opening of bile duct. (Repro­
duced by permission from Nickel et alls.)
the presence of deep mucosal folds and of 
many lymph nodules in the cardia and the 
distribution of parietal cells of the fundus 
in clusters.18 Fig. 1 shows the stomach of 
the pig opened at the visceral surface.19
Perfusion System
Fig. 2 shows schematically the blood flow 
circuitry used in the present experiment. 
The perfusion chamber housing an ex vivo 
organ assures a precise control of tempera­
ture, humidity and pressure. Blood is deliv­
ered to the stomach with the help of an oc­
clusive roller pump.11’13' 15 Arterial blood 
flow rate can be arbitrarily raised by ad­
justing the pump speed selector, or it can 
be controlled automatically to deliver a 
constant, selected, arterial perfusion pres­
sure. The latter facility utilizes a feedback 
channel responding to the galvanometer 
voltage from an arterial pressure channel on 
a recorder. The height-adjustable reservoir 
receives venous outflow blood from the 
stomach. A second roller pump returns 
blood to the supporting animal11' 13 at a 
rate that is automatically controlled by 
photoelectric sensing of the blood level in 
a venous reservoir.20
A small amount of blood escaping from 
the perfused stomach is delivered by a third 
pump to the venous circuit. Priming volume 
of the entire flow circuit is about 400 ml.
Anesthesia
No preoperative medication was used. 
Each pig was anesthetized, after a 24-hour 
fast, with a mixture of halothane (Fluothane, 
Ayerst Laboratories, Montreal, Que.) and 
air, using a Fluotec Mark III anesthetic 
machine (Fraser, Sweatman Canada Ltd., 
Scarborough, Ont.). Anesthesia was induced 
directly by means of a face mask at a flow 
rate of 5 1/min and a halothane concen­
tration of 5% . Once surgical anesthesia 
was accomplished, the pig was placed supine 
and intubated with an inflatable cuffed 6- 
mm endotracheal tube which had been 
lengthened by the addition of a 10-cm sec­
tion of plastic tubing. A small stiff metal 
rod was inserted into the endotracheal tube 
to facilitate its introduction and then re­
moved. The tube was inflated, connected 
to the anesthetic machine and anesthesia
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maintained at a flow rate of 2 1/min and a 
concentration of 1%.
Stomach for Perfusion
During dissection of the donor stomach, 
we attempted not to handle it and limited 
our work essentially to the vascular system. 
The purpose of surgery was to mobilize the 
entire organ with preservation of all gastric 
vascular arcades intact. Because splenic 
vessels are located deeply in the splenic 
hilus, splenectomy appeared difficult to per­
form without serious damage to gastric 
branches. We therefore left the spleen at­
tached to the dissected stomach. Major 
steps of dissection were as follows: (a) 
laparotomy; (b) dissection of the major 
omentum; (c) isolation and removal of the 
small and large intestine, with exception of 
the cranial part of the duodenum, about 
5 cm distal to the pyloric sphincter; (d) 
total pancreatectomy; (e) bilateral thora­
cotomy through both crura of the diaphragm 
and central tendon; (f) isolation, ligation and
trans-section of the esophagus about 3 cm 
cranial to the cardia; (g) isolation of the por­
tal vein and dissection of the minor omen­
tum; (h) heparinization of the animal; (i) li­
gation and transection of the postceliac and 
preceliac aorta and of the portal vein; (j) re­
moval of the stomach with attached spleen; 
(k) weighing of dissected organs and can- 
nulation of the preceliac segment of the 
aorta and portal vein (these cannulas were 
later connected with the arterial and venous 
perfusion circuit [Fig. 2] when the stomach 
was placed in the chamber); (1) cannulation 
of the stomach through the pyloric sphinc­
ter; (m) placement of the stomach in the 
chamber. The transfer period, equivalent 
to the complete arrest of circulation and 
anoxia, lasted from eight to 10 minutes.
Supporting Pig
The anesthetized animal was connected 
with the perfusion circuit using the right 
carotid artery and vein cannulated with 
appropriate vinyl catheters. The right fem-
recorder
drug infusion pump gastric A.P 
gastric V.P 
pigs A.P.
gastric blood flow
compressed
thermostat @ -
manometer
heater =•—O -
water
reservoir
W
gastric secretion
Fig. 2.—Circuitry for ex vivo homologous perfusion of isolated whole porcine stomach. A sup­
porting pig supplies perfusion blood and serves as oxygenator and dialyzer.
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oral artery was cannulated with a poly­
ethylene tube which was connected to a 
transducer and blood pressure recorder. On 
completion of surgery the animal was 
heparinized and placed on its side, the op­
timal position for an anesthetized pig. As 
the supporting pig serves as an oxygenator 
and dialyzer of blood used for perfusion of 
the homologous stomach, it is carefully 
watched during the perfusion experiment: 
its respiration, blood pressure, temperature 
and blood gases are studied and recorded. 
Our experience with perfusion of canine 
stomachs indicates that deterioration of the 
supporting animal results in a rapid inhibi­
tion of secretory function of the isolated 
homologous stomach.
Perfusion
The stomach vasculature was connected 
with the perfusion circuit as explained above. 
The outlet of the intragastric cannula, se­
cured by a ligature around the duodenal 
sphincter, was conducted outside the cham­
ber. The chamber was closed and intermit­
tent positive respiratory-rate pressures (3 
to 8 mm Hg) were produced, using respira­
tory pumps. Venous reservoir height and 
pump volumes were adjusted to produce a 
pressure of 8 to 9 mm Hg in the portal vein. 
During the first 15 minutes of perfusion, the 
stomach, which was not washed after dis­
section, was permitted to drain spontane­
ously. Most of the pre-formed secretion was 
thereby evacuated. When circulation in the 
system was well stabilized and the stomach 
was emptied we began intra-arterial infu­
sion of a secretagogue.
Stimulation
Using various doses of histamine dihy­
drochloride infused into the gastric artery 
of the ex vivo canine stomach, we found 
that 150 pg/hr represented a dose inducing 
maximal output of HC1 in 30 minutes. We 
accepted this dose as maximal13, 14, 17 for 
the isolated canine stomach. We had no in­
formation regarding the response of the 
porcine stomach in vivo to a parenteral 
dosage of histamine and we first used 150 
/j,g/hr in our ex vivo experiments. We noted 
that with this dose the 30-min output of 
HC1 was much lower in the porcine than 
in the canine ex vivo stomach. In a prelimi­
nary study we used various doses of hista­
mine: 50, 150, 250 and 350 pg/hr, and we 
found that 150 pg/hr represented the maxi­
mal dose. Therefore we used 150 pg /h r of 
histamine dihydrochloride as the stimulant 
in the present study. The similarity of doses 
used in canine and porcine ex vivo stomachs 
facilitates comparison of secretory reactions 
of these two preparations with respect to 
their response to histamine.
Measurements
Arterial and venous blood from vessels 
of the isolated stomach was sampled every 
30 minutes. Arterial and portal venous 
pressure and arterial flow rate were moni­
tored. Arterial and venous Po2, Pco2, pH 
hemoglobin, hematocrit, bicarbonate, lactic 
and pyruvic acids, calcium, electrolytes15, 16 
and osmotic pressure were determined. Oxy­
gen consumption was calculated using ar­
terial flow rate, arteriovenous oxygen satur­
ation difference and hemoglobin.16 For de­
termination of H + concentration and pH of 
gastric secretion we used an automatic ti- 
trator (Radiometer, model TTTI); total H 
titrable to pH 7 was measured. Pepsin, elec­
trolytes and osmotic pressure of gastric con­
tent were also analyzed. Analytical tech­
niques and instruments used for these meas­
urements have been previously described. 
12-16 For calculation of significance we used 
Student’s t test.
Results
Perfused Stomachs
Seven stomachs were perfused for six to 
nine hours. During perfusion the behaviour 
of the stomachs was observed through the 
plexiglass windows of the chamber; coloura­
tion, state of vessels and mobility were 
periodically noted and recorded. No changes 
in colouration of the serosa and no conges­
tion was noted in these stomachs, nor was 
any macroscopic damage of mucosa ob­
served at the end of perfusion. This sug­
gested that porcine stomachs tolerated well 
ex vivo perfusion. Canine stomachs are less 
resistant and, in about 10% of cases, show 
severe congestion and mucosal bleeding after 
seven to nine hours of perfusion. Contrac­
tions were observed and counted. For the 
first two to three hours they were hardly 
noticeable and occurred about six to seven
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times per minute. After this period regular 
contractions of four to five per minute con­
tinued throughout the experiment. Weight 
of the stomach and spleen preparation aver­
aged 551 g before perfusion and 571 g 
after perfusion. Change in weight during 
perfusion varied from -4 %  to + 6 % .  
Change in the canine stomach always ranged 
between +  8% and + 1 2 %  and was con­
sidered due to marked edema. Only slight 
edema of the pyloric portion of the porcine 
stomach was observed after nine hours of 
perfusion.
Secretion
All ex vivo porcine stomachs secreted 
HC1 and pepsin during histamine infusion. 
However, the first two to four 30-minute 
samples contained alkaline juice and H + 
appeared only in later samples. A progres­
sive rise of H + continued for three to four 
hours and reached a plateau after four to 
five hours of perfusion. Table I shows the 
measurements of various components of 
gastric secretion. Because the “O” values 
were included in the calculation of H + out­
put, this was low. However, the concentra­
tions of H + were also low compared with 
those found in other animals. Interesting 
findings were the high output and concen­
tration of pepsin. Table II and Fig. 3 
show the difference between the pig and dog 
regarding secretion of HC1 and pepsin by 
ex vivo gastric preparations.
As mentioned above, all stomachs studied 
secreted HC1. In one case, not included in
TABLE I.—M easurements in Gastric Juice 
During the Perfusion of e x  vivo Porcine 
Stomachs with Homologous Blood and Conti­
nuous Stimulation with 150 mg /hr of H istamine 
D ihydrochloride, Infused into Gastric Artery
Average Range
No. of 30-minute
collections 82
Volume (ml/30 min) 16 0.5-46
HC1 (mEq/30 min) 1.2 0-5.19
HC1 (mEq/1) 59 0-121
Pepsin (mg/30 min) 147 6-434
Pepsin (mg/ml) 9.1 2.7-22.5
Na+ (mEq/1) 68 10-145
K+ (mEq/1) 10 4.5-26
Cl-  (mEq/1) 139 108-166
H C03 (mEq/1) 4 0-26
Osmotic pressure
(mOsm/kg) 277 211-311
this series, we lost the supporting pig before 
its connection to the perfusion circuit. The 
isolated stomach remained in normothermic 
total anoxia for 65 minutes, which was the 
time necessary to find another pig and pre­
pare it for perfusion. We perfused this 
“anoxic stomach” without too much hope 
for the usual response to histamine. After 
four hours of secretion of alkaline juice, this 
stomach started to secrete titrable H + and
TABLE II.—Measurements in Perfusion 
Blood* During P erfusion of e x  vivo Porcine 
Stomach with H omologous Blood. Same Stom­
achs as in T able I
Average Range
pH (a) 7.41 7.31-7.61
pH (v) 7.38 7.19-7.53
Hb (g/100 ml) (v) 9.0 6.7-10.6
Hct (%) (v) 28 21-35
Po2 (mm Hg) (a) 94 36-165
Po2 (mm Hg) (v) 49 22-63
Pco2 (mm Hg) (a) 41 19-46
Pco2 (mm Hg) (v) 40 20-45
Na+ (mEq/1) (v) 137 130-146
K+ (mEq/1) (v) 3.9 3.0-5.4
Cl“ (mEq/1) (v) 106 100-111
Ca++ (mEq/1) (v) 4.8 4.4-6.0
HCO3 (mEq/1) (a) 19 10-26
HCO3 (mEq/1) (v) 19 10-27
Lactic acid (mg/100) (a) 18 10-50
Lactic acid (mg/100) (v) 
Pyruvic acid
22 14-45
(mg/100 ml) (a) 
Pyruvic acid
0.9 0.4-1.4
(mg/100 ml) (v) 
Osmotic pressure
1.1 0.6-1.9
(mOsm/kg) (v) 
0 2 consumption
304 293-327
(ml/min/stomach) 
Arterial blood flow
3.8 0.7-7.5
(ml/min /stomach) 100 60-120
*Blood sanSple from gastric vein (v) or artery (a).
TABLE III.—Volume, HC1 and Pepsin in the 
Secretion of Porcine and Canine e x  vivo 
Stomachs. Stimulated with 150 mg/ hr of H ista­
mine, Infused into Gastric Artery
Pig Dog* P
No. of 30-minute 
collections 82 100
Volume (ml) 16 36 <0.05
HC1 (mEq/30 min)
(0.5-46)
1.2
(2-78)
5.2 <0.01
HC1 (mEq/1)
(0-5.2)
59
(0.5-8.8)
119 <0.01
Pepsin (mg/30 min)
(0-121)
147
v.8-168)
31 <0.01
Pepsin (mg/ml)
(6-434)
9.1
(6-73)
1.2 <0.01
(2.7-22.5) (0.1-2.21
*These 30-minute collections were taken, at random, 
from our experimental protocols on ex vivo canine 
stomachs. Some of these results were included in 
previous publications.12- IS-23-2,i
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continued to do so for the remaining three 
hours. This appears to be an interesting 
example of temporary functional damage 
to the parietal cell. The delayed response of 
isolated stomachs to a secretagogue was 
observed in our experiments with ex vivo 
canine stomachs under various conditions of 
prolonged preservation.21’ 22 These studies 
as well as the experiment quoted above 
demonstrate the possibility of recovery of 
the parietal cell after temporary inhibition of 
its function.
Perfusion Blood
The composition of perfusion blood used 
in this study is given in Table III. There 
were no marked differences between porcine 
blood and canine blood, analyzed during
perfusion of the ex vivo stomach. Some com­
ponents of blood showed a very wide range 
of values, but this was also observed in 
studies of canine blood14' 16, 23 and we were 
unable to correlate such range differences 
with changes in gastric secretion. Certain 
basic requirements in the composition of 
perfusion fluid are conditio sine qua non of 
every successful organ perfusion24 and these 
were carefully observed in our experiments. 
Perfusion of an organ with the blood of a 
living supporting animal depends upon many 
factors affecting both the composition and 
circulatory dynamics of this animal. As long 
as the supporting animal appears clinically 
normal, its blood is probably satisfactory 
as a perfusate of homologous isolated 
stomach. In the present study the supporting 
pig always survived the perfusion and after
HOURS 0 2 4 6 8 0 2 4 6 8
Fig. 3.—Comparison of the canine and porcine ex vivo stomach response to histamine infused into 
the gastric artery.
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a few weeks of rest was used for another 
study.
D iscussion
The results of experiments presented here 
provide baseline information concerning the 
use of the totally isolated whole porcine 
stomach for study of gastric secretion. This 
preliminary report shows that the stomach 
of the domestic pig can be isolated and ex 
vivo perfused with the blood of another pig. 
During such homologous perfusion the ex 
vivo stomach can be stimulated by infusion 
of histamine into the gastric artery. We 
found that all stomachs used secreted H + 
and pepsin during infusion of histamine. We 
also noted some interesting differences in 
the ex vivo secretion of HC1 and pepsin be­
tween porcine and canine stomachs. With 
maximal stimulation of the canine ex vivo 
stomach by histamine, H + appears not later 
than 30 minutes after the initiation of in­
fusion and, in 90% of cases, is present in 
the first 30-minute sample. In the porcine 
stomach the first two to four 30-minute 
samples to not contain titrable H + and then 
we observe a slow rise in H +.
It appears from the available literature 
that the concentration of gastric acid in pigs 
is lower than in other animals. In a study of 
young pigs (average body weight 15 lbs) the 
concentration of free HC1 in samples col­
lected three hours after feeding averaged 22 
mEq/1.6 In another study, domestic pigs 
(body weight ranging from 10 to 37 kg) 
received an intramuscular deposition of 
histamine in oil. The dose used was ulcero­
genic in 76% of animals. The highest con­
centration of free HC1 observed in this series 
was 108 mEq/1 and average values ranged 
from 31 to 66 mEq/1.8 Intravenous infusion 
of histamine was used as a stimulant of 
gastric secretion in miniature pigs (body 
weight from 5 to 22 kg). With a dose of 
histamine considered maximal, the highest 
concentration of free HC1 observed was 
125 mEq/1.10 In these three studies8' 10 
gastric juice was collected from a simple 
fistula in non-anesthetized animals.
In the canine ex vivo stomach a concentra­
tion of 160 mEq/1 is not unusual after hista­
mine infusion. In the porcine stomach, 
both concentration and output of H + were 
much lower than in the canine stomach per­
fused under identical conditions. Output of 
free HC1 in vivo in miniature pigs stimulated 
by the maximal dose of histamine averaged 
1.40 m Eq/kg/hr.10 This is a much higher 
output than the one observed in the present 
experiment on ex vivo stomachs of domestic 
pigs. One should be reminded, however, 
that we use a totally denervated stomach. 
The enhancing role of the vagus nerve on 
histamine-induced gastric secretion is well 
known, particularly from the studies on 
cholinergic potentiation, also demonstrated 
in the canine ex vivo stomach.13 Low out­
put of HC1 in the ex vivo porcine stomach 
is probably due, in part, to the absence of 
vagal tone. Another important cause of low 
H + concentration and output may be the 
neutralizing effect of alkaline secretion pro­
duced by the large cardiac mucosa and by 
the pyloric part of the porcine stomach.
As explained above, the acid-secreting 
area of the canine stomach occupies about 
50% of gastric mucosa, but only about 25% 
of the porcine mucosa contains parietal 
cells. The contribution of the non-acid- 
secreting segments of the mucosa to the 
volume of secretion in the pig stomach is 
not known. In the future we will study this 
problem in porcine gastric pouches.
Another interesting difference between ex 
vivo canine and porcine stomachs is the out­
put and concentration of pepsin which is 
much higher in pigs than in dogs (Table II). 
It was observed previously that histamine is 
a strong stimulant of pepsin secretion in 
pigs, as it is in rodents and primates.10 It 
is also known that histamine is a poor stimu­
lant of pepsin in dogs and this was con­
firmed in our ex vivo studies.25' 26 It is 
worth mentioning again that the pepsin- 
secreting area of the porcine stomach is 
much larger than that of the canine stomach; 
in pigs both the cardiac region (deprived of 
parietal cells) and fundus contain chief cells 
and these areas correspond to three-quarters 
of the gastric mucosa. In dogs only the fun­
dus, or about one-half of the gastric mucosa, 
secretes pepsin. Whether this anatomical 
peculiarity of porcine stomachs affects the 
secretion of pepsin quantitatively has yet to 
be investigated.
This study was supported by a grant from the 
Alberta Agricultural Research Trust. Mr. A. 
Todd, Mr. T. Germaine and Mrs. M. McCubbin 
are thanked for their valuable technical assistance.
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B O O K  R E V I E W S
ACUTE URETERIC OBSTRUCTION. A 
Clinical and Radiological Study. P. M. Bret- 
land. 219 pp. Illust. Butterworth & Co. Can­
ada Ltd., Toronto; Butterworth & Co. (Pub­
lishers) Ltd., London, 1972. $20.25.
This book deals with the problem of acute 
ureteric obstruction based on the clinical and 
radiological findings in 150 patients. The author 
points out that some of the observed phenom­
ena are not in accord with the conventional 
theory of this subject.
The discussion of renal anatomy and phy­
siology is adequate to introduce the casual 
reader to this subject but the student of renal 
physiology will find it deficient in many areas. 
The account of the experimental work on the 
pathophysiology of acute ureteric obstruction 
is extensive and includes references to authors 
whose investigations were done in the early 
part of this century. A good deal of space is 
devoted to ureteral function, particularly 
pressure studies conducted by Narath, Risholm, 
Kiil, and others. This portion of the book is 
very informative. Several chapters are con­
cerned with the explanation of the radio­
logical findings in ureteric obstruction and 
compare these in chronic and acute obstruc­
tion. Readers will have a better understanding 
of the use of the intravenous pyelogram and 
in what clinical situations it is warranted.
The book is primarily a review of the 
literature related to obstructed renal function. 
No new clinical experimental evidence is 
presented but the continuing problems are 
indicated. The author offers a few guidelines 
for future research in the areas of vascular, 
tubular, and ureteric pressure and flow studies.
This book is well presented and written and 
contains a wealth of information and observa­
tions on the kidney and ureter. It should be 
of interest to nephrologists, urologists, and 
radiologists and those who are training in 
these specalties.
L. A. LeBoldus
Winnipeg Clinic,
Winnipeg, Man.
ATLAS OF HAND SURGERY. Robert A. 
Chase. 438 pp. Illust. W. B. Saunders Com­
pany, Philadelphia; W. B. Saunders Com­
pany Canada Limited, Toronto, 1973. 
$3(K90.
This atlas is an excellent textbook because of 
its concise elucidation of basic principles, the 
clear diagrams, and its extensive scope. A 
minor criticism would be the absence of an 
account of the anatomy of ligaments and liga­
mentous injuries to the joints of the hand. The 
sections on skin grafting, island pedicle grafts
and amputation of fingers are extremely well 
done. It is refreshing to see a section on 
rheumatoid arthritis with discussion of resec- « 
tion and replacement arthroplasty.
This volume is recommended as a basic -< 
textbook for anyone who is called upon to 
perform hand surgery.
J. F. Schweigel
Division of Orthopaedics,
University of British Columbia, br
Vancouver, B.C.
FLEXIBLE IMPLANT RESECTION AR­
THROPLASTY IN THE HAND AND  
EXTREMITIES. Alfred B. Swanson. 352 
pp. Illust. The C. V. Mosby Company, St. 
Louis, 1973. $39.40.
The author, a pioneer in the development of 
flexible silicone rubber implants, has writ­
ten an exciting, readable, surprisingly compre­
hensive book covering many aspects of his 
subject. It describes a wide variety of silicone 
implants, both experimental and in current 
use. The major emphasis, however, is on the 
place of implants in surgery of the rheumatoid 
hand.
The initial chapter deals with evolution of 
implant surgery—the development of bioengi­
neering testing devices and the step-by-step 
improvement in design of the intramedullary 
finger prostheses from 1964 to 1969. The 1969 
model design, for example, has increased the 
flex life of the former implants which averaged 
124 million flexion-extension movements be­
fore cracks were noted in the material. Cur­
rent clinical experience with these implants 
is discussed in some detail. Other chapters dis­
cuss effectively such matters as pathogenesis 
of arthritic lesions, pathologic mechanisms of 
hand deformities in rheumatoid arthritis, dis­
ability evaluation and operative considerations, 
in implant arthroplasty. The excellent illustra­
tions and clear diagrammatic representations 
clarify the text.
One would have liked to see emphasis 
on the advantages of a close-working 
relationship between the rheumatologist and 
surgeon. Surgery in the rheumatoid patient 
should not be an isolated event and a com­
bined approach facilitates overall management. 
Dr. Swanson states that most patients can be 
managed by the surgeon alone, though in an­
other context he indicates that the trained 
therapist can complement the work of the 
surgeon. Rheumatologists working closely in a 
team situation would heartily endorse the 
trained therapists’ contribution to successful 
rehabilitation.
There is an interesting discussion of the 
functional results of hand surgery. Unfortun-
A
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ately, methods of meaningful preoperative and 
postoperative functional appraisal are not yet 
adequate. In the 'two studies quoted, results 
are based on such matters as joint range, pinch 
strength and grasp strength, but not on actual 
objective time-tested functional tasks. These 
will be applied, we are told, in the future. 
Questions as to the precise functional benefits 
of implant surgery, its results as compared 
with metacarpophalangeal excisional arthro­
plasty, and the in vitro life expectancy of im­
plants, for example, are still incompletely 
answered. Functional testing is an area where 
the specialized occupational therapist can play 
an effective, objective third-party role.
The problems facing the anesthetist and 
surgeon are reviewed in some detail. One pre­
caution omitted is the need to rule out atlan­
toaxial subluxation in the rheumatoid subject 
by lateral cervical radiographs in flexion be­
cause the high incidence of this complication 
represents a special hazard to the integrity of 
the cervical cord. Foreknowledge of this con­
dition is critical to the anesthetist and surgeon.
In summary, despite some omissions and 
lack of emphasis on some details, the book 
provides a wealth of interesting information. 
While directed to the surgeon, both the rheu­
matologist and specialist therapist will find 
this volume of great interest.
H. S. Robinson
Canadian Arthritis and Rheumatism Society. 
British Columbia Division,
Vancouver, B.C.
ORGAN PRESERVATION. A Symposium 
Held at the Clinical Research Centre, North- 
wick Park Hospital, Harrow. Edited by 
David E. Pegg. 286 pp. Illust. Churchill 
Livingstone, Edinburgh; Longman Canada 
Limited, Toronto, 1973. $18.00.
To those interested in organ preservation, the 
importance of this book is that it presents a 
comprehensive review of progress made on the 
European continent up to November 1972. It 
brings together some consensus of opinion in 
renal preservation, with lesser emphasis on 
liver and heart preservation. Current methods 
for perfusion, non-perfusion, cold storage and 
prediction of organ viability before trans­
plantation are clarified and assessed.
Defects in even the best experimental 
studies include non-standardized models, inter­
species extrapolation, unclear definitions of ac­
ceptable organ function and a paucity of 
clinically-tested experimental data. The main 
obstacles to successful preservation continue to 
be warm ischemia and donor deterioration. 
Short-term preservation of organs harvested 
in good condition appears to be most easily 
achieved by use of washout solutions which 
manipulate the extracellular environment and 
simultaneously cool the organ. Necessity for
preservation periods in excess of 24 hours or 
the presence of sub-optimal harvest conditions 
appears to demand some form of perfusion 
technique which attempts to supply substrate 
for the reversal of cellular damage. Currently, 
renal preservation for more than 24 hours is 
best accomplished by perfusion, but there are 
still unsolved problems in hardware design, 
perfusate composition, acceptable perfusion 
parameters and the role of hyperbaric condi­
tions. Studies of cellular metabolism have pro­
duced some ingenious new approaches to the 
prediction of organ viability but their applica­
tion has been hampered by a lack of clinical 
testing.
This book is of interest mainly to specialists 
and suffers from the usual lack of cohesiveness 
seen in multiple-author symposia. It neverthe­
less offers good value as a reference for hard 
data and current bibliography in organ preser­
vation. In addition, it provides stimulating sug­
gestions for the researcher in quest of unsolved 
problems.
C. E. Bayliss
Department of Surgery,
Toronto Western Hospital,
Toronto, Ont.
THE PALMAR FASCIA. H. Graham Stack. 
236 pp. Illust. Churchill Livingstone, Edin­
burgh; Longman Canada Limited, Toronto, 
1973. $29.00.
This is a unique book and is highly recom­
mended to those interested in both the ana­
tomy and surgery of the hand. The author 
has been successful in attaining the goal that 
he has set out to achieve. He presents “an 
overall view of the problem based on an ana­
tomical study with a strong surgical viewpoint”.
A full account of the author’s anatomical 
studies is included and is accompanied by 
superb reproductions of the cross-sections of 
fetal hands that the author studied in Lands- 
mere’s laboratory. Two chapters are devoted to 
the clinical features and treatment of Dupuy- 
tren’s contracture; this alone is worth the 
modest cost of the book.
Any serious student of the hand will treasure 
this volume.
R. M. McFarlane
Plastic and Reconstructive Surgery,
University of Western Ontario,
London, Ont.
POSTOPERATIVE DISORDERS OF THE 
GASTROINTESTINAL TRACT. Hastings 
K. Wright and M. David Tilson. 204 pp. 
Illust. Grune & Stratton, Inc., New York: 
Longman Canada Limited, Toronto, 1973. 
$16.75.
According to the authors this book was written 
as a partial answer to the surgical residents’
when shock 
threatens 
the lung
Abstract visualization of lung tissue
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lysosome and 
cell membranes, 
thereby preventing 
the release of destruc­
tive lysosomal enzymes3
• preserves platelets 
thereby reducing the risk
of intravascular coagulation1
• preserves leukocyte in­
tegrity thereby helping to main­
tain the pulmonary architecture1
Solu-Medroi
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pulmonary 
damage 
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The recovery of patients in shock 
is often complicated by a pattern of 
deteriorating pulmonary function.
This pulmonary insufficiency pro­
gresses despite restoration of haemo­
dynamic balance and apparent stabili­
zation of the acute episode.
Under conditions of prolonged shock, 
lack of oxygen at the cellu lar level 
causes alterations in the oxygen-carbon 
dioxide exchange mechanism . These  
changes in cell metabolism lead ultimately 
to interstitial oedema and perivascular 
haemorrhage.1 Polym orphonuclear leuko­
cytes aggregate in the pulmonary capillaries 
and obstruct the pulmonary vascular bed. 
As these trapped cells break down, they 
release lysosomes, tiny subcellular par­
ticles containing proteolytic enzym es.1 
These enzymes attack their host cell and 
go on to dapiage or destroy other cells.2 
The resulting tissue damage may not 
readily repair itself even if the shock 
patient survives.
When administered in conjunction 
with standard therapeutic measures, 
Solu-Medrol exerts a protective 
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In the treatment 
of shock and its 
pulmonary 
complications
Soiu-Medroi
soon enough, 
often enough, 
in pharmacologic 
doses
Dosage and Administration:
In treating severe shock, there is a tendency 
in current medical practice to use massive 
(pharmacologic) doses of corticosteroids. (The 
anti-inflammatory activity of 1 mg of Solu- 
Medrol is equal to 4 mg or more of hydrocor­
tisone.)
The suggested dosage of Solu-Medrol for se­
vere shock is 30 mg/kg stat and repeated in 
four hours, if necessary.
Therapy is initiated by administering Solu- 
Medrol intravenously over a period of at least 
ten minutes. In general, therapy should be con­
tinued only until the patient’s condition has 
stabilized-usually not beyond 48 to 72 hours. 
Solu-Medrol may be given by intravenous in­
jection, by intravenous infusion, or by intra­
muscular injection. The preferred method for 
initial emergency use is intravenous injection.
Cautions: The general precautions and con­
traindications to systemic corticosteroid ther­
apy should apply to the use of Solu-Medrol. 
However, when used for medical emergencies, 
or in shock-like states, the possible lifesaving 
effects must be weighed against the possible 
undesired hormonal effects. In the treatment 
of shock, Solu-Medrol should be adjunctive to 
conventional supportive therapy such as fluid 
replacement, etc. Although adverse effects 
associated with high-dose short-term corti- 
coid therapy are uncommon, peptic ulceration 
may occur.
Supplied: In Mix-O-Vials containing Medrol 
(as methylprednisolone sodium succinate),40 
mg, 125 mg, 500 mg, and 1 g vials with water 
for injection.
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lament, “Why did everything eventually go 
wrong when the operation went so well?”. 
They have produced a work which will be 
warmly welcomed by all with an interest in 
gastroenterology and with enthusiasm by the 
practising surgeon.
The book is divided into three sections 
headed, respectively: postgastrectomy com­
plications, malfunction of the small intestine 
after surgery, and disorders of function after 
colon surgery. Each section is introduced by 
a review of the normal physiology and func­
tion, and in succeeding chapters the way in 
which surgery may disturb function is dis­
cussed.
In the first section there is a detailed review 
of the motor and secretory functions of the 
stomach together with the pathophysiology of 
peptic ulceration. Interspersed in this section 
are interesting items of information on the 
reduction in intestinal inhibition of gastric 
secretion following truncal vagotomy and the 
role of serotonin and enterogastrone in intes­
tinal inhibition of gastic secretion. There is an 
intriguing hypothesis about gastric ulcer pa­
tients— those with raised serum gastrin levels 
are likely to have either structural or func­
tional obstruction to gastric emptying and re­
quire relief of obstruction, while in the rest 
abolition of secretion only may be sufficient.
In the sections that follow the causes ... 
early and late sequelae of gastric surgery and 
vagotomy are discussed with recommendations 
on the best way to recognize and manage these 
problems.
Probably the most impressive section, and 
the longest, is that dealing with malfunction of 
the small intestine following surgery. A  mas­
terly review of the modern concepts of the 
mechanism of digestion and absorption from 
the small intestine is followed by a detailed 
account of how these mechanisms become de­
ranged by surgical procedures. Of more than 
passing interest to all concerned in patient 
management will be the findings that transport 
sites for vitamin B12 may develop in the 
proximal remnant of intestine following resec­
tion of ileum; that a jejunal remnant may de­
velop the capacity actively to transport con­
jugated bile salts; that the ileum and color, 
have the capacity to assume the work-’oac 
formerly subserved by the jejunum; and the 
observation that both gastric emptying and 
intestinal propagation are accelerated after 
distal but not proximal resection of small 
bowel.
A  section is devoted to the metabolic prob­
lems resulting from massive resections of the 
small bowel and this is followed by a lengthy 
account of the care of such patients. There 
are useful hints about the manipulation of 
the digestive/absorptive mechanisms in the 
remaining small bowel to promote adequate 
caloric intake, and the optimal time for wean-
(Continued on page 354)
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